Banzai International (BNZI) S-124 Sep 24IPO registrationFinancial data

Company Profile

Cover

Cover	6 Months Ended
Cover	Jun. 30, 2024
Entity Addresses [Line Items]
Document Type	S-1
Amendment Flag	false
Entity Registrant Name	Banzai International, Inc.
Entity Central Index Key	0001826011
Entity Primary SIC Number	7372
Entity Tax Identification Number	85-3118980
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	435 Ericksen Ave
Entity Address, Address Line Two	Suite 250
Entity Address, City or Town	Bainbridge Island
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98110
City Area Code	206
Local Phone Number	414-1777
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Business Contact [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	435 Ericksen Ave
Entity Address, Address Line Two	Suite 250
Entity Address, City or Town	Bainbridge Island
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98110
City Area Code	206
Local Phone Number	414-1777
Contact Personnel Name	Joseph Davy

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 471,747	$ 2,093,718	$ 1,023,499
Accounts receivable		110,797	176,276
Less: Allowance for credit losses		(5,748)	(107,860)
Accounts receivable, net	26,161	105,049	68,416
Prepaid expenses and other current assets	1,080,936	741,155	333,507
Total current assets	1,578,844	2,939,922	1,425,422
Property and equipment, net	1,819	4,644	11,803
Goodwill	2,171,526	2,171,526	2,171,526
Operating lease right-of-use assets	46,434	134,013	307,258
Deferred offering costs			1,524,934
Other assets	38,381	38,381	38,381
Total assets	3,837,004	5,288,486	5,479,324
Current liabilities:
Accounts payable	9,429,803	6,439,863	1,100,249
Accrued expenses and other current liabilities	4,264,028	5,194,240	745,373
Bifurcated embedded derivative liabilities	0	0
Deferred underwriting fees	4,000,000	4,000,000
Deferred fee		500,000
Earnout liability	37,125	59,399	289,099
Due to related party	67,118	67,118
GEM commitment fee liability		2,000,000
Deferred revenue	1,322,238	1,214,096	930,436
Operating lease liabilities, current	81,708	234,043	284,963
Total current liabilities	35,610,924	37,089,615	29,284,339
Operating lease liabilities, non-current			234,043
Other long-term liabilities	75,000	75,000	75,000
Total liabilities	35,685,924	37,164,615	29,593,382
Commitments and contingencies (Note 17)
Stockholders’ deficit:
Common stock, value	300	259	394
Preferred stock, value
Additional paid-in capital	23,582,484	14,889,936	8,245,610
Accumulated deficit	(55,431,704)	(46,766,324)	(32,360,062)
Total stockholders’ deficit	(31,848,920)	(31,876,129)	(24,114,058)
Total liabilities and stockholders’ deficit	3,837,004	5,288,486	5,479,324
Nonrelated Party [Member]
Current liabilities:
Simple agreement for future equity			663,804
Convertible notes	3,530,571	2,693,841
Bifurcated embedded derivative liabilities			845,473
Notes payable	7,088,209	6,659,787	6,494,051
Warrant liability	79,000	641,000
Related Party [Member]
Current liabilities:
Simple agreement for future equity			8,802,196
Convertible notes		2,540,091	3,506,508
Bifurcated embedded derivative liabilities			1,936,827
Notes payable	3,468,124	2,505,137
Warrant liability	230,000	575,000
Yorkville [Member]
Current liabilities:
Convertible notes	$ 2,013,000	1,766,000	1,408,826
CPBF Lending LLC [Member]
Current liabilities:
Convertible notes		$ 2,693,841	$ 2,276,534

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Allowance for credit losses	$ 6,713	$ 5,748
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	275,000,000	275,000,000	275,000,000
Common stock, shares issued	3,003,810	2,585,296	3,935,892
Common stock, shares outstanding	3,003,810	2,585,296	3,935,892
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, par authorized	75,000,000	75,000,000	75,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common Class A [Member]
Common stock, shares authorized	25,000,000	250,000,000	250,000,000
Common stock, shares issued	692,676	274,162	51,219
Common stock, shares outstanding	692,676	274,162	51,219
Common Class B [Member]
Common stock, shares authorized	25,000,000	25,000,000	25,000,000
Common stock, shares issued	2,311,134	2,311,134	3,884,673
Common stock, shares outstanding	2,311,134	2,311,134	3,884,673

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Condensed Consolidated Statements of Operations - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Operating income:
Revenue	$ 1,068,197	$ 1,193,321	$ 2,147,669	$ 2,370,382	$ 4,561,300	$ 5,332,979
Cost of revenue	330,008	379,294	711,388	791,520	1,444,618	1,956,964
Gross profit	738,189	814,027	1,436,281	1,578,862	3,116,682	3,376,015
Operating expenses:
General and administrative expenses	4,319,014	2,929,150	8,627,943	6,099,213	12,905,073	9,275,251
Depreciation expense	1,261	1,621	2,825	4,025	7,160	9,588
Impairment loss on operating lease						303,327
Total operating expenses	4,320,275	2,930,771	8,630,768	6,103,238	12,912,233	9,588,166
Operating loss	(3,582,086)	(2,116,744)	(7,194,487)	(4,524,376)	(9,795,551)	(6,212,151)
Other expenses (income):
GEM settlement fee expense			200,000
Other expense (income), net	64,145	(22,145)	60,027	(84,683)	(62,985)	(150,692)
SEPA commitment fee and deferred fee expense					3,826,176
GEM warrant expense					2,448,000
GEM commitment fee expense					2,000,000
Interest income			(10)	(111)	(813)
Loss on extinguishment of debt			(527,980)			56,653
Loss on debt issuance			171,000
Change in fair value of convertible promissory notes	34,000		578,000		(34,000)
Yorkville prepayment premium expense	80,760		80,760
Total other expenses (income), net	576,398	1,356,837	1,465,202	2,711,050	4,610,711	9,256,351
Loss before income taxes	(4,158,484)	(3,473,581)	(8,659,689)	(7,235,426)	(14,406,262)	(15,468,502)
Provision for income taxes	6,624	12,472	5,691	15,749
Net loss	$ (4,165,108)	$ (3,486,053)	$ (8,665,380)	$ (7,251,175)	$ (14,406,262)	$ (15,468,502)
Net loss per share Basic	$ (7.69)	$ (26.98)	$ (19.50)	$ (56.16)	$ (105.10)	$ (111.83)
Net loss per share Diluted	$ (7.69)	$ (26.98)	$ (19.50)	$ (56.16)	$ (105.10)	$ (111.83)
Weighted average common shares outstanding Basic	541,836	129,193	444,474	129,127	137,074	128,822
Weighted average common shares outstanding Diluted	541,836	129,193	444,474	129,127	137,074	128,822
Nonrelated Party [Member]
Other expenses (income):
Loss on modification of simple agreement for future equity						$ 120,826
Interest expense	$ 396,019	$ 521,420	847,418	$ 1,059,298	2,631,060	1,651,141
Change in fair value of warrant liability	(154,000)		(562,000)		(1,807,000)
Change in fair value of simple agreement for future equity		68,582		91,443	(207,570)	307,569
Change in fair value of bifurcated embedded derivative liabilities		(194,643)		(162,228)	(1,404,863)	254,443
Related Party [Member]
Other expenses (income):
Loss on modification of simple agreement for future equity						1,602,174
Interest expense	385,474	552,403	962,987	935,687	2,923,414	728,949
Change in fair value of warrant liability	(230,000)		(345,000)		115,000
Change in fair value of simple agreement for future equity		909,418		1,212,557	(2,752,430)	4,078,431
Change in fair value of bifurcated embedded derivative liabilities		$ (478,198)		$ (340,913)	$ (3,063,278)	$ 606,857

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Deficit - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series A Preferred Stock [Member] Related Party [Member]	Preferred Stock [Member] Series A Preferred Stock [Member] Yorkville [Member]	Preferred Stock [Member] Series A Preferred Stock [Member] Gem [Member]	Preferred Stock [Member] Series A Preferred Stock [Member] Nonrelated Party [Member]	Common Stock [Member]	Common Stock [Member] Related Party [Member]	Common Stock [Member] Yorkville [Member]	Common Stock [Member] Gem [Member]	Common Stock [Member] Nonrelated Party [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Related Party [Member]	Additional Paid-in Capital [Member] Yorkville [Member]	Additional Paid-in Capital [Member] Gem [Member]	Additional Paid-in Capital [Member] Nonrelated Party [Member]	Retained Earnings [Member]	Retained Earnings [Member] Related Party [Member]	Retained Earnings [Member] Yorkville [Member]	Retained Earnings [Member] Gem [Member]	Retained Earnings [Member] Nonrelated Party [Member]	Total	Related Party [Member]	Yorkville [Member]	Gem [Member]	Nonrelated Party [Member]
Balance at Dec. 31, 2021	$ 6,318,491					$ 636					$ 1,151,525					$ (16,891,560)					$ (9,420,908)
Balance, shares at Dec. 31, 2021	2,328,823					6,359,139
Stock-based compensation											770,336										770,336
Net loss																(15,468,502)					(15,468,502)
Exercise of stock options											5,016										$ 5,016
Exercise of stock options, shares						171															171
Retroactive application of recapitalization	$ (6,318,491)					$ (242)					6,318,737
Retroactive application of recapitalization, shares	(2,328,823)					(2,421,780)
Adjusted balance, beginning of period						$ 394					7,470,258					(16,891,560)					(9,420,908)
Adjusted balance, beginning of period, shares						3,937,359
Repurchase of shares in High Attendance sale
Repurchase of shares in High Attendance sale, shares						(1,638)
Conversion of simple agreement for future equity-related party
Modification of convertible notes payable-related party
Shares issued under share transfer agreement-related party
Balance at Dec. 31, 2022						$ 394					8,245,610					(32,360,062)					(24,114,058)
Balance, shares at Dec. 31, 2022						3,935,892
Stock-based compensation											402,448										402,448
Net loss																(3,765,122)					(3,765,122)
Exercise of stock options											5,543										5,543
Exercise of stock options, shares						171
Balance at Mar. 31, 2023						$ 394					8,653,601					(36,125,184)					(27,471,189)
Balance, shares at Mar. 31, 2023						3,936,063
Balance at Dec. 31, 2022						$ 394					8,245,610					(32,360,062)					(24,114,058)
Balance, shares at Dec. 31, 2022						3,935,892
Net loss																					(7,251,175)
Conversion of simple agreement for future equity-related party
Modification of convertible notes payable-related party
Shares issued under share transfer agreement-related party
Balance at Jun. 30, 2023						$ 394					8,879,960					(39,611,237)					(30,730,883)
Balance, shares at Jun. 30, 2023						3,936,189
Balance at Dec. 31, 2022						$ 394					8,245,610					(32,360,062)					(24,114,058)
Balance, shares at Dec. 31, 2022						3,935,892
Conversion of convertible notes-related party							$ 2			$ 1		$ 7,271,366			$ 3,346,231							7,271,368			3,346,232
Conversion of convertible notes-related party, shares							22,929			10,597
Shares issued to Yorkville for aggregate commitment fee								$ 1					$ 3,287,999										$ 3,288,000
Shares issued to Yorkville for aggregate commitment fee, shares								6,000
Stock-based compensation											1,245,796										1,245,796
Net loss																(14,406,262)					(14,406,262)
Exercise of stock options											30,761										$ 30,761
Exercise of stock options, shares						353															353
Reverse recapitalization (Note 4)						$ (142)					(17,858,417)										$ (17,858,559)
Reverse recapitalization (Note 4), shares						(1,424,624)
Conversion of simple agreement for future equity-related party							$ 1					6,049,765			$ 456,234							6,049,766			$ 456,234
Conversion of simple agreement for future equity-related party, shares							11,039			833
Modification of convertible notes payable-related party												9,909									9,909	9,909
Shares issued under share transfer agreement-related party												2,498,965										2,498,965
Issuance of Cantor fee shares						$ 2					(2)
Issuance of Cantor fee shares, shares						22,279
Excise tax											305,719										305,719
Balance at Dec. 31, 2023						$ 259					14,889,936					(46,766,324)					(31,876,129)
Balance, shares at Dec. 31, 2023						2,585,296
Balance at Mar. 31, 2023						$ 394					8,653,601					(36,125,184)					(27,471,189)
Balance, shares at Mar. 31, 2023						3,936,063
Stock-based compensation											218,539										218,539
Net loss																(3,486,053)					(3,486,053)
Exercise of stock options											7,820										7,820
Exercise of stock options, shares						126
Balance at Jun. 30, 2023						$ 394					8,879,960					(39,611,237)					(30,730,883)
Balance, shares at Jun. 30, 2023						3,936,189
Balance at Dec. 31, 2023						$ 259					14,889,936					(46,766,324)					(31,876,129)
Balance, shares at Dec. 31, 2023						2,585,296
Conversion of convertible notes-related party							$ 2	$ 4				$ 2,540,089	1,666,996									$ 2,540,091	1,667,000
Conversion of convertible notes-related party, shares							17,812	44,675
Shares issued to Yorkville for aggregate commitment fee								$ 1					499,999										500,000
Shares issued to Yorkville for aggregate commitment fee, shares								14,201
Shares issued to Roth for advisory fee						$ 0					278,333										278,833
Shares issued to Roth for advisory fee, shares						35,000
Shares issued to GEM									$ 0					$ 100,000										$ 100,000
Shares issued to GEM, shares									2,789
Shares issued for marketing expenses						$ 0					194,935										194,935
Shares issued for marketing expense, shares						3,070
Forfeiture of sponsor shares						$ 0					0
Forfeiture of sponsor shares, shares						(2,000)
Stock-based compensation											252,967										252,967
Net loss																(4,500,272)					(4,500,272)
Balance at Mar. 31, 2024						$ 267					20,423,754					(51,266,596)					(30,842,575)
Balance, shares at Mar. 31, 2024						2,669,343
Balance at Dec. 31, 2023						$ 259					14,889,936					(46,766,324)					(31,876,129)
Balance, shares at Dec. 31, 2023						2,585,296
Net loss																					$ (8,665,380)
Exercise of stock options, shares
Balance at Jun. 30, 2024						$ 300					23,582,484					(55,431,704)					$ (31,848,920)
Balance, shares at Jun. 30, 2024						3,003,810
Balance at Mar. 31, 2024						$ 267					20,423,754					(51,266,596)					(30,842,575)
Balance, shares at Mar. 31, 2024						2,669,343
Conversion of convertible notes-related party								$ 2					334,998										335,000
Conversion of convertible notes-related party, shares								20,176
Shares issued to GEM									$ 2					$ 299,998										$ 300,000
Shares issued to GEM, shares									18,113
Shares issued for marketing expenses						$ 1					139,836										139,837
Shares issued for marketing expense, shares						6,400
Stock-based compensation											412,442										412,442
Net loss																(4,165,108)					(4,165,108)
Issuance of common stock and warrants, net of issuance costs						$ 10					1,854,808										1,854,818
Issuance of common stock and warrants, net of issuance costs, shares						104,556
Shares issued for exercise of Pre-Funded warrants						$ 17					849										866
Shares issued for exercise of Pre-Funded warrants, shares						173,222
Shares issued to Yorkville for redemption premium								$ 1					$ 115,799										$ 115,800
Shares issued to Yorkville for redemption premium, shares								$ 12,000
Balance at Jun. 30, 2024						$ 300					$ 23,582,484					$ (55,431,704)					$ (31,848,920)
Balance, shares at Jun. 30, 2024						3,003,810

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flow - USD ($)	6 Months Ended		12 Months Ended
Condensed Consolidated Statements of Cash Flow - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (8,665,380)	$ (7,251,175)	$ (14,406,262)	$ (15,468,502)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,825	4,025	7,160	9,588
Provision for credit losses on accounts receivable	(2,191)	(68,285)	(102,112)	92,619
Non-cash shares issued to Yorkville for aggregate commitment fee			3,288,000
Non-cash issuance of warrants accounted for as liabilities			2,448,000
Non-cash share issuance for marketing expenses	175,334
Non-cash GEM commitment fee expense	200,000		2,000,000
Amortization of operating lease right-of-use assets	87,579	86,320	173,245	152,018
Impairment of operating lease right-of-use assets				303,327
Stock based compensation expense	665,409	620,987	1,245,796	770,336
Loss on extinguishment of debt	(527,980)			56,653
Excise tax			305,719
Loss on debt issuance	171,000
Change in fair value of convertible promissory notes	578,000		(34,000)
Changes in operating assets and liabilities:
Accounts receivable	81,079	27,168	65,479	(86,308)
Prepaid expenses and other current assets	(180,343)	(93,137)	(407,648)	425,011
Deferred offering costs		(427,664)	(1,708,163)
Other assets				52,591
Accounts payable	2,989,940	1,218,775	5,339,614	660,844
Due to related party			67,118
Deferred revenue	108,142	32,124	283,660	(129,604)
Accrued expenses and other current liabilities			4,448,867	384,641
Accrued expenses	(123,399)	(336,332)
Operating lease liabilities	(152,335)	(138,804)	(284,963)	(243,596)
Earnout liability	(22,274)	(200,000)	(229,700)	(710,901)
Deferred fees			500,000
Other liabilities				(37,837)
Net cash used in operating activities	(3,812,695)	(4,046,650)	(1,550,781)	(5,168,175)
Cash flows from investing activities:
Purchase of property and equipment				(10,806)
Net cash used in investing activities				(10,806)
Cash flows from financing activities:
Effect of Merger, net of transaction costs (Note 4)			(7,615,462)
Deferred offering costs				(1,524,934)
Payment of GEM commitment fee	(1,200,000)
Repayment of convertible notes (Yorkville)	(750,000)
Proceeds received for exercise of Pre-Funded warrants	866
Proceeds from issuance of common stock	1,854,818	13,362	30,761	5,016
Net cash provided by financing activities	2,190,724	3,446,362	2,621,000	4,415,930
Net increase / (decrease) in cash	(1,621,971)	(600,288)	1,070,219	(763,051)
Cash at beginning of period	2,093,718	1,023,499	1,023,499	1,786,550
Cash at end of period	471,747	423,211	2,093,718	1,023,499
Supplemental disclosure of cash flow information:
Cash paid for interest	158,518	313,813	955,848	630,454
Cash paid (refund) for taxes	5,075	8,825	9,862	(4,875)
Non-cash investing and financing activities
Issuance of Cantor Fee Shares			(111)
Modification of convertible notes payable-related party			9,909
Shares issued to Roth for advisory fee	278,833
Shares issued to GEM	400,000
Shares issued for marketing expenses	334,772
Settlement of GEM commitment fee	200,000
Shares issued to Yorkville for aggregate commitment fee	500,000		3,288,000
Issuance of warrants accounted for as a liability			2,448,000
GEM commitment fee			2,000,000
Deferred offering costs			(3,233,097)
Debt issuance costs				25,896
Right-of-use assets obtained in exchange for lease obligations				762,603
Shares issued to Yorkville for redemption premium	115,800
Shares issued for exercise of Pre-Funded warrants	866
Issuance of convertible promissory note - GEM	1,000,000
Nonrelated Party [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash share issuance for Yorkville redemption premium	80,760
Non-cash interest expense	596,693	471,076	686,016	854,379
Amortization of debt discount and issuance costs	68,459	272,670	958,822	235,463
Change in fair value of warrant liability	(562,000)		(1,807,000)
Loss on modification of simple agreement for future equity				120,826
Change in fair value of simple agreement for future equity		91,443	(207,570)	307,569
Change in fair value of bifurcated embedded derivative liabilities			(1,404,863)	254,443
Change in fair value of bifurcated embedded derivative liabilities		(162,228)	(1,404,863)	254,443
Cash flows from financing activities:
Proceeds from Yorkville redemption premium	35,040
Proceeds from issuance of convertible notes, net of issuance costs	2,250,000	850,000	3,235,000	1,753,558
Non-cash investing and financing activities
Conversion of simple agreement for future equity			456,234
Conversion of convertible notes			3,346,232
Bifurcated embedded derivative liabilities at issuance				541,223
Convertible note issued in settlement of accrued interest				321,345
Related Party [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense	175,517	214,830	513,977	55,086
Amortization of debt discount and issuance costs	787,470	719,913	2,410,735	485,717
Change in fair value of warrant liability	(345,000)		115,000
Loss on modification of simple agreement for future equity				1,602,174
Change in fair value of simple agreement for future equity		1,212,557	(2,752,430)	4,078,431
Change in fair value of bifurcated embedded derivative liabilities		(162,228)	(3,063,278)	606,857
Change in fair value of bifurcated embedded derivative liabilities		(340,913)	(3,063,278)	606,857
Cash flows from financing activities:
Proceeds from issuance of notes payable, net of issuance costs-related party			4,387,701
Proceeds from issuance of convertible notes, net of issuance costs		2,583,000	2,583,000	4,182,290
Non-cash investing and financing activities
Modification of convertible notes payable-related party			9,909
Shares issued under share transfer agreement-related party			2,498,965
Conversion of simple agreement for future equity			6,049,766
Conversion of convertible notes	2,540,091		7,271,368
Bifurcated embedded derivative liabilities at issuance				1,292,777
Convertible note issued in settlement of accrued interest				$ 100,538
Yorkville [Member]
Non-cash investing and financing activities
Conversion of convertible notes	$ 2,002,000

Organization

Organization	6 Months Ended	12 Months Ended
Organization	Jun. 30, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	1. Organization The Business Banzai International, Inc. (the “Company” or “Banzai”) was incorporated in Delaware on September 30, 2015 Close of the Merger On December 14, 2023 (the “Closing Date”), 7GC & Co. Holdings Inc. (“7GC”), our predecessor company, consummated the business combination pursuant to the Agreement and Plan of Merger and Reorganization, dated as of December 8, 2022 (the “Original Merger Agreement”), by and among 7GC, Banzai International, Inc. (“Legacy Banzai”), 7GC Merger Sub I, Inc., an indirect wholly owned subsidiary of 7GC (“First Merger Sub”), and 7GC Merger Sub II, LLC, a direct wholly owned subsidiary of 7GC (“Second Merger Sub”), as amended by the Amendment to Agreement and Plan of Merger, dated as of August 4, 2023 (the “Merger Agreement Amendment” and, together with the Original Merger Agreement, the “Merger Agreement”), by and between 7GC and Legacy Banzai. Pursuant to the terms of the Merger Agreement, a business combination between 7GC and Legacy Banzai was effected through (a) the merger of First Merger Sub with and into Legacy Banzai, with Legacy Banzai surviving as a wholly-owned subsidiary of 7GC (Legacy Banzai, in its capacity as the surviving corporation of the merger, the “Surviving Corporation”) (the “First Merger”) and (b) the subsequent merger of the Surviving Corporation with and into Second Merger Sub, with Second Merger Sub being the surviving entity of the Second Merger, which ultimately resulted in Legacy Banzai becoming a wholly-owned direct subsidiary of 7GC (the “Second Merger” and, together with the First Merger, the “Mergers” and, collectively with the other transactions described in the Merger Agreement, the “Merger”). On the Closing Date, and in connection with the closing of the Merger (the “Closing”), 7GC changed its name to Banzai International, Inc. Although 7GC was the legal acquirer of Legacy Banzai in the merger, Legacy Banzai is deemed to be the accounting acquirer, and the historical financial statements of Legacy Banzai became the basis for the historical financial statements of the Company upon the closing of the merger. As a result, the financial statements included here reflect (i) the historical operating results of Legacy Banzai prior to the merger; (ii) the combined results of 7GC and Legacy Banzai following the close of the merger; (iii) the assets and liabilities of Legacy Banzai at their historical cost and (iv) the Legacy Banzai’s equity structure for all periods presented, as affected by the recapitalization presentation after completion of the merger. The aggregate consideration payable to securityholders of Legacy Banzai at the Closing consisted of a number of shares of Class A Common Stock or shares of Class B Common Stock, and cash in lieu of any fractional shares of Class A Common Stock or shares of Class B Common Stock that would otherwise have been payable to any Legacy Banzai securityholders, equal to $ 100,000,000 Note 4 - Reverse Merger Capitalization with 7GC & Co. Holdings Inc. Emerging Growth Company Upon closure of the Merger, the Company became an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to public companies that are not emerging growth companies. Section 102(b) (1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply. Private companies are those companies that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act of 1934, as amended (the “Exchange Act”). The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies. Any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, it adopts the new or revised standard at the time private companies adopt the new or revised standard. Therefore, the Company’s financial statements may not be comparable to certain public companies.	1. Organization The Business Banzai International, Inc. (the “Company” or “Banzai”) was incorporated in Delaware on September 30, 2015 Close of the Merger On December 14, 2023 (the “Closing Date”), 7GC & Co. Holdings Inc. (“7GC”), our predecessor company, consummated the business combination pursuant to the Agreement and Plan of Merger and Reorganization, dated as of December 8, 2022 (the “Original Merger Agreement”), by and among 7GC, Banzai International, Inc. (“Legacy Banzai”), 7GC Merger Sub I, Inc., an indirect wholly owned subsidiary of 7GC (“First Merger Sub”), and 7GC Merger Sub II, LLC, a direct wholly owned subsidiary of 7GC (“Second Merger Sub”), as amended by the Amendment to Agreement and Plan of Merger, dated as of August 4, 2023 (the “Merger Agreement Amendment” and, together with the Original Merger Agreement, the “Merger Agreement”), by and between 7GC and Legacy Banzai. Pursuant to the terms of the Merger Agreement, a business combination between 7GC and Legacy Banzai was effected through (a) the merger of First Merger Sub with and into Legacy Banzai, with Legacy Banzai surviving as a wholly-owned subsidiary of 7GC (Legacy Banzai, in its capacity as the surviving corporation of the merger, the “Surviving Corporation”) (the “First Merger”) and (b) the subsequent merger of the Surviving Corporation with and into Second Merger Sub, with Second Merger Sub being the surviving entity of the Second Merger, which ultimately resulted in Legacy Banzai becoming a wholly-owned direct subsidiary of 7GC (the “Second Merger” and, together with the First Merger, the “Mergers” and, collectively with the other transactions described in the Merger Agreement, the “Merger”). On the Closing Date, and in connection with the closing of the Merger (the “Closing”), 7GC changed its name to Banzai International, Inc. Although 7GC was the legal acquirer of Legacy Banzai in the merger, Legacy Banzai is deemed to be the accounting acquirer, and the historical financial statements of Legacy Banzai became the basis for the historical financial statements of the Company upon the closing of the merger. Furthermore, the historical financial statements of Legacy Banzai became the historical financial statements of the Company upon the consummation of the merger. As a result, the financial statements included in this Annual Report reflect (i) the historical operating results of Legacy Banzai prior to the merger; (ii) the combined results of 7GC and Legacy Banzai following the close of the merger; (iii) the assets and liabilities of Legacy Banzai at their historical cost and (iv) the Legacy Banzai’s equity structure for all periods presented, as affected by the recapitalization presentation after completion of the merger. The aggregate consideration payable to securityholders of Legacy Banzai at the Closing consisted of a number of shares of Class A Common Stock or shares of Class B Common Stock, and cash in lieu of any fractional shares of Class A Common Stock or shares of Class B Common Stock that would otherwise have been payable to any Legacy Banzai securityholders, equal to $ 100,000,000 Note 4-Reverse Merger Capitalization with 7GC & Co. Holdings Inc. Termination of Hyros Acquisition and Amended Merger Agreement with 7GC In December 2022, the Company entered into an Agreement and Plan of Merger with Hyros, Inc., (“Hyros”) (the “Hyros Purchase Agreement”) whereby Banzai would acquire 100 110 Concurrently, in December 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the “Original Merger Agreement”) with 7GC & Co. Holdings Inc. (“7GC”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities, pending the close of the Hyros Purchase Agreement. On July 31, 2023, Banzai sent a notice of termination to Hyros. On August 1, 2023, Banzai and Hyros terminated the Hyros Purchase Agreement and the Hyros Side Letter (the “Hyros Transaction Termination”), with immediate effect, in connection with the inability to procure the Hyros audited financial statements on the timeline contemplated by the Hyros Purchase Agreement. On August 4, 2023, the Company entered into an Amendment to the Agreement and Plan of Merger and Reorganization (the “Amended Merger Agreement” and together with the Original Merger Agreement, the “Merger Agreement”) with 7GC (the “Merger”). As a result of the Merger Agreement, all outstanding shares of capital stock of Banzai will be canceled and converted into the right to receive newly issued shares of common stock, par value $ 0.0001 100 10.00 Emerging Growth Company Upon closure of the Merger, the Company became an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b) (1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. Private companies are those companies that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, it adopts the new or revised standard at the time private companies adopt the new or revised standard. Therefore, the Company’s financial statements may not be comparable to certain public companies.

Going Concern

Going Concern	6 Months Ended	12 Months Ended
Going Concern	Jun. 30, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	2. Going Concern As of June 30, 2024 the Company had cash of approximately $ 0.5 3.8 55.4 The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders and debt holders. Specifically, continuation is contingent on the Company’s ability to obtain necessary equity or debt financing to continue operations, and ultimately the Company’s ability to generate profit from sales and positive operating cash flows, which is not assured. The Company’s plans include obtaining future debt and equity financings associated with the close of the Merger described in Note 4 - Reverse Merger Capitalization with 7GC & Co. Holdings Inc.. These accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that might result from the outcome of this uncertainty.	2. Going Concern As of December 31, 2023 the Company had cash of approximately $ 2.1 1.6 46.8 The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders and debt holders. Specifically, continuation is contingent on the Company’s ability to obtain necessary equity or debt financing to continue operations, and ultimately the Company’s ability to generate profit from sales and positive operating cash flows, which is not assured. The Company’s plans include obtaining future debt and equity financings associated with the close of the Merger described in Note 4-Reverse Merger Capitalization with 7GC & Co. Holdings Inc.. These accompanying audited consolidated financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended	12 Months Ended
Summary of Significant Accounting Policies	Jun. 30, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	3. Summary of Significant Accounting Policies Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and applicable regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with the instructions to Form 10-Q of Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations of the SEC relating to interim financial statements. The December 31, 2023 balance sheet information was derived from the audited financial statements as of that date. Except as disclosed herein, there has been no material change in the information disclosed in the notes to the consolidated financial statements for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on April 1, 2024. The interim unaudited condensed consolidated financial statements should be read in conjunction with those consolidated financial statements included in the Form 10-K. In the opinion of management, all adjustments considered necessary for a fair statement of the financial statements, consisting solely of normal recurring adjustments, have been made. Operating results for the periods ended June 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. Effective September 19, 2024, the Company completed a one-for-fifty (1-for-50) reverse stock split Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Warrant Liability - related party The warrants originally issued in 7GC’s initial public offering (the “Public Warrants”) are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercise or expiration, and any change in fair value is recognized in the Company’s consolidated statements of operations. The Public Warrants were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based on the listed market price of such warrants. Warrant liabilities are classified as current liabilities on the Company’s consolidated balance sheets. Warrant Liability The GEM Warrants were not considered indexed to the issuer’s stock pursuant to ASC 815, as the holder’s ability to receive in lieu of the Warrant one percent of the total consideration received by the Company’s stockholders in connection with a Change of Control, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company’s control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially measured at fair value with subsequent changes in fair value recognized in earnings each reporting period. The measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected time to conversion). Loss Per Share Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share excludes, when applicable, the potential impact of stock options and convertible preferred stock because their effect would be anti-dilutive due to the net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same. The calculation of basic and diluted net loss per share attributable to common stock was as follows: Schedule of Basic and Diluted Net Loss Per Share 2024 2023 2024 2023 For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Numerator: Net loss attributable to common stock—basic and diluted $ (4,165,108 ) $ (3,486,053 ) $ (8,665,380 ) $ (7,251,175 ) Denominator: Weighted average shares—basic and diluted 541,836 129,193 444,474 129,127 Net loss per share attributable to common stock—basic and diluted $ (7.69 ) $ (26.98 ) $ (19.50 ) $ (56.16 ) Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be dilutive in future periods are as follows: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share 2024 2023 As of June 30, 2024 2023 Options 33,649 13,405 RSUs 17,558 — Public warrants 230,000 — GEM warrants 16,571 — Common warrants 277,778 — Placement agent warrants 16,667 — Total 592,222 13,405 Antidilutive Securities 592,222 13,405 Derivative Financial Instruments The Company evaluates all its financial instruments to determine if such instruments contain features that qualify as embedded derivatives. Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated embedded derivatives are classified with the related host contract in the Company’s balance sheet. Refer to Note 7 - Fair Value Measurements Note 11 - Debt Fair Value of Financial Instruments In accordance with FASB ASC 820 Fair Value Measurements and Disclosures Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace. Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. The fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management during the three and six months ended June 30, 2024 and 2023. The carrying amount of cash, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued expenses, deferred revenue, and other current liabilities approximated their fair values as of June 30, 2024 and December 31, 2023. Recent Accounting Pronouncements Recent accounting pronouncements not yet effective In December 2023, the FASB issued ASU 2023-09 (Topic 740), Improvements to income tax disclosures, which enhances the disclosure requirements for the income tax rate reconciliation, domestic and foreign income taxes paid, requiring disclosure of disaggregated income taxes paid by jurisdiction, unrecognized tax benefits, and modifies other income tax-related disclosures. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively. The Company is currently evaluating the effect of adopting this guidance on its consolidated financial statements. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update intend to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. This ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, the addition of a category for other segment items by reportable segment, that all annual segment disclosures be disclosed in interim periods, and other related segment disclosures. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of adopting this guidance on its consolidated financial statements.	3. Summary of Significant Accounting Policies Basis of Presentation The Company’s audited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. Effective September 19, 2024, the Company completed a one-for-fifty (1-for-50) reverse stock split Principles of Consolidation The accompanying audited consolidated financial statements include the accounts of Banzai and its subsidiaries. The Company consolidates all entities over which the Company has the power to govern the financial and operating policies and therefore exercises control, and upon which the Company has a controlling financial interest. The existence and effect of both current voting rights and potential voting rights that are currently exercisable or convertible are considered when assessing whether control of an entity is exercised. The subsidiary is consolidated from the date at which the Company obtains control and is de-consolidated from the date at which control ceases. All intercompany balances and transactions have been eliminated. The accounting policies of the subsidiary has been changed where necessary to ensure consistency with the policies adopted by the Company. In the opinion of management, all necessary adjustments (consisting of normal recurring adjustments, intercompany adjustments, reclassifications and non-recurring adjustments) have been recorded to present fairly our financial position as of December 31, 2023 and 2022, and the results of operations and cash flows for the years ended December 31, 2023 and 2022. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the audited consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that estimates made as of the date of the financial statements could change in the near term due to one or more future events. Actual results could differ significantly from these estimates. Significant accounting estimates reflected in the Company’s consolidated financial statements include estimates of impairment of goodwill, recognition and measurement of convertible and Simple Agreement for Future Equity (SAFE) notes, including the associated embedded derivatives, determination of the fair value of the warrant liabilities, and recognition and measurement of stock compensation. Certain Risks and Uncertainties The Company’s business and operations are sensitive to general business and economic conditions. These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the general condition of the world economy. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse developments in these general business and economic conditions could have a material adverse effect on the Company’s financial condition and the results of its operations. In addition, the Company will compete with many companies that currently have extensive and well-funded products, marketing and sales operations. The Company may be unable to compete successfully against these companies. The Company’s industry is characterized by rapid changes in technology and market demands. As a result, the Company’s products, services, or expertise may become obsolete or unmarketable. The Company’s future success will depend on its ability to adapt to technological advances, anticipate customer and market demands, and enhance its current technology. The Company is also subject to risks which include, but are not limited to, dependence on key personnel, reliance on third parties, successful integration of business acquisitions, protection of proprietary technology, and compliance with regulatory requirements. Cash The Company considers all highly liquid investments purchased with original maturities of 90 days or less to be cash equivalents. As of December 31, 2023 and 2022, the Company does no The Company has no significant off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other hedging arrangements. The Company holds cash in banks in excess of federally insured limits. However, the Company believes risk of loss is minimal as the cash is held by large highly rated financial institutions. To reduce its risk associated with the failure of such financial institutions, the Company evaluates at least annually the rating of the financial institutions in which it holds cash. Any material loss that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make other payments and may require the Company to move its cash to other high quality financial institutions. Currently, the Company is reviewing its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits. Accounts Receivable and Allowance for Credit Losses Accounts receivable consist of balances due from customers as well as from payment service providers. Payment terms range from due upon receipt, to net 30 days. Accounts receivable are stated net of an allowance for credit losses. The allowance for expected credit losses is based on the probability of future collection under the current expected credited loss (“CECL”) impairment model which was adopted by the Company on January 1, 2023, as discussed below within Recent Accounting Pronouncements. The adoption of ASU No. 2016-13, Financial Instruments: Credit Losses (Topic 326) (“ASU 2016-13”) did not have a material impact on these consolidated financial statements. Account balances are written off after all means of collection are exhausted and the balance is deemed uncollectible. Subsequent recoveries are credited to the allowance. Changes in the allowance are recorded as adjustments to credit losses in the period incurred. As of December 31, 2023 and 2022, the Company determined an allowance for credit losses of $ 5,748 107,860 65,013 142,162 The following table presents changes in the allowance for credit losses for the year ended December 31, 2023: Summary of Changes in Allowance for Credit Losses Balance-January 1, 2023 $ 107,860 Change in provision for credit losses (102,112 ) Balance-December 31, 2023 $ 5,748 Property and Equipment Property and equipment are recorded at cost and presented net of accumulated depreciation. Major additions and betterments are capitalized while maintenance and repairs, which do not improve or extend the life of the respective assets, are expensed. Property and equipment are depreciated on the straight-line basis over their estimated useful lives ( 3 years Goodwill Goodwill represents the excess of the purchase price over the fair value of the net identifiable assets acquired in a business combination. Goodwill is reviewed for impairment at least annually, in December, or more frequently if a triggering event occurs between impairment testing dates. As of December 31, 2023, the Company had one The Company’s impairment assessment begins with a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. Qualitative factors may include, macroeconomic conditions, industry and market considerations, cost factors, and other relevant entity and Company specific events. If, based on the qualitative test, the Company determines that it is “more likely than not” that the fair value of a reporting unit is less than its carrying value, then we evaluate goodwill for impairment by comparing the fair value of our reporting unit to its respective carrying value, including its goodwill. If it is determined that it is not likely that the fair value of the reporting unit is less than its carrying value, then no further testing is required. The selection and assessment of qualitative factors used to determine whether it is more likely than not that the fair value of a reporting unit exceeds the carrying value involves significant judgment and estimates. Fair values may be determined using a combination of both income and market-based approaches. There were no Deferred Offering Costs In 2022 and 2023, the Company capitalized fees related to the Merger Agreement (see Note 1-Organization Note 4-Merger Capitalized deferred offering costs consisted of the following, as of December 14, 2023 and December 31, 2022: Summary of Capitalized Deferred Offering Costs December 14, December 31, SPAC-related legal fees $ 2,973,077 $ 1,264,914 Investment bank advisory services 135,000 135,000 Federal Trade Commission filing fees 125,020 125,020 Total deferred offering costs capitalized $ 3,233,097 $ 1,524,934 The entire balance of Deferred Offering Costs capitalized as of December 14, 2023, was reclassified to Additional Paid-in- Capital, on December 14, 2023, in connection with the closing of the Merger. As a result, there was no Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Warrant Liability-related party The Public Warrants are recognized as derivative liabilities in accordance with ASC 815 Derivatives and Hedging The Public Warrants were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liabilities may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Warrant liabilities are classified as current liabilities on the Company’s consolidated balance sheets. Warrant Liability The GEM Warrants were not considered indexed to the issuer’s stock pursuant to ASC 815, as the holder’s ability to receive one percent of the total consideration received by the Company’s stockholders in connection with a Change of Control in lieu of the Warrant, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company’s control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially measured at fair value with subsequent changes in fair value recognized in earnings each reporting period. The measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected time to conversion). The Company determined the Warrants were share issuance costs associated with an aborted offering to purchase equity. Aborted offering costs may not be deferred and charged against proceeds of a subsequent offering. As such, the Company recorded an expense for the corresponding fair value. Simple Agreements for Future Equity-SAFE The Company accounts for Simple Agreements for Future Equity (“SAFE”) at fair value in accordance with ASC 480 Distinguishing Liabilities from Equity Concentration of Business and Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company has no financial instruments with off-balance sheet risk of loss. At December 31, 2023, no customers accounted for 10% or more of accounts receivable. At December 31, 2022, three customers accounted for 10% or more of accounts receivable with concentrations of 21 16 10 47 259,635 At December 31, 2023 and 2022, one supplier accounted for 10% or more of accounts payable. Loss Per Share Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the year. Diluted net loss per share excludes, when applicable, the potential impact of stock options and convertible preferred stock because their effect would be anti-dilutive due to the net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same. The calculation of basic and diluted net loss per share attributable to common stock was as follows: Schedule of Basic and Diluted Net Loss Per Share 2023 2022 As of December 31, 2023 2022 Numerator: Net loss attributable to common stock-basic and diluted $ (14,406,262 ) $ (15,468,502 ) Denominator: Weighted average shares-basic and diluted 137,074 128,822 Net loss per share attributable to common stock-basic and diluted $ (105.10 ) $ (111.83 ) Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be dilutive in future periods are as follows: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share 2023 2022 As of December 31, 2023 2022 Options 14,962 7,420 Public warrants 230,000 - GEM warrants 16,571 - Total 261,533 7,420 Antidilutive Securities 261,533 7,420 Leases The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as right-of-use (“ROU”) assets and the corresponding lease liabilities are included in operating lease liabilities, current and operating lease liabilities, non-current on the Company’s balance sheets. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. ROU assets and lease liabilities are recognized at commencement date and determined using the present value of the future minimum lease payments over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing since the Company’s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when it is reasonably certain that the Company will exercise that option. In addition, the Company does not recognize short-term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company recognizes operating lease expense on a straight-line basis over the lease term. The Company has lease agreements which contain both lease and non-lease components, which it has elected to account for as a single lease component when the payments are fixed. As such, variable lease payments, including those not dependent on an index or rate, such as real estate taxes, common area maintenance, and other costs that are subject to fluctuation from period to period are not included in lease measurement. The Company evaluates long-lived assets for recoverability if there are indicators of potential impairment. Indicators of potential impairment may include subleasing a location for less than the head lease cost. If there are indicators of potential impairment, the Company will test the assets for recoverability. If the undiscounted cash flows estimated to be generated are less than the carrying value of the underlying assets, the assets are deemed impaired. If it is determined that assets are impaired, an impairment loss is calculated based on the amount that the asset’s book value exceeds its fair value. Revenue Recognition Revenue is generated through Banzai providing marketing and webinar platform subscription software service for a set period of time. The Statement of Work (“SOW”) or Invoice, and the accompanying documents are negotiated and signed by both parties (if applicable). Alternatively, customer contracting is achieved via self service and invoicing is initiated automatically once the customer accepts the terms and conditions on the platform, based on their selection of the desired subscription product. When execution or completion of the contract occurs, the contract is valid and revenue is earned when the service is provided for each period of performance, daily. The amount is paid by the customer based on the contract terms monthly, quarterly, or annually, with the majority paid via credit card processing. The Company recognizes revenue in an amount that reflects the consideration to which it expects to be entitled in exchange for the transfer of promised services to its customers. To determine revenue recognition for contracts with customers, the Company performs the following steps described in ASC 606: (1) identifies the contract with the customer, or Step 1, (2) identifies the performance obligations in the contract, or Step 2, (3) determines the transaction price, or Step 3, (4) allocates the transaction price to the performance obligations in the contract, or Step 4, and (5) recognizes revenue when (or as) the entity satisfies a performance obligation, or Step 5. Revenue from contracts with customers are not recorded until the Company has the approval and commitment from the parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of the consideration is probable. The Company also evaluates the following indicators, amongst others, when determining whether it is acting as a principal in the transaction (and therefore whether to record revenue on a gross basis): (i) whether the Company is primarily responsible for fulfilling the promise to provide the specified good or service, (ii) whether the Company has the inventory risk before the specified good or service has been transferred to a customer or after transfer of control to the customerCan and (iii) whether the Company has the discretion to establish the price for the specified good or service. If the terms of a transaction do not indicate that the Company is acting as a principal in the transaction, then the Company is acting as an agent in the transaction and therefore, the associated revenue is recognized on a net basis (that is revenue net of costs). Revenue is recognized once control passes to the customer. The following indicators are evaluated in determining when control has passed to the customer: (i) whether the Company has a right to payment for the product or service, (ii) whether the customer has legal title to the product or service, (iii) whether the Company has transferred physical possession of the product or service to the customer, (iv) whether the customer has the significant risk and rewards of ownership of the product or service and (v) whether the customer has accepted the product or service. When an arrangement contains more than one performance obligation, the Company will allocate the transaction price to each performance obligation on a relative standalone selling price basis. The Company utilizes the observable price of products and services when they are sold separately to similar customers in order to estimate standalone selling price. Costs of Revenue Costs of revenue consist primarily of infrastructure, streaming service, data license and contracted services costs, as well as merchant fees and payroll costs. Advertising Costs Advertising costs are expensed as incurred. Advertising costs were $ 941,737 783,764 Stock-Based Compensation The Company expenses stock-based compensation to employees and non-employees over the requisite service period based on the estimated grant-date fair value of the awards in accordance with ASC 718, Stock Compensation Income Taxes Income taxes are recorded in accordance with ASC 740, Income Taxes Derivative Financial Instruments The Company evaluates all its financial instruments to determine if such instruments contain features that qualify as embedded derivatives. Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated embedded derivatives are classified with the related host contract in the Company’s balance sheet. Refer to Note 8-Fair Value Measurements Note 14-Debt Fair Value of Financial Instruments In accordance with FASB ASC 820 Fair Value Measurements and Disclosures Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace. Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. The fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management during the years ended December 31, 2023 and 2022. The carrying amount of cash, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued expenses, deferred revenue, and other current liabilities approximated their fair values as of December 31, 2023 and 2022. During 2022, the Company carried convertible notes bifurcated embedded derivatives and Simple Agreements for Future Equity (“SAFE”) investments at their fair value (see Note 8-Fair Value Measurements Business Combinations The Company accounts for business combinations in accordance with FASB ASC 805 (“ASC 805”), Business Combinations Recent Accounting Pronouncements Recent accounting pronouncements not yet effective In December 2023, the FASB issued ASU 2023-09 (Topic 740), Improvements to income tax disclosures, which enhances the disclosure requirements for the income tax rate reconciliation, domestic and foreign income taxes paid, requiring disclosure of disaggregated income taxes paid by jurisdiction, unrecognized tax benefits, and modifies other income tax-related disclosures. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively. The Company is currently evaluating the effect of adopting this guidance on its consolidated financial statements.

Reverse Merger Capitalization w

Reverse Merger Capitalization with 7GC & Co. Holdings Inc.	6 Months Ended	12 Months Ended
Reverse Merger Capitalization with 7GC & Co. Holdings Inc.	Jun. 30, 2024	Dec. 31, 2023
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Reverse Merger Capitalization with 7GC & Co. Holdings Inc.	4. Reverse Merger Capitalization with 7GC & Co. Holdings Inc. On December 14, 2023 (the “Closing Date”), Banzai consummated the previously announced Merger with 7GC, as a result of which Banzai became a wholly-owned subsidiary of 7GC. While 7GC was the legal acquirer of Banzai in the merger, for accounting purposes, Legacy Banzai was deemed to be the accounting acquirer in the merger. The determination was primarily based on Legacy Banzai’s stockholders having a majority of the voting power in the combined Company, Legacy Banzai having the ability to appoint a majority of the Board of Directors of the Company, Legacy Banzai’s existing management team comprising the senior management of the combined Company, Legacy Banzai comprising the ongoing operations of the combined Company and the combined Company assumed the name “Banzai International, Inc.”. Accordingly, for accounting purposes, the merger was treated as the equivalent of Legacy Banzai issuing stock for the net assets of 7GC, accompanied by a recapitalization. The net assets of 7GC are stated at historical cost, with no goodwill or other intangible assets recorded. Retroactive Restatement for Conversion of Common Stock and Series A Preferred Stock by Applying Exchange Ratio Upon the closing of the merger, holders of Legacy Banzai common stock and Series A preferred stock received shares of common stock in an amount determined by application of the Exchange Ratio. In accordance with guidance applicable to these circumstances, the equity structure has been restated in all comparable periods, prior to the merger, up to December 14, 2023, to reflect the number of shares of the Company’s common stock, $ 0.0001 0.6147 The aggregate consideration payable to securityholders of Banzai at the Closing Date was equal to $ 100,000,000 3,207,428 0.0001 10.76 34,524,065 0.0001 one On the terms and subject to the conditions set forth in the Merger Agreement, at the Second Effective Time, each share of common stock of the Surviving Corporation issued and outstanding immediately prior to the Second Effective Time was cancelled and no consideration was delivered therefore. Upon the closing of the merger, the Company’s certificate of incorporation was amended and restated to, among other things, increase the total number of authorized shares of all classes of capital stock to 350,000,000 5,000,000 25,000,000 75,000,000 0.0001 3,003,810 no Effect of Merger on Class A and Class B Common Stock Upon the Close of the Merger, holders of Legacy Banzai common stock and Series A preferred stock were converted into shares of common stock in an amount determined by application of the Exchange Ratio. As noted above, the equity structure has been restated in all comparable periods, prior to the Merger, up to December 14, 2023, to reflect the number of shares of the Company’s common stock, $ 0.0001 Schedule of Reconciliation of the Merger to the Company's Consolidated Cash Flows	4. Reverse Merger Capitalization with 7GC & Co. Holdings Inc. On December 14, 2023 (the “Closing Date”), Banzai consummated the previously announced Merger with 7GC, as a result of which Banzai became a wholly-owned subsidiary of 7GC. While 7GC was the legal acquirer of Banzai in the merger, for accounting purposes, Legacy Banzai was deemed to be the accounting acquirer in the merger. The determination was primarily based on Legacy Banzai’s stockholders having a majority of the voting power in the combined Company, Legacy Banzai having the ability to appoint a majority of the Board of Directors of the Company, Legacy Banzai’s existing management team comprising the senior management of the combined Company, Legacy Banzai comprising the ongoing operations of the combined Company and the combined Company assumed the name “Banzai International, Inc.”. Accordingly, for accounting purposes, the merger was treated as the equivalent of Legacy Banzai issuing stock for the net assets of 7GC, accompanied by a recapitalization. The net assets of 7GC are stated at historical cost, with no goodwill or other intangible assets recorded. Preferred Stock Conversion Immediately prior to the First Merger (the “First Effective Time”), each share of Legacy Banzai Series A preferred stock, par value $ 0.0001 one 0.0001 At the First Effective Time, by virtue of the First Merger and without any action on the part of 7GC, First Merger Sub, Legacy Banzai or the holders of any of the following securities: (a) each outstanding share of Legacy Banzai Class A Common Stock, including the shares of Legacy Banzai Class A Common Stock from the conversion of the Legacy Banzai Preferred Stock described above, and each outstanding share of Class B common stock of Legacy Banzai, par value $ 0.0001 0.0001 10.00 (b) (1) each option to purchase Legacy Banzai Class A Common Stock (“Legacy Banzai Option”), whether vested or unvested, that was outstanding immediately prior to the First Effective Time and held by any securityholders of Legacy Banzai immediately prior to the First Effective Time (each, a “Pre-Closing Holder”) who was providing services to Legacy Banzai immediately prior to the First Effective Time (a “Pre-Closing Holder Service Provider”), was assumed and converted into an option (a “Company Option”) to purchase shares of Class A Common Stock, calculated in the manner set forth in the Merger Agreement; and (2) the vested portion of each Legacy Banzai Option that was outstanding at such time and held by a Pre-Closing Holder who was not then providing services to Legacy Banzai (a “Pre-Closing Holder Non-Service Provider”) was assumed and converted into a Company Option to purchase shares of Class A Common Stock, calculated in the manner set forth in the Merger Agreement; (c) each right of each SAFE investor to receive a portion of the Total Consideration (as defined below) pursuant to certain Simple Agreements for Future Equity (“each, a “SAFE Agreement”) that was outstanding immediately prior to the First Effective Time was cancelled and converted into the right (each, a “SAFE Right”) to receive a number of shares of Class A Common Stock equal to (i) the Purchase Amount as defined in the applicable SAFE Agreement that governed such SAFE Right (the “SAFE Purchase Amount”) in respect of such SAFE Right divided by the Valuation Cap Price as defined in each SAFE Agreement in respect of such SAFE Right multiplied by (ii) the Exchange Ratio; and (d) each Subordinated Convertible Note set forth in Section 1.1(a) of the Legacy Banzai disclosure schedules to the Merger Agreement (the “Subordinated Convertible Notes”) that was outstanding immediately prior to the First Effective Time was cancelled and converted into the right to receive a number of shares of Class A Common Stock equal to (i) all of the outstanding principal and interest in respect of such Subordinated Convertible Note, divided by the quotient obtained by dividing the Valuation Cap by the Fully Diluted Capitalization (each as defined in and determined pursuant to the terms of such Subordinated Convertible Note) in respect of such Subordinated Convertible Note, multiplied by (ii) the Exchange Ratio. (e) “Per Share Value” equals (i) an amount equal to $ 100,000,000 At the effective time of the Second Merger (the “Second Effective Time”), by virtue of the Second Merger and without any action on the part of 7GC, Surviving Corporation, Second Merger Sub or the holders of any securities of 7GC or the Surviving Corporation or the Second Merger Sub, each share of common stock of the Surviving Corporation issued and outstanding immediately prior to the Second Effective Time was cancelled and extinguished, and no consideration was delivered therefor. Retroactive Restatement for Conversion of Common Stock and Series A Preferred Stock by Applying Exchange Ratio Upon the closing of the merger, holders of Legacy Banzai common stock and Series A preferred stock received shares of common stock in an amount determined by application of the Exchange Ratio. In accordance with guidance applicable to these circumstances, the equity structure has been restated in all comparable periods, prior to the merger, up to December 14, 2023, to reflect the number of shares of the Company’s common stock, $ 0.0001 0.6147 The aggregate consideration payable to securityholders of Banzai at the Closing Date was equal to $ 100,000,000 3,207,428 0.0001 10.76 34,524,065 one 0.0001 one On the terms and subject to the conditions set forth in the Merger Agreement, at the Second Effective Time, each share of common stock of the Surviving Corporation issued and outstanding immediately prior to the Second Effective Time was cancelled and no consideration was delivered therefore. Treatment of Outstanding Equity Awards In addition, as of the First Effective Time: (i) each Legacy Banzai Option, whether vested or unvested, that was outstanding immediately prior to the First Effective Time and held by a Pre-Closing Holder Service Provider, was assumed and converted into a Company Option with respect to a number of shares of Class A Common Stock calculated in the manner set forth in the Merger Agreement; and (ii) the vested portion of each Legacy Banzai Option that was outstanding at such time and held by a Pre-Closing Holder Non-Service Provider was assumed and converted into a Company Option with respect to a number of shares of Class A Common Stock calculated in the manner set forth in the Merger Agreement. See Note 19-Stock-Based Compensation Treatment of SAFE Rights As of the First Effective Time, each SAFE Right that was outstanding immediately prior to the First Effective Time was cancelled and converted into and became the right to receive a number of shares of Class A Common Stock equal to the SAFE Purchase Amount in respect of such SAFE Right divided by the SAFE Conversion Price in respect of such SAFE Right multiplied by (ii) the Exchange Ratio. See Note 16-Simple Agreements for Future Equity Treatment of Convertible Notes As of the First Effective Time, each Subordinated Convertible Note that was outstanding immediately prior to the First Effective Time was cancelled and converted into the right to receive a number of shares of Class A Common Stock equal to (i) all of the outstanding principal and interest in respect of such Subordinated Convertible Note divided by the Subordinated Convertible Note Conversion Price in respect of such Subordinated Convertible Note, multiplied by (ii) the Exchange Ratio. In connection with the Forbearance Agreement and amended and restated Senior Convertible Notes, each Senior Convertible Note remained outstanding following the Closing (to be convertible at CP BF’s option into shares of Class A Common Stock after the Merger). On December 14, 2023, Legacy Banzai entered into the Forbearance Amendment, pursuant to which CP BF agreed not to exercise any right or remedy under the Loan Agreement with CP BF entered into on February 19, 2021 (the “CP BF Loan Agreement”), including its right to accelerate the aggregate amount outstanding under the CP BF Loan Agreement, until (a) the date that is the earlier of the date that all Yorkville Promissory Notes to be issued under the SEPA (See below for further detail) have been repaid (and/or converted) in full, or (b) six months after the Closing of the Merger. See below and Note 14-Debt Material Agreements Related to the Close of the Merger In connection with the close of the merger, the following material agreements and transactions were entered into by 7GC and Legacy Banzai: ● Sponsor Forfeiture Agreement 7,350,000 11.50 ● Yorkville Standby Equity Purchase Agreement (“SEPA”) 3.5 1.0 4.5 Note 14-Debt Note 18-Equity ● Share Transfer Agreements and Alco Promissory Notes 3,000 1,500 150,000 1,500 On December 13, 2023, in connection with the Merger, 7GC and the Sponsor entered into a share transfer agreement (the “December Share Transfer Agreement”) with Alco, pursuant to which for each $ 10.00 12,000 2.0 8 1.5 January 10, 2024 September 30, 2024 16,500 16,500 Note 14-Debt ● GEM Agreements 100,000,000 3 650 On December 13, 2023, Legacy Banzai and GEM entered into that certain binding term sheet (the “GEM Term Sheet”) and, on December 14, 2023, a letter agreement (the “GEM Letter”), agreeing to terminate in its entirety the GEM Agreement by and between Legacy Banzai and GEM, other than with respect to the Company’s obligation (as the post-combination company in the Merger) to issue to GEM a warrant (the “GEM Warrant”) granting the right to purchase Class A Common Stock in an amount equal to 3 2.0 five-year 0 Note 15-Warrant Liabilities Note 21-Subsequent Events ● 7GC Promissory Notes 2,300,000 30 30 2.86 Note 14-Debt and Note 6-Related Party Transactions Note 21-Subsequent Events ● CP BF Senior Convertible Notes 1,500,000 321,345 5 217.43 Note 14-Debt ● Cantor Fee Agreement 4,050,000 8,050,000 4,000,000 400,000 22,279 Note 17-Commitments and Contingencies Upon the closing of the merger, the Company’s certificate of incorporation was amended and restated to, among other things, increase the total number of authorized shares of all classes of capital stock to 105,000,000 5,000,000 25,000,000 75,000,000 0.0001 2,585,296 no Reconciliation of the Merger to the Company’s Consolidated Financial Statements The following table reconciles the elements of the Merger to the consolidated statements of cash flows: Schedule of Reconciliation of the Merger to the Company's Consolidated Cash Flows Recapitalization Deferred underwriting fees assumed $ 4,000,000 Convertible notes payable assumed 2,550,000 Warrant liabilities assumed 460,000 Less: effect on equity (14,625,462 ) Effect of reverse recapitalization, net of transaction costs $ (7,615,462 ) The following table reconciles the elements of the Merger to the consolidated statements of changes in stockholders’ deficit: Schedule of Reconciliation of the Merger to the Company’s Statements of Changes in Stockholders’ Deficit Recapitalization Cash $ 197,166 Non-cash net working capital assumed (7,812,628 ) Deferred underwriting fees assumed (4,000,000 ) Convertible notes payable assumed (2,550,000 ) Fair value of assumed warrant liabilities (460,000 ) Transaction costs (3,233,097 ) Effect of reverse recapitalization $ (17,858,559 ) The effect of the reverse recapitalization above differs from the effect of equity on the consolidated statements of cash flows, due to the transaction costs. Effect of Merger on Class A and Class B Common Stock Upon the Close of the Merger, holders of Legacy Banzai common stock and Series A preferred stock were converted into shares of common stock in an amount determined by application of the Exchange Ratio. As noted above, the equity structure has been restated in all comparable periods, prior to the Merger, up to December 14, 2023, to reflect the number of shares of the Company’s common stock, $ 0.0001 6,359,139 39,139 6,320,000 2,328,823 15,082 2,435,327 897,380 1,758,003 15,082 2,435,327 28,629 The total shares of common stock issued and outstanding at December 31, 2022, after giving effect to the recapitalization and activity during the year, was 3,935,892 51,219 3,884,673 2,585,297 274,162 2,311,134

Related Party Transactions

Related Party Transactions	6 Months Ended	12 Months Ended
Related Party Transactions	Jun. 30, 2024	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	5. Related Party Transactions 7GC Related Party Promissory Notes On December 21, 2022, 7GC issued an unsecured promissory note (the “December 2022 7GC Note”) to the Sponsor, 7GC & Co. Holdings LLC, which provides for borrowings from time to time of up to an aggregate of $ 2,300,000 0.0001 10.00 On October 3, 2023, 7GC issued an additional unsecured promissory note (the “October 2023 7GC Note”, together with the December 2022 7GC Note, the “ 7GC Promissory Notes”) to the Sponsor, which provides for borrowings from time to time of up to an aggregate of $ 500,000 no 10.00 Upon Closing of the Merger, Banzai assumed the 7GC Promissory Notes which subsequently converted on February 2, 2024. At the date of conversion, the total balance of the Notes converted was $ 2,540,092 Due to Related Party of 7GC During the year ended December 31, 2023, the Sponsor paid certain expenses on behalf of 7GC. Upon Closing of the Merger, Banzai assumed the $ 67,118 Legacy Banzai Related Party Transactions During 2023, Legacy Banzai issued Promissory Notes and Convertible Notes to related parties. See Note 11 - Debt	6. Related Party Transactions 7GC Related Party Promissory Notes On December 21, 2022, 7GC issued an unsecured promissory note (the “December 2022 7GC Note”) to the Sponsor, 7GC & Co. Holdings LLC, which provides for borrowings from time to time of up to an aggregate of $ 2,300,000 500,000 1,800,000 1,100,000 900,000 200,000 0.0001 10.00 177,500 122,500 500,000 900,000 1,800,000 On October 3, 2023, 7GC issued an additional unsecured promissory note (the “October 2023 7GC Note”, together with the December 2022 7GC Note, the “ 7GC Promissory Notes”) to the Sponsor, which provides for borrowings from time to time of up to an aggregate of $ 500,000 no 10.00 Upon Closing of the Merger, Banzai assumed the 7GC Promissory Notes which remained outstanding as of December 31, 2023. As of December 31, 2023, $ 2,540,091 Note 14-Debt Note 21-Subsequent Events Due to Related Party of 7GC During the year ended December 31, 2023, the Sponsor paid certain expenses on behalf of 7GC. Upon Closing of the Merger, Banzai assumed the $ 67,118 Legacy Banzai Related Party Transactions During 2022 and 2023, Legacy Banzai issued Promissory Notes and Convertible Notes to related parties. See Note 14-Debt Note 16-Simple Agreements for Future Equity

Revenue

Revenue	6 Months Ended	12 Months Ended
Revenue	Jun. 30, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue	6. Revenue Under ASC 606, revenue is recognized throughout the life of the executed agreement. The Company measures revenue based on considerations specified in terms and conditions agreed to by a customer. Furthermore, the Company recognizes revenue when a performance obligation is satisfied by transferring control of the service to the customer, which occurs over time. The Company’s services include providing end-to-end video engagement solutions that provide a fast, intuitive and powerful platform of marketing tools that create more intent-driven videos, webinars, virtual events and other digital and in-person marketing campaigns. As noted within the SOW’s and invoices, agreements range from monthly to annual and Banzai generally provides for net 30 Banzai’s Management believes its exposure to credit risk is sufficiently mitigated by collection through credit card sales or direct payment from established clients. Nature of Products and Services The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each, as applicable: Demio The Demio product is a full-stack technology that marketers can leverage live and automated for video marketing content such as webinars and virtual events. Software products are provided to Demio customers for a range of attendees and hosts within a specified time frame at a specified established price. The performance obligations identified include access to the suite and platform, within the parameters established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of webinars and hosts as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Demio services over time which corresponds with the period of time that access to the service is provided. Reach While the Reach product is in the process of being phased out, the Company continues to generate revenues from the product. The Reach product provides a multi-channel targeted audience acquisition (via Reach) to bolster engagement and Return on Investment (ROI). Banzai enables marketing teams to create winning webinars and virtual and in-person events that increase marketing efficiency and drive additional revenue. Software products are provided to Reach customers for a range of simultaneous events and registrations within a specified time frame at a specified established price. The performance obligations identified include access to the suite and platform, within the parameters established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of simultaneous published events as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Reach services over time which corresponds with the timing the service is rendered. Disaggregation of Revenue The following table summarizes revenue by region based on the billing address of customers for the three months ended June 30, 2024 and 2023: Summary of Revenue by Region Three Months Ended June 30, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue Americas $ 587,712 55 % $ 704,626 59 % Europe, Middle East and Africa (EMEA) 360,666 34 % 389,318 33 % Asia Pacific 119,819 11 % 99,377 8 % Total $ 1,068,197 100 % $ 1,193,321 100 % The following table summarizes revenue by region based on the billing address of customers for the six months ended June 30, 2024 and 2023: Six Months Ended June 30, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue Americas $ 1,170,539 55 % $ 1,374,401 62 % Europe, Middle East and Africa (EMEA) 746,916 34 % 797,228 30 % Asia Pacific 230,214 11 % 198,753 8 % Total $ 2,147,669 100 % $ 2,370,382 100 % Contract Balances Accounts Receivable, Net A receivable is recorded when an unconditional right to invoice and receive payment exists, such that only the passage of time is required before payment of consideration is due. The Company receives payments from customers based upon agreed-upon contractual terms, typically within 30 days of invoicing the customer. Summary of Accounts Receivable, Net Opening Balance Closing Balance Opening Balance Closing Balance 1/1/2024 6/30/2024 1/1/2023 6/30/2023 Accounts receivable, net $ 105,049 $ 26,161 $ 68,416 $ 109,533 Costs to Obtain a Contract Sales commissions, the principal costs incurred to obtain a contract, are earned when the contract is executed. Management has capitalized these costs and amortized the commission expense over time in accordance with the related contract’s term. For the three and six months ended June 30, 2024, commission expenses were $ 61,146 143,288 91,243 190,619 Capitalized commissions at June 30, 2024 and December 31, 2023 were $ 39,144 51,472 The following summarizes the Costs to obtain a contract activity during the three and six months ended June 30, 2024: Summary of Costs to Obtain Contract Activity Balance - December 31, 2023 $ 51,472 Commissions Incurred 31,610 Deferred Commissions Recognized (44,620 ) Balance - March 31, 2024 38,462 Commissions Incurred 48,316 Deferred Commissions Recognized (47,634 ) Balance - June 30, 2024 $ 39,144 The following summarizes the Costs to obtain a contract activity during the three and six months ended June 30, 2023: Balance - December 31, 2022 $ 69,737 Commissions Incurred 88,928 Deferred Commissions Recognized (104,289 ) Balance - March 31, 2023 54,376 Commissions Incurred 60,777 Deferred Commissions Recognized (75,001 ) Balance - June 30, 2023 $ 40,152	7. Revenue Under ASC 606, revenue is recognized throughout the life of the executed agreement. The Company measures revenue based on considerations specified in terms and conditions agreed to by a customer. Furthermore, the Company recognizes revenue when a performance obligation is satisfied by transferring control of the service to the customer, which occurs over time. The Company’s services include providing end-to-end video engagement solutions that provide a fast, intuitive and powerful platform of marketing tools that create more intent-driven videos, webinars, virtual events and other digital and in-person marketing campaigns. As noted within the SOW’s and invoices, agreements range from monthly to annual and Banzai generally provides for net 30 Banzai’s Management believes its exposure to credit risk is sufficiently mitigated by collection through credit card sales or direct payment from established clients. The Company follows the provisions of ASC 606, under which the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognize revenues following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenues when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Sales, value add, and other taxes collected on behalf of third parties are excluded from revenue. Nature of Products and Services The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each, as applicable: Demio The Demio product is a full-stack technology that marketers can leverage live and automated for video marketing content such as webinars and virtual events. Software products are provided to Demio customers for a range of attendees and hosts within a specified time frame at a specified established price. The performance obligations identified include access to the suite and platform, within the parameters established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of webinars and hosts as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Demio services over time which corresponds with the period of time that access to the service is provided. Reach While the Reach product is in the process of being phased out, the Company continues to generate revenues from the product. The Reach product provides a multi-channel targeted audience acquisition (via Reach) to bolster engagement and Return on Investment (ROI). Banzai enables marketing teams to create winning webinars and virtual and in-person events that increase marketing efficiency and drive additional revenue. Software products are provided to Reach customers for a range of simultaneous events and registrations within a specified time frame at a specified established price. The performance obligations identified include access to the suite and platform, within the parameters established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of simultaneous published events as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Reach services over time which corresponds with the timing the service is rendered. Service Trade Revenue The Company has one 375,000 293,500 Disaggregation of Revenue The following table summarizes revenue by region based on the billing address of customers: Summary of Revenue by Region Year Ended December 31, 2023 2022 Amount Percentage Amount Percentage Americas $ 2,677,050 59 % $ 3,307,129 62 % Europe, Middle East and Africa (EMEA) 1,511,886 33 % 1,588,539 30 % Asia Pacific 372,364 8 % 437,311 8 % Total $ 4,561,300 100 % $ 5,332,979 100 % Contract Balances Accounts Receivable, Net A receivable is recorded when an unconditional right to invoice and receive payment exists, such that only the passage of time is required before payment of consideration is due. The Company receives payments from customers based upon agreed-upon contractual terms, typically within 30 days of invoicing the customer. Summary of Accounts Receivable, Net For The Years Ended December 31, 2023 2022 Opening Closing Opening Closing Accounts receivable, net $ 68,416 $ 105,049 $ 74,727 $ 68,416 Costs to Obtain a Contract Sales commissions, the principal costs incurred to obtain a contract, are earned when the contract is executed. Management has capitalized these costs and amortized the commission expense over time in accordance with the related contract’s term. For the years ended December 31, 2023 and 2022, commission expenses were $ 299,450 434,446 51,472 69,737 The following summarizes the Costs to obtain a contract activity during the years ended December 31, 2023 and 2022: Summary of Costs to Obtain Contract Activity Balance-December 31, 2021 $ 90,662 Commissions Incurred 343,003 Deferred Commissions Recognized (363,928 ) Balance-December 31, 2022 69,737 Commissions Incurred 242,810 Deferred Commissions Recognized (261,075 ) Balance-December 31, 2023 $ 51,472

Fair Value Measurements

Fair Value Measurements	6 Months Ended	12 Months Ended
Fair Value Measurements	Jun. 30, 2024	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	7. Fair Value Measurements The fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of and during the periods ended June 30, 2024 and the year ended December 31, 2023. The carrying amount of accounts payable approximated fair value as they are short term in nature. Fair Value on a Non-recurring Basis The fair value of non-financial assets measured at fair value on a non-recurring basis, classified as Level 3 in the fair value hierarchy, is determined based on using market-based approaches, or estimates of discounted expected future cash flows. Fair Value on a Recurring Basis The Company follows the guidance in ASC 820 Fair Value Measurements and Disclosures The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis at June 30, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Schedule of Fair Value on Recurring Basis Description Level June 30, 2024 December 31, 2023 Liabilities: Warrant liabilities - public 1 $ 230,000 $ 575,000 GEM warrant liabilities 3 $ 79,000 $ 641,000 Yorkville convertible note 3 $ 2,013,000 $ 1,766,000 Warrant Liability - Public Warrants The Company assumed 230,000 Note 12 - Warrant Liabilities As of June 30, 2024, the Company recognized a benefit of approximately $ 345,000 The following tables set forth a summary of the changes in the fair value of the Public Warrants liability which are Level 1 financial liabilities that are measured at fair value on a recurring basis: Summary of Changes in the Fair Value of the Warrants Liability Fair Value Balance at December 31, 2023 $ 575,000 Change in fair value (115,000 ) Balance at March 31, 2024 460,000 Change in fair value (230,000 ) Balance at June 30, 2024 $ 230,000 Warrant Liability - GEM Warrants The measurement of fair value of the GEM Warrants were determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected time to conversion). Refer to Note 12 - Warrant Liabilities As of June 30, 2024, the Company recognized a benefit of approximately $ 562,000 The following tables set forth a summary of the changes in the fair value of the GEM Warrants liability which are Level 3 financial liabilities that are measured at fair value on a recurring basis: Summary of Changes in the Fair Value of the Warrants Liability Fair Value Balance at December 31, 2023 $ 641,000 Change in fair value (408,000 ) Balance at March 31, 2024 233,000 Change in fair value (154,000 ) Balance at June 30, 2024 $ 79,000 Yorkville Convertible Notes The measurement of fair value of the Yorkville convertible notes were determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, term, volatility, risk-free rate, and probability of optional redemption). Refer to Note 11 - Debt As of June 30, 2024, the Company recognized a loss of approximately $ 578,000 The following tables set forth a summary of the changes in the fair value of the Yorkville convertible notes which is a Level 3 financial liability measured at fair value on a recurring basis: Summary of Changes in Fair Value of Yorkville Convertible Note Fair Value Balance at December 31, 2023 $ 1,766,000 Issuance of Yorkville convertible note 2,250,000 Loss on debt issuance 171,000 Payment in shares to settle Yorkville convertible notes (1,667,000 ) Change in fair value 544,000 Balance at March 31, 2024 3,064,000 Payment in shares to settle Yorkville convertible notes (335,000 ) Repayment in cash of Yorkville convertible notes (750,000 ) Change in fair value 34,000 Balance at June 30, 2024 $ 2,013,000 Bifurcated Embedded Derivative Liabilities The fair value of the embedded put options, relating to the Convertible Notes - Related Party, Convertible Notes, and Term and Convertible Notes (CP BF) , 0 Note 11 - Debt The following table sets forth a summary of the changes in the fair value of the bifurcated embedded derivative liabilities for the six months ended June 30, 2023, related to the Related Party and Third Party Convertible Debt, respectively, which are Level 3 financial liabilities that are measured at fair value on a recurring basis: Schedule of Derivative Liabilities Related Party Third Party Fair Value Related Party Third Party Balance at December 31, 2022 $ 1,936,827 $ 845,473 Issuance of convertible notes with bifurcated embedded derivative 707,000 — Change in fair value 137,285 32,415 Balance at March 31, 2023 2,781,112 877,888 Issuance of convertible notes with bifurcated embedded derivative 419,451 330,390 Change in fair value (478,198 ) (194,643 ) Balance at June 30, 2023 $ 2,722,365 $ 1,013,635 Simple Agreements for Future Equity (SAFE) During 2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements (the “SAFEs”). In the event of an Equity Financing (as defined in the SAFEs agreements), the SAFEs will automatically convert into shares of the Company’s common or preferred stock at a discount of 15 Note 13 - Simple Agreements for Future Equity The fair value of the SAFEs was determined using a scenario-based method for the pre-modification SAFE’s and a Monte Carlo simulation method for the post-modification SAFEs. The value of the SAFE liability as of December 31, 2023 is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The fair value of the SAFEs on the date of issuance was determined to be $ 3,836,000 0 Note 13 - Simple Agreements for Future Equity The following tables set forth a summary of the activity of the Related Party and Third Party SAFE liabilities, respectively (See Note 13 - Simple Agreements for Future Equity Schedule of Fair Value Measurements Related Party Third Party Fair Value Related Party Third Party Balance at December 31, 2022 $ 8,802,196 $ 663,804 Change in fair value 303,139 22,861 Balance at March 31, 2023 9,105,335 686,665 Change in fair value 909,418 68,582 Balance at June 30, 2023 $ 10,014,753 $ 755,247	8. Fair Value Measurements The fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of and during the years ended December 31, 2023 and 2022. The carrying amount of accounts payable approximated fair value as they are short term in nature. Fair Value on a Non-recurring Basis The fair value of non-financial assets measured at fair value on a non-recurring basis, classified as Level 3 in the fair value hierarchy, is determined based on using market-based approaches, or estimates of discounted expected future cash flows. Fair Value on a Recurring Basis The Company follows the guidance in ASC 820 Fair Value Measurements and Disclosures The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis at December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Schedule of Fair Value on Recurring Basis Description Level December 31, December 31, Liabilities: Warrant liabilities-public 2 $ 575,000 $ - GEM warrant liabilities 3 $ 641,000 $ - Yorkville convertible note 3 $ 1,766,000 $ - Bifurcated embedded derivative liabilities 3 $ - $ 845,473 Bifurcated embedded derivative liabilities-related party 3 $ - $ 1,936,827 SAFE 3 $ - $ 663,804 SAFE-related party 3 $ - $ 8,802,196 Warrant Liability-Public Warrants The Company assumed 230,000 Note 15-Warrant Liabilities For the period from December 14, 2023 through December 31, 2023, the Company recognized a benefit of approximately $ 115,000 The estimated fair values of the Public Warrants prior to being separately listed and traded, were initially determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following tables set forth a summary of the changes in the fair value of the Public Warrants liability which are Level 2 financial liabilities that are measured at fair value on a recurring basis: Summary of Changes in the Fair Value of the Warrants Liability Fair Value Balance at December 31, 2022 $ - Merger date assumption of public warrants 460,000 Change in fair value 115,000 Balance at December 31, 2023 $ 575,000 Warrant Liability-GEM Warrants The measurement of fair value of the GEM Warrants were determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected time to conversion). Refer to Note 15-Warrant Liabilities As of December 31, 2023, the Company recognized a benefit (loss) of approximately $ 1,807,000 The following tables set forth a summary of the changes in the fair value of the GEM Warrants liability which are Level 3 financial liabilities that are measured at fair value on a recurring basis: Summary of Changes in the Fair Value of the Warrants Liability Fair Value Balance at December 31, 2022 $ - Issuance of GEM warrants 2,448,000 Change in fair value (1,807,000 ) Balance at December 31, 2023 $ 641,000 Yorkville Convertible Note The measurement of fair value of the Yorkville convertible note were determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, term, volatility, risk-free rate, and probability of optional redemption). Refer to Note 14-Debt Issuance of yorkville convertible note As of December 31, 2023, the Company recognized a benefit (loss) of approximately $( 34,000 The following tables set forth a summary of the changes in the fair value of the Yorkville convertible note which is a Level 3 financial liability measured at fair value on a recurring basis: Summary of Changes in Fair Value of Yorkville Convertible Note Fair Value Balance at December 31, 2022 $ - Issuance of yorkville convertible note 1,800,000 Change in fair value (34,000 ) Balance at December 31, 2023 $ 1,766,000 Bifurcated Embedded Derivative Liability The fair value of the embedded put option was determined using a Black Scholes option pricing model. Estimating fair values of embedded conversion features requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. Because the embedded conversion features are initially and subsequently carried at fair values, the Company’s consolidated statements of operations will reflect the volatility in these estimate and assumption changes. On December 14, 2023, all outstanding principal and accrued interest, including the carrying value of any related embedded derivative, related to the Related Party Convertible Notes and Third Party Convertible Notes converted into the Company’s Class A Common Stock pursuant to the close of the Merger Agreement. Refer to Note 14-Debt The following tables set forth a summary of the changes in the fair value of the bifurcated embedded derivative liability, related to the Related Party and Third Party Convertible Debt, respectively, which are Level 3 financial liabilities that are measured at fair value on a recurring basis: Schedule of Derivative Liabilities Fair Value Related Party Third Party Balance at December 31, 2021 $ - $ 4,000 Issuance of convertible notes with bifurcated embedded derivatives 1,398,595 586,405 Issuance of CP BF convertible notes with bifurcated embedded derivative 1,375 625 Extinguishment of Old Alco Note derivative (70,000 ) - Change in fair value 606,857 254,443 Balance at December 31, 2022 1,936,827 845,473 Issuance of convertible notes with bifurcated embedded derivative 1,126,451 559,390 Change in fair value (3,063,278 ) (1,404,863 ) Balance at December 31, 2023 $ - $ - Simple Agreements for Future Equity (SAFE) During 2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements (the “SAFEs”). In the event of an Equity Financing (as defined in the SAFEs agreements), the SAFEs will automatically convert into shares of the Company’s common or preferred stock at a discount of 15 Note 16-Simple Agreements for Future Equity The fair value of the SAFEs was determined using a scenario-based method for the pre-modification SAFE’s and a Monte Carlo simulation method for the post-modification SAFEs. The value of the SAFE liability as of December 31, 2023 and 2022 is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The fair value of the SAFEs on the date of issuance was determined to be $ 3,836,000 Note 16-Simple Agreements for Future Equity The following tables set forth a summary of the activity of the Related Party and Third Party SAFE liabilities, respectively (See Note 16-Simple Agreements for Future Equity Schedule of Fair Value Measurements Fair Value Related Party Third Party Balance at December 31, 2021 $ 3,121,591 $ 235,409 Change in fair value 4,078,431 307,569 Loss on modification 1,602,174 120,826 Balance at December 31, 2022 8,802,196 663,804 Change in fair value (2,752,430 ) (207,570 ) Conversion of SAFEs (6,049,766 ) (456,234 ) Balance at December 31, 2023 $ - $ -

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	6 Months Ended	12 Months Ended
Prepaid Expenses and Other Current Assets	Jun. 30, 2024	Dec. 31, 2023
Prepaid Expenses And Other Current Assets
Prepaid Expenses and Other Current Assets	8. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following at the dates indicated: Summary of Prepaid Expenses and Other Current Assets June 30, 2024 December 31, 2023 Prepaid expenses and other current assets: Service Trade $ 302,055 $ 364,384 Prepaid insurance costs 282,265 17,661 Prepaid advertising and marketing costs 259,438 11,074 Prepaid software costs 97,912 29,887 Prepaid commissions 39,144 51,472 Prepaid data license and subscription costs 34,375 53,124 Prepaid merchant fees 28,488 26,224 Prepaid consulting costs 26,539 120,332 Other current assets 10,720 66,997 Total prepaid expenses and other current assets $ 1,080,936 $ 741,155	10. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following at the dates indicated: Summary of Prepaid Expenses and Other Current Assets 2023 2022 December 31, 2023 2022 Prepaid expenses and other current assets: Service Trade $ 364,384 $ 97,875 Prepaid consulting costs 120,332 3,124 Prepaid data license and subscription costs 53,124 40,000 Prepaid commissions 51,472 69,737 Prepaid software costs 29,887 10,255 Prepaid merchant fees 26,224 26,401 Prepaid insurance costs 17,661 15,430 Prepaid advertising and marketing costs 11,074 32,178 Other current assets 66,997 38,507 Total prepaid expenses and other current assets $ 741,155 $ 333,507

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	6 Months Ended	12 Months Ended
Accrued Expenses and Other Current Liabilities	Jun. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	9. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following at the dates indicated: Summary of Accrued Expenses and Other Current Liabilities June 30, 2024 December 31, 2023 Accrued expenses and other current liabilities: Accrued accounting and professional services costs $ 2,458,192 $ 1,511,889 Accrued subscription costs 510,549 22,110 Sales tax payable 363,883 314,873 Excise tax payable 223,717 223,717 Accrued legal costs 159,417 2,694,439 Accrued payroll and benefit costs 123,335 185,504 Deposits 52,000 54,102 Accrued streaming service costs 48,218 37,765 Accrued offering costs - - Other current liabilities 324,717 149,841 Total accrued expenses and other current liabilities $ 4,264,028 $ 5,194,240	12. Accrued and Other Current Liabilities Accrued Expenses and Other Current Liabilities Accrued and other current liabilities consisted of the following at the dates indicated: Summary of Accrued Expenses and Other Current Liabilities December 31, December 31, Accrued and other current liabilities: Accrued legal costs $ 2,694,439 $ 31,355 Accrued accounting and professional services costs 1,511,889 94,573 Sales tax payable 314,873 230,617 Excise tax payable 223,717 - Accrued payroll and benefit costs 185,504 95,947 Deposits 54,102 - Accrued streaming service costs 37,765 - Accrued subscription costs 22,110 28,774 Accrued offering costs - 261,090 Other current liabilities 149,841 3,017 Total accrued and other current liabilities $ 5,194,240 $ 745,373

Deferred Revenue

Deferred Revenue	6 Months Ended	12 Months Ended
Deferred Revenue	Jun. 30, 2024	Dec. 31, 2023
Deferred Revenue
Deferred Revenue	10. Deferred Revenue Deferred revenue represents amounts that have been collected in advance of revenue recognition and is recognized as revenue when transfer of control to customers has occurred or services have been provided. The deferred revenue balance does not represent the total contract value of annual or multi-year, non-cancelable revenue agreements. Differences between the revenue recognized per the below schedule, and the revenue recognized per the consolidated statement of operations, reflect amounts not recognized through the deferred revenue process, and which have been determined to be insignificant. For the six months ended June 30, 2024 and 2023, the Company recognized $ 861,496 887,219 The change in deferred revenue was as follows for the periods indicated: Summary of Changes in Deferred Revenue Six Months Ended Year Ended June 30, 2024 December 31, 2023 Deferred revenue, beginning of period $ 1,214,096 $ 930,436 Billings 2,255,811 4,781,924 Revenue recognized (prior year deferred revenue) (861,496 ) (930,436 ) Revenue recognized (current year deferred revenue) (1,286,173 ) (3,567,828 ) Deferred revenue, end of period $ 1,322,238 $ 1,214,096 The deferred revenue balance is short-term and included under current liabilities on the accompanying unaudited condensed consolidated balance sheet.	13. Deferred Revenue Deferred revenue represents amounts that have been collected in advance of revenue recognition and is recognized as revenue when transfer of control to customers has occurred or services have been provided. The deferred revenue balance does not represent the total contract value of annual or multi-year, non-cancelable revenue agreements. Differences between the revenue recognized per the below schedule, and the revenue recognized per the consolidated statement of operations, reflect amounts not recognized through the deferred revenue process, and which have been determined to be insignificant. For the year ended December 31, 2023, the Company recognized $ 930,436 The change in deferred revenue was as follows for the periods indicated: Summary of Changes in Deferred Revenue 2023 2022 December 31, 2023 2022 Deferred revenue, beginning of period $ 930,436 $ 1,060,040 Billings 4,781,924 5,040,665 Revenue recognized (prior year deferred revenue) (930,436 ) (1,004,697 ) Revenue recognized (current year deferred revenue) (3,567,828 ) (4,165,572 ) Deferred revenue, end of period $ 1,214,096 $ 930,436

Debt

Debt	6 Months Ended	12 Months Ended
Debt	Jun. 30, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Debt	11. Debt Convertible Notes Convertible Notes - Related Party During 2022 and 2023, the Company issued subordinated convertible promissory notes to related parties Alco Investment Company (“Alco”), Mason Ward, DNX, and William Bryant. Alco held approximately 5 5 8 For the three and six months ended June 30, 2023, the Company recorded a $ 707,000 1,126,451 552,403 125,352 427,051 935,687 215,774 719,913 March 2023 Amendment In March 2023, the Related Party Convertible Notes were amended to extend the maturity to December 31, 2023. The Company evaluated the terms of the First Amendment in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and Extinguishments. The Company determined that the Company was granted a concession by the lender based on the decrease of the effective borrowing rate on the First Amendment. Accordingly, the Company accounted for the First Amendment as a troubled debt restructuring. As a result, the Company accounted for the troubled debt restructuring by calculating a new effective interest rate for the First Amendment based on the carrying amount of the debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring did not result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized in the future. Convertible Notes - Third Party During 2022 and 2023, the Company issued additional subordinated convertible notes (the “Third Party Convertible Notes”). The Third Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company to be issued to other investors upon a Qualified Financing (as defined in the agreement). For the three and six months ended June 30, 2023, the Company recorded a $ 0 330,390 142,353 37,845 104,508 293,977 72,562 221,415 March 2023 Amendment In March 2023, the Third Party Convertible Notes were amended to extend the maturity to December 31, 2023. The Company evaluated the terms of the First Amendment in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and Extinguishments. The Company determined that the Company was granted a concession by the lender based on the decrease of the effective borrowing rate on the First Amendment. Accordingly, the Company accounted for the First Amendment as a troubled debt restructuring. As a result, the Company accounted for the troubled debt restructuring by calculating a new effective interest rate for the First Amendment based on the carrying amount of the debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring did not result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized in the future. The following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2023: Summary of Related Party and Third Party Convertible Notes Related Party Third Party Face value of the convertible notes $ 6,783,538 $ 3,196,206 Debt discount, net (131,867 ) (83,688 ) Carrying value of the convertible notes 6,651,671 3,112,518 Accrued interest 619,697 233,714 Conversion of convertible notes (7,271,368 ) (3,346,232 ) Total convertible notes and accrued interest $ — $ — Promissory Notes Promissory Notes - Related Party On August 30, 2023, the Company issued a subordinate promissory note (“Alco August Promissory Note”) in the aggregate principal amount of $ 150,000 10 8 April 29, 2024 3,711 2,908 2,992 84 8,357 5,983 2,374 150,000 10,027 4,044 On September 13, 2023, the Company issued a subordinate promissory note (“Alco September Promissory Note”) in the aggregate principal amount of up to $ 1,500,000 8 September 30, 2024 8,588 638,808 95,935 29,918 66,017 187,498 59,836 127,662 1,500,000 90,411 30,575 On November 16, 2023, the Company issued a subordinate promissory note (“Alco November Promissory Note”) in the aggregate principal amount of up to $ 750,000 8 April 13, 2024 363,905 31,036 14,959 45,995 217,249 29,918 187,331 750,000 37,315 7,397 On December 13, 2023, the Company issued a subordinate promissory note (“Alco December Promissory Note”) in the aggregate principal amount of up to $ 2,000,000 8 December 31, 2024 1,496,252 317,667 39,890 277,777 549,883 79,780 470,103 2,000,000 87,670 7,890 In connection with the issuances of the Alco September, November, and December Promissory Notes, the Company, 7GC and the Sponsor entered into share transfer agreements (the “Alco Share Transfer Agreements”) with Alco Investment Company. Pursuant to which for each $ 500.00 500.00 3,000 1,500 12,000 180 For the Alco Share Transfer Agreements, the Company considered the guidance under ASC 815, Derivatives and Hedging, and determined that the Investor Shares underlying each of the Share Transfer Agreements described above, met the definition of a freestanding financial instrument and are not precluded from being considered indexed to the Company’s common stock. The Company determined that these shares represent a freestanding equity contract issued to the lender, resulting in a discount recorded on the notes when they are issued. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized if the contracts continue to be classified in equity. The measurement of fair value was determined utilizing various put option models in estimating the discount lack of marketability (the “DLOM”) applied to the public share price as the shares underlying each of the Share Transfer Agreements are subject to a lock-up period pursuant to each agreement, to estimate the fair value of the shares transferred. Option pricing models assume that the cost to purchase a stock option relates directly to the measurement of the DLOM. The logic behind these models is that investors may be able to quantify this price risk, due to lack of marketability, over a particular holding period where price volatility is usually estimated as a proxy for risk. The inputs and assumptions utilized in the fair value estimation included the Company’s stock price on the measurement date, a DLOM as described above, the number of shares pursuant to each Share Transfer Agreement, and a probability weighted factor for the Company’s expected percentage of completing its Business Combination, at each Share Transfer Agreement date. For the Alco September Promissory Note, of which $ 1,000,000 0.77 1,000,000 180 54.0 5.3 10.7 16.0 12.5 80 For the remaining $ 500,000 0.72 500,000 180 52.0 5.4 10.0 15.0 11.5 80 For the Alco November Promissory Note, the DLOM was estimated using the put option models described above and the following assumptions: a holding period for the shares of 208 days (approximately 0.60 180 54.0 5.2 9.5 15.0 11.5 100 For the Alco December Promissory Note, the DLOM was estimated using the put option models described above and the following assumptions: a holding period for the shares of 180 days (approximately 0.49 180 47.0 5.2 7.5 12.0 9.0 100 April 2024 and May 2024 Amendment On April 18, 2024, the Company amended the Alco August Promissory Note and Alco November Promissory Note to extend the maturity dates of each note to May 31, 2024 (the “Alco April 2024 Amendment”). On May 30, 2024, both parties agreed to again amend the Alco August Promissory Note and Alco November Promissory Note to further amend the maturity date to the earlier of (a) August 29, 2024 or (b) the closing of the next transaction (an “Offering”) in which the Company sells any of its Common Stock for cash with net proceeds of $ 4,000,000 Promissory Notes - 7GC The Company assumed two 2,540,091 17,812 Promissory Note - GEM On December 14, 2023, the Company and GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (collectively, “GEM”) agreed to terminate in its entirety the GEM Agreement, pursuant to which GEM was to purchase from the Company shares of common stock having an aggregate value up to $ 100,000,000 3 2.0 five 0 2.0 2.0 On February 5, 2024, the Company and GEM entered into a settlement agreement (the “GEM Settlement Agreement”), pursuant to which (a) the Company and GEM agreed to (i) settle the Company’s obligations under and terminate the binding term sheet entered into between Legacy Banzai and GEM, dated December 13, 2023, and (ii) terminate the share repurchase agreement, dated May 27, 2022, by and among the Company and GEM, and (b) the Company (i) agreed to pay GEM $ 1.2 1.0 100,000 1.2 The GEM Promissory Note provides that, in the event the Company fails to make a required monthly payment when due, the Company shall issue to GEM a number of shares of Class A Common Stock equal to the monthly payment amount divided by the VWAP of the Class A Common Stock for the trading day immediately preceding the applicable payment due date. In addition, the Company agreed to register on a registration statement 40,000 As of June 30, 2024, the Company has issued an aggregate of 20,902 600,000 Convertible Promissory Notes (Yorkville) On December 14, 2023, in connection with and pursuant to the terms of its Standby Equity Purchase Agreement (“SEPA”) with YA II PN, LTD, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (“Yorkville”), (refer to Note 15 - Equity 3,500,000 2,000,000 1,800,000 200,000 On February 5, 2024, the Company and Yorkville entered into a supplemental agreement (the “SEPA Supplemental Agreement”) to increase the amount of convertible promissory notes allowed to be issued under SEPA by $ 1,000,000 4,500,000 1,000,000 900,000 100,000 On March 26, 2024, the Company, in exchange for a convertible promissory note with a principal amount of $ 1,500,000 1,250,000 250,000 On May 3, 2024, the Company and Yorkville entered into a Debt Repayment Agreement (the “Original Debt Repayment Agreement”) with respect to the Yorkville Promissory Notes. Under the Original Debt Repayment Agreement, Yorkville agreed that, upon completion of a Company registered offering and repayment of an aggregate $ 2,000,000 200,000 0.0001 On May 22, 2024, the Company and Yorkville entered into an Amended and Restated Debt Repayment Agreement (the “Amended Debt Repayment Agreement”) with respect to the Yorkville Promissory Notes, which amends and restates the Original Debt Repayment Agreement. Under the Amended Debt Repayment Agreement, Yorkville has agreed that, upon completion of a registered offering and repayment of an aggregate $ 750,000 75,000 Pursuant to the terms of the Amended Repayment Agreement, the Company made a cash principal payment of $ 750,000 12,000 75,000 110,040 75,000 35,040 115,800 The Yorkville Promissory Notes have a maturity date (as modified by the Amended Debt Repayment Agreement) of September 25, 2024 0 18 Yorkville has the right to convert any portion of the outstanding principal into shares of Class A common stock at any time subsequent to the Stand-still Period through maturity. The number of shares issuable upon conversion is equal to the amount of principal to be converted (as specified by Yorkville) divided by the Conversion Price (as defined in the Standby Equity Purchase Agreement disclosure in Note 15). Yorkville will not have the right to convert any portion of the principal to the extent that after giving effect to such conversion, Yorkville would beneficially own in excess of 9.99 Additionally, the Company, at its option, shall have the right, but not the obligation, to redeem early a portion or all amounts outstanding under the Promissory Notes at a redemption amount equal to the outstanding principal balance being repaid or redeemed, plus a 10 Upon the occurrence of certain triggering events, as defined in the Yorkville Promissory Notes agreement (each an “Amortization Event”), the Company may be required to make monthly repayments of amounts outstanding under the Yorkville Promissory Notes, with each monthly repayment to be in an amount equal to the sum of (x) $ 1,000,000 10 During January 2024, the Company’s stock price per share fell below the then in effect Floor Price (as defined in the Standby Equity Purchase Agreement disclosure in Note 15) of $ 2.00 14.70 During the three and six months ended June 30, 2024, $ 300,000 800,000 20,176 35,940 1,000,000 28,910 As of June 30, 2024 and December 31, 2023, the principal amount outstanding under the Yorkville Promissory Notes was $ 1,950,000 2,000,000 80,760 The Yorkville Promissory Notes are required to be measured at fair value pursuant to ASC 480 Distinguishing Liabilities from Equity 2,013,000 1,766,000 1.88 71 0.46 14 5.28 10.0 During the three and six months ended June 30, 2024, the Company recorded a loss of $ 34,000 578,000 0.17 125 0.24 20.6 5.48 75.0 Term and Convertible Notes (CP BF) During 2021, the Company entered into a loan agreement with CP BF Lending, LLC (“CP BF”) comprised of a Term Note and a Convertible Note. The Term Note bears cash interest at a rate of 14 1.5 15.5 For all respective periods presented, the Company was not in compliance with the Minimum Gross Profit Margin covenant in section 7.14.1 of the Loan Agreement, the Minimum ARR Growth covenant in section 7.14.2 of the Loan Agreement, and the Fixed Charge Coverage Ratio covenant in section 7.14.3 of the Loan Agreement. As a result of the Company’s noncompliance with the financial covenants, the entire principal amount and all unpaid and accrued interest will be classified as current on the Company’s consolidated balance sheets. The effective interest rate for the Term Note was 16 294,613 586,940 267,359 533,707 27,254 53,233 284,097 562,261 264,320 523,763 19,777 38,498 The effective interest rate for the CP BF Convertible Note and First Amendment Convertible Note was 16 121,448 237,859 112,908 221,504 8,540 16,355 101,719 200,151 95,534 187,394 6,185 12,757 The Company utilizes a combination of scenario-based methods and Black-Scholes option pricing models to determine the average share count outstanding at conversion and the simulated price per share for the Company as of the valuation date. Key inputs into these models included the timing and probability of the identified scenarios, and for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility. The following table presents the CP BF convertible notes as of June 30, 2024: Summary of Convertible Notes Face value of the CB BF convertible notes $ 1,821,345 Debt discount, net (26,757 ) Carrying value of the CB BF convertible notes 1,794,588 Accrued interest 1,135,983 Total CB BF convertible notes and accrued interest $ 2,930,571 The following table presents the CP BF convertible notes as of December 31, 2023: Face value of the CB BF convertible notes $ 1,821,345 Debt discount, net (41,983 ) Carrying value of the CB BF convertible notes 1,779,362 Accrued interest 914,479 Total CB BF convertible notes and accrued interest $ 2,693,841 The following table presents the CP BF term note as of June 30, 2024: Face value of the CB BF term note $ 6,500,000 Debt discount, net (76,353 ) Carrying value of the CB BF term note 6,423,647 Accrued interest 664,562 Total CB BF term note and accrued interest $ 7,088,209 The following table presents the CP BF term note as of December 31, 2023: Face value of the CB BF term note $ 6,500,000 Debt discount, net (129,586 ) Carrying value of the CB BF term note 6,370,414 Accrued interest 289,373 Total CB BF term note and accrued interest $ 6,659,787	14. Debt Convertible Notes Convertible Notes-Related Party On March 21, 2022, the Company issued a subordinated convertible promissory note (“Old Alco Note”) for a principal sum of $ 2,000,000 5 15 The outstanding principal and interest under the Old Alco Note was, at the Holder’s election, either (i) effective upon the closing of an Equity Financing (as defined in the agreement), to be converted into shares of the same series of preferred stock of the Company issued to other investors in the Equity Financing (the “Equity Financing Securities”) at a conversion price equal to 85 The embedded redemption put feature upon an Equity Financing is not clearly and closely related to the debt host instrument, was separated from the debt host and initially measured at fair value. Subsequent changes in fair value of the feature are recognized in the Consolidated Statement of Operations. The fair value (see Note 8-Fair Value Measurements Discounts to the principal amounts were included in the carrying value of the Old Alco Note and amortized to interest expense over the remaining term of the underlying debt. During 2022, the Company recorded a $ 151,000 124,621 100,274 24,347 20 On July 19, 2022, the Company and Alco entered into an exchange agreement whereby Alco and the Company agreed to the cancellation of the Old Alco Note in exchange for the issuance of a new subordinated convertible promissory note in the principal amount of $ 2,101,744 Debt 56,653 Between July and September 2022, the Company issued additional subordinated convertible notes (together with the New Alco Note, the “2022 Related Party Convertible Notes”) for an aggregate amount of $ 4,200,538 2,583,000 5 The Related Party Convertible Notes bear interest at a rate of 8 80 50,000,000 The embedded redemption put feature upon an Equity Financing and the optional redemption upon a Liquidity Event at a substantial premium are not clearly and closely related to the debt host instrument, were separated and bundled together, assigned probabilities of being affected and initially measured at fair value. Subsequent changes in fair value of the feature will be recognized in the Consolidated Statement of Operations. The fair value of the bifurcated derivative liability was estimated utilizing the with and without method which uses the probability weighted difference between the scenarios with the derivative and the plain vanilla maturity scenario without a derivative (see Note 8-Fair Value Measurements Discounts to the principal amounts are included in the carrying value of the Related Party Convertible Notes and amortized to interest expense over the contractual term of the underlying debt. During 2022, the Company recorded a $ 1,311,025 1,292,777 18,248 1,126,451 2,307,013 464,071 1,842,942 March 2023 Amendment In March 2023, the 2022 Related Party Convertible Notes were amended to extend the maturity to December 31, 2023. The Company evaluated the terms of the First Amendment in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and Extinguishments. The Company determined that the Company was granted a concession by the lender based on the decrease of the effective borrowing rate on the First Amendment. Accordingly, the Company accounted for the First Amendment as a troubled debt restructuring. As a result, the Company accounted for the troubled debt restructuring by calculating a new effective interest rate for the First Amendment based on the carrying amount of the debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring did not result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized in the future. Conversion of Related Party Convertible Notes On December 14, 2023, all outstanding principal and accrued interest, net of the remaining debt discount, related to the Related Party Convertible Notes, totaling $ 7,271,368 22,929 Convertible Notes-Third Party Between July and September 2022, the Company issued additional subordinated convertible notes (the “2022 Third Party Convertible Notes”) for an aggregate amount of $ 1,761,206 1,435,000 The Third Party Convertible Notes bear interest at a rate of 8 80 50,000,000 The embedded redemption put feature upon an Equity Financing and the optional redemption upon a Liquidity Event at a substantial premium are not clearly and closely related to the debt host instrument, were separated and bundled together, assigned probabilities of being affected and initially measured at fair value. Subsequent changes in fair value of the feature will be recognized in the Consolidated Statement of Operations. The fair value of the bifurcated derivative liability was estimated utilizing the with and without method which uses the probability weighted difference between the scenarios with the derivative and the plain vanilla maturity scenario without a derivative (see Note 8-Fair Value Measurements Discounts to the principal amounts are included in the carrying value of the Third Party Convertible Notes and amortized to interest expense over the contractual term of the underlying debt. During 2022, the Company recorded a $ 548,871 541,223 7,648 559,390 1,063,093 188,059 875,034 March 2023 Amendment In March 2023, the 2022 Related Party Convertible Notes were amended to extend the maturity to December 31, 2023. The Company evaluated the terms of the First Amendment in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and Extinguishments. The Company determined that the Company was granted a concession by the lender based on the decrease of the effective borrowing rate on the First Amendment. Accordingly, the Company accounted for the First Amendment as a troubled debt restructuring. As a result, the Company accounted for the troubled debt restructuring by calculating a new effective interest rate for the First Amendment based on the carrying amount of the debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring did not result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized in the future. Conversion of Third Party Convertible Notes On December 14, 2023, all outstanding principal and accrued interest, net of the remaining debt discount, related to the Third Party Convertible Notes, totaling $ 3,346,232 10,597 The following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2023: Schedule of Related Party and Third Related Party Convertible Notes Related Party Third Party Face value of the convertible notes $ 6,783,538 $ 3,196,206 Debt discount, net (131,867 ) (83,688 ) Carrying value of the convertible notes 6,651,671 3,112,518 Accrued interest 619,697 233,714 Conversion of convertible notes (7,271,368 ) (3,346,232 ) Total convertible notes and accrued interest $ - $ - The following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2022: Related Party Third Party Face value of the convertible notes $ 4,200,538 $ 1,761,206 Debt discount, net (849,656 ) (398,034 ) Carrying value of the convertible notes 3,350,882 1,363,172 Accrued interest 155,626 45,654 Total convertible notes and accrued interest $ 3,506,508 $ 1,408,826 Promissory Notes Promissory Notes-Related Party On August 30, 2023, the Company issued a subordinate promissory note (“Alco August Promissory Note”) in the aggregate principal amount of $ 150,000 10 8 April 29, 2024 3,711 4,494 4,044 450 150,000 4,044 On September 13, 2023, the Company issued a subordinate promissory note (“Alco September Promissory Note”) in the aggregate principal amount of up to $ 1,500,000 8 January 10, 2024 8,588 638,808 478,815 30,575 448,240 1,500,000 30,575 In connection with the issuance of the Alco September Promissory Note, the Company, 7GC and the Sponsor entered into a share transfer agreement (the “Alco October Share Transfer Agreement”) with Alco Investment Company, pursuant to which for each $ 500.00 3,000 180 On November 16, 2023, the Company issued a subordinate promissory note (“Alco November Promissory Note”) in the aggregate principal amount of up to $ 750,000 8 April 13, 2024 363,905 94,005 7,397 86,608 750,000 7,397 In connection with the issuance of the Alco November Promissory Note, the Company, 7GC and the Sponsor entered into a share transfer agreement (the “November 2023 Share Transfer Agreement”) with Alco Investment Company, pursuant to which for each $ 500.00 1,500 180 On December 13, 2023, the Company issued a subordinate promissory note (“Alco December Promissory Note”) in the aggregate principal amount of up to $ 2,000,000 8 December 31, 2024 1,496,252 39,087 7,890 31,197 2,000,000 7,890 In connection with the issuance of the Alco December Promissory Note, the Company, 7GC and the Sponsor entered into a share transfer agreement (the “December 2023 Share Transfer Agreement”, together with the November 2023 Share Transfer Agreement and Alco October Share Transfer Agreement, the “Alco Share Transfer Agreements”) with Alco Investment Company, pursuant to which for each $ 500.00 12,000 180 For the Alco Share Transfer Agreements, the Company considered the guidance under ASC 815, Derivatives and Hedging, and determined that the Investor Shares underlying each of the Share Transfer Agreements described above, met the definition of a freestanding financial instrument and are not precluded from being considered indexed to the Company’s common stock. The Company determined that these shares represent a freestanding equity contract issued to the lender, resulting in a discount recorded on the notes when they are issued. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized if the contracts continue to be classified in equity. The measurement of fair value was determined utilizing various put option models in estimating the discount lack of marketability (the “DLOM”) applied to the public share price as the shares underlying each of the Share Transfer Agreements are subject to a lock-up period pursuant to each agreement, to estimate the fair value of the shares transferred. Option pricing models assume that the cost to purchase a stock option relates directly to the measurement of the DLOM. The logic behind these models is that investors may be able to quantify this price risk, due to lack of marketability, over a particular holding period where price volatility is usually estimated as a proxy for risk. The inputs and assumptions utilized in the fair value estimation included the Company’s stock price on the measurement date, a DLOM as described above, the number of shares pursuant to each Share Transfer Agreement, and a probability weighted factor for the Company’s expected percentage of completing its Business Combination, at each Share Transfer Agreement date. For the Alco September Promissory Note, of which $ 1,000,000 0.77 1,000,000 180 54.0 5.3 10.7 16.0 12.5 80 For the remaining $ 500,000 0.72 500,000 180 52.0 5.4 10.0 15.0 11.5 80 For the Alco November Promissory Note, the DLOM was estimated using the put option models described above and the following assumptions: a holding period for the shares of 208 days (approximately 0.60 180 54.0 5.2 9.5 15.0 11.5 100 For the Alco December Promissory Note, the DLOM was estimated using the put option models described above and the following assumptions: a holding period for the shares of 180 days (approximately 0.49 180 47.0 5.2 7.5 12.0 9.0 100 Modification of Alco September Promissory Note In December 2023, the September 2023 Alco Promissory Note was amended to extend the maturity date to September 30, 2024 10 Promissory Notes-7GC The Company assumed two 2,300,000 250,000 0.0001 10.00 2,550,000 2,550,000 9,909 2,540,091 Note 6-Related Party Transactions Note 21-Subsequent Events Modification of Promissory Notes-7GC On December 12, 2023, in connection with the Merger, the Sponsor came to a non-binding agreement (“First Amendment”) with the Company to amend the optional conversion provision of the 7GC Promissory Notes. The First Amendment provided that the holder has the right to elect to convert up to the full amount of the principal balance of the 7GC Promissory Notes, in whole or in part, 30 30 9,909 Convertible Promissory Notes (Yorkville) On December 14, 2023, in connection with and pursuant to the terms of its Standby Equity Purchase Agreement (“SEPA”) with YA II PN, LTD, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (“Yorkville”), (refer to Note 18-Equity 3,500,000 2,000,000 1,500,000 7,000,000 7,000,000 The Company received net proceeds of $ 1,800,000 .2 The Yorkville Convertible Note has a maturity date of June 14, 2024 0 18 Additionally, Yorkville has the right to convert any portion of the outstanding principal into shares of Class A common stock at any time. The number of shares issuable upon conversion is equal to the amount of principal to be converted (as specified by Yorkville) divided by the Conversion Price (as defined in the Standby Equity Purchase Agreement disclosure below). Yorkville will not have the right to convert any portion of the principal to the extent that after giving effect to such conversion, Yorkville would beneficially own in excess of 9.99 Additionally, the Company, at its option, shall have the right, but not the obligation, to redeem early a portion or all amounts outstanding under the Promissory Notes at a redemption amount equal to the outstanding principal balance being repaid or redeemed, plus a 10 Upon the occurrence of certain triggering events, as defined in the Yorkville Convertible Note agreement (each an “Amortization Event”), the Company may be required to make monthly repayments of amounts outstanding under the Yorkville Convertible Note, with each monthly repayment to be in an amount equal to the sum of (x) $ 1,000,000 10 Note 21-Subsequent Events As of December 31, 2023, the principal amount outstanding under the Yorkville Convertible Note is $ 2 0 The Yorkville Convertible Note is required to be measured at fair value pursuant to ASC 480 Distinguishing Liabilities from Equity 1,800,000 1,766,000 10.96 43 0.5 14.9 5.30 10.0 During the year ended December 31, 2023, the Company recorded a gain of $ 34,000 1.88 71 0.46 14 5.28 10.0 Term and Convertible Notes (CP BF) On February 19, 2021, the Company entered into a loan agreement with CP BF Lending, LLC (“CP BF”) for $ 8,000,000 6,500,000 1,500,000 7,000,000 81.25 18.75 14 monthly 15.5 20 no Additionally, the Company may voluntarily prepay the Principal of the Loans, in accordance with their terms, in whole or in part at any time. On the date of any such prepayment, the Company will owe to Lender: (i) all accrued and unpaid Cash Interest with respect to the principal amount so prepaid through the date the prepayment is made; (ii) if such prepayment is prior to the twelve-month anniversary of the Closing Date, all unpaid interest (including for the avoidance of doubt, PIK Interest and Cash Interest) with respect to the principal amount so prepaid that would have been due and payable on or prior to the twelve-month anniversary of the Closing Date had the Loans remained outstanding until such twelve-month anniversary date (the “Yield Maintenance Premium”); (iii) the Exit Fee with respect to the principal amount so prepaid, calculated as 1.0 The Loan Agreement contains customary covenants, including restrictions on the Company’s ability to incur indebtedness, grant liens or security interest on assets, make acquisitions, loans, advances or investments, or sell or otherwise transfer assets, among others. The Loan Agreement also contains other financial covenants related to minimum gross profit margin, minimum ARR (Annual Recurring Revenue) growth rate, and fixed charge ratio, among other financial covenants per the terms of the Loan Agreement. For all respective periods presented, the Company was not in compliance with the Minimum Gross Profit Margin covenant in section 7.14.1 of the Loan Agreement, the Minimum ARR Growth covenant in section 7.14.2 of the Loan Agreement, and the Fixed Charge Coverage Ratio covenant in section 7.14.3 of the Loan Agreement. As a result of the Company’s noncompliance with the financial covenants, the entire principal amount and all unpaid and accrued interest will be classified as current on the Company’s consolidated balance sheets. Upon the occurrence of an Event of Default, and at any time thereafter unless and until such Event of Default has been waived by CP BF or cured to the satisfaction of Lender, subject to the exercise of customary commercial underwriting standards in determining such satisfaction, Lender may, without notice or demand to the Credit Parties declare the unpaid principal of and any accrued interest shall be immediately due and payable. While the Company and the Lender are engaged in good faith discussions to resolve these matters, no agreement to resolve such matters has been reached and all of the Loans remain in default for the reasons stated above, and the Lender is not presently exercising remedies, which the Lender reserves the right to so do at any time. On February 19, 2021, the Company capitalized $ 310,589 71,674 The embedded redemption put feature upon a Prepayment and Default Interest triggering events that are unrelated to the creditworthiness of the Company are not clearly and closely related to the debt host instrument, were separated and bundled together, as a derivative and assigned probabilities of being affected and initially measured at fair value in the amount of $ 3,000 Note 8-Fair Value Measurements On October 10, 2022 the Loan Agreement was amended, where CP BF waived payment by the Company of four months of cash interest with respect to the Term Note in replacement for a Convertible Note (“First Amendment Convertible Note”) in the principal amount of $ 321,345 Discounts to the principal amounts, relating to the debt issuance costs and embedded features, are included in the carrying value of the Convertible Notes and amortized to interest expense over the remaining term of the underlying debt. During 2022, the Company recorded a $ 2,000 1,140,106 1,058,230 81,876 16 422,507 395,575 26,932 16 1,110,296 1,042,291 68,006 319,743 303,121 16,622 The Company utilizes a combination of scenario-based methods and Black-Scholes option pricing models to determine the average share count outstanding at conversion and the simulated price per share for the Company as of the valuation date. Key inputs into these models included the timing and probability of the identified scenarios, and for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility. Modification of Term and Convertible Notes (CP BF) On August 24, 2023, the Company entered into a forbearance agreement (the “Forbearance Agreement”) with CP BF Lending. Under the terms of this Forbearance Agreement, and as a result of the Company’s non-compliance with certain covenants of its Loan Agreement with CP BF, CP BF agreed to (i) amend certain provisions of the Loan Agreement to clarify the treatment of the Merger with 7GC under the Loan Agreement, (ii) consent to the consummation of the Merger Agreement with 7GC and (iii) forbear from exercising any of its rights and remedies under the Loan Agreement with the Company from the effective date of the Forbearance Agreement until the earlier of (a) the four-month anniversary of the closing of the Merger if the Merger is closed on or prior to December 29, 2023, (b) December 29, 2023 if the Merger is not consummated on or prior to December 29, 2023 or (c) the date on which any Termination Event (as defined within the Forbearance Agreement) shall have occurred. In connection with the Forbearance Agreement, CP BF and the Company also agreed to amend and restate CP BF’s existing convertible promissory notes (the “A&R CP BF Notes”) so that they may remain outstanding following the closing of the Merger and, at CP BF’s option, be convertible into Class A shares of the combined company. On December 14, 2023, the Company entered into the First Amendment to the Forbearance Agreement with the Lender. In particular, the Company agreed to pay the Lender an amount in cash equal to $ 23,748 The following table presents the CP BF convertible notes as of December 31, 2023: Summary of Convertible Notes Face value of the CB BF convertible notes $ 1,821,345 Debt discount, net (41,983 ) Carrying value of the CB BF convertible notes 1,779,362 Accrued interest 914,479 Total CB BF convertible notes and accrued interest $ 2,693,841 The following table presents the CP BF convertible notes as of December 31, 2022: Face value of the CB BF convertible notes $ 1,821,345 Debt discount, net (63,715 ) Carrying value of the CB BF convertible notes 1,757,630 Accrued interest 518,904 Total CB BF convertible notes and accrued interest $ 2,276,534 The following table presents the CP BF term note as of December 31, 2023: Summary of Term Notes Face value of the CB BF term note $ 6,500,000 Debt discount, net (129,586 ) Carrying value of the CB BF term note 6,370,414 Accrued interest 289,373 Total CB BF term note and accrued interest $ 6,659,787 The following table presents the CP BF term note as of December 31, 2022: Face value of the CB BF term note $ 6,500,000 Debt discount, net (192,911 ) Carrying value of the CB BF term note 6,307,089 Accrued interest 186,962 Total CB BF term note and accrued interest $ 6,494,051

Warrant Liabilities

Warrant Liabilities	6 Months Ended	12 Months Ended
Warrant Liabilities	Jun. 30, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Warrant Liabilities	12. Warrant Liabilities Public Warrants The Company assumed 230,000 The Public Warrants have an exercise price of $ 575.00 five years The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its obligations described below with respect to registration, or a valid exemption from registration is available. No 60 Redemption of Public Warrants When the price per Share of Class A Common Stock Equals or Exceeds $ 900.00 Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants: ● in whole and not in part; ● at a price of $ 0.01 ● upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and ● if, and only if, the closing price per share of Class A Common Stock equals or exceeds $ 900.00 The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the issuance of shares of Class A Common Stock issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available throughout the 30-day redemption period. If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the Public Warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public Warrants, each warrant holder will be entitled to exercise his, her or its Public Warrant prior to the scheduled redemption date. However, the price per share of Class A Common Stock may fall below the $ 900.00 575.00 No GEM Financing Arrangement In association with the GEM Letter, see Note 11 - Debt 16,571 324.50 The exercise price will be adjusted to 105% of the then-current exercise price if on the one-year anniversary date of the Effective Time, the GEM Warrant has not been exercised in full and the average closing price per share of Class A Common Stock for the 10 days preceding the anniversary date is less than 90% of the initial exercise price. GEM may exercise the GEM Warrant at any time and from time to time until December 14, 2026. The terms of the GEM Warrant provide that the exercise price of the GEM Warrant, and the number of shares of Class A Common Stock for which the GEM Warrant may be exercised, are subject to adjustment to account for increases or decreases in the number of outstanding shares of New Banzai Common Stock resulting from stock splits, reverse stock splits, consolidations, combinations and reclassifications. Additionally, the GEM Warrant contains weighted average anti-dilution provisions that provide that if the Company issues shares of common stock, or securities convertible into or exercisable or exchange for, shares of common stock at a price per share that is less than 90% of the exercise price then in effect or without consideration, then the exercise price of the GEM Warrant upon each such issuance will be adjusted to the price equal to 105% of the consideration per share paid for such common stock or other securities. In the event of a Change of Control, if the Surviving Corporation does not have registered class of equity securities and common shares listed on a U.S. national securities exchange, then the Holder is entitled to receive one percent of the total consideration received by the Company’s stockholders and the GEM Warrants will expire upon payment. The Warrants were not considered indexed to the issuer’s stock pursuant to ASC 815, as the holder’s ability to receive in lieu of the Warrant one percent of the total consideration received by the Company’s stockholders in connection with a Change of Control, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company’s control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially measured at fair value with subsequent changes in fair value recognized in earnings each reporting period. The measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected time to conversion). As of June 30, 2024 and December 31, 2023, the fair value of the Warrants, as determined by the Monte Carlo simulation option pricing model, were $ 79,000 641,000 If the per share market value of one share of Class A Common Stock is greater than the then-current exercise price, then GEM will have the option to exercise the GEM Warrant on a cashless basis and receive a number of shares of Class A Common Stock equal to (x) the number of shares of Class A Common Stock purchasable upon exercise of all of the GEM Warrant or, if only a portion of the GEM Warrant is being exercised, the portion of the GEM Warrant being exercised, less (y) the product of the then-current exercise price and the number of shares of Class A Common Stock purchasable upon exercise of all of the GEM Warrant or, if only a portion of the GEM Warrant is being exercised, the portion of the GEM Warrant being exercised, divided by the per share market value of one share of Class A Common Stock. The GEM Warrant may not be exercised if such exercise would result in the beneficial ownership of the holder and its affiliates in excess of 9.99	15. Warrant Liabilities Public Warrants The Company assumed 230,000 The Public Warrants have an exercise price of $575.00 per share, subject to adjustments, and will expire five years The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its obligations described below with respect to registration, or a valid exemption from registration is available. No The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the Merger, it will its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the Merger, the warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the Public Warrants for that number of shares of Class A Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A Common Stock underlying the Public Warrants, multiplied by the excess of the “fair market value” (as defined below) less the exercise price of the Public Warrants by (y) the fair market value. The “fair market value” as used in this paragraph shall mean the average last sale price of Class A Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the warrant holders. Redemption of Public Warrants When the price per Share of Class A Common Stock Equals or Exceeds $ 900.00 Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants: ● in whole and not in part; ● at a price of $ 0.01 ● upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and ● if, and only if, the closing price per share of Class A Common Stock equals or exceeds $ 900.00 The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the issuance of shares of Class A Common Stock issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those shares of Class A Common Stock is available throughout the 30-day redemption period. If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the Public Warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public Warrants, each warrant holder will be entitled to exercise his, her or its Public Warrant prior to the scheduled redemption date. However, the price per share of Class A Common Stock may fall below the $ 900.00 575.00 No GEM Financing Arrangement In May 2022, the Company entered into a Share Purchase Agreement with GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (collectively, “GEM”) (the “GEM Agreement”) pursuant to which, among other things, upon the terms and subject to the conditions of the GEM Agreement, GEM is to purchase from the Company (or its successor following a Reverse Merger Transaction (as defined in the GEM Agreement)) up to the number of duly authorized, validly issued, fully paid and non-assessable shares of common stock having an aggregate value of $ 100,000,000 3 650 On December 13, 2023, the Company and GEM entered into a binding term sheet (the “GEM Term Sheet”) and, on December 14, 2023, a letter agreement (the “GEM Letter”), agreeing to terminate in its entirety the GEM Agreement by and between the Company and GEM, other than with respect to the Company’s obligation (as the post-combination company in the Merger) to issue the GEM Warrant granting the right to purchase Class A Common Stock in an amount equal to 3 2.0 five 0 2.0 2.0 Note 21-Subsequent Events At Closing, the GEM Warrant automatically became an obligation of the Company, and on December 15, 2023, the Company issued the GEM Warrant granting GEM the right to purchase 828,533 6.49 The exercise price will be adjusted to 105% of the then-current exercise price if on the one-year anniversary date of the Effective Time, the GEM Warrant has not been exercised in full and the average closing price per share of Class A Common Stock for the 10 days preceding the anniversary date is less than 90% of the initial exercise price. GEM may exercise the GEM Warrant at any time and from time to time until December 14, 2026. The terms of the GEM Warrant provide that the exercise price of the GEM Warrant, and the number of shares of Class A Common Stock for which the GEM Warrant may be exercised, are subject to adjustment to account for increases or decreases in the number of outstanding shares of New Banzai Common Stock resulting from stock splits, reverse stock splits, consolidations, combinations and reclassifications. Additionally, the GEM Warrant contains weighted average anti-dilution provisions that provide that if the Company issues shares of common stock, or securities convertible into or exercisable or exchange for, shares of common stock at a price per share that is less than 90% of the exercise price then in effect or without consideration, then the exercise price of the GEM Warrant upon each such issuance will be adjusted to the price equal to 105% of the consideration per share paid for such common stock or other securities. In the event of a Change of Control, if the Surviving Corporation does not have registered class of equity securities and common shares listed on a U.S. national securities exchange, then the Holder is entitled to receive one percent of the total consideration received by the Company’s stockholders and the GEM Warrants will expire upon payment. The Warrants were not considered indexed to the issuer’s stock pursuant to ASC 815, as the holder’s ability to receive one percent of the total consideration received by the Company’s stockholders in connection with a Change of Control in lieu of the Warrant, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company’s control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially measured at fair value with subsequent changes in fair value recognized in earnings each reporting period. The measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected time 1to conversion). The fair value of the Warrants on the grant date, as determined by the Monte Carlo simulation option pricing model, was $ 2,448,000 641,000 If the per share market value of one share of Class A Common Stock is greater than the then-current exercise price, then GEM will have the option to exercise the GEM Warrant on a cashless basis and receive a number of shares of Class A Common Stock equal to (x) the number of shares of Class A Common Stock purchasable upon exercise of all of the GEM Warrant or, if only a portion of the GEM Warrant is being exercised, the portion of the GEM Warrant being exercised, less (y) the product of the then-current exercise price and the number of shares of Class A Common Stock purchasable upon exercise of all of the GEM Warrant or, if only a portion of the GEM Warrant is being exercised, the portion of the GEM Warrant being exercised, divided by the per share market value of one share of Class A Common Stock. The GEM Warrant is subject to a restriction on exercise of the GEM Warrant such that the GEM Warrant may not be exercised if such exercise would result in the beneficial ownership of the holder and its affiliates in excess of 9.99

Simple Agreements for Future Eq

Simple Agreements for Future Equity	6 Months Ended	12 Months Ended
Simple Agreements for Future Equity	Jun. 30, 2024	Dec. 31, 2023
Simple Agreements For Future Equity
Simple Agreements for Future Equity	13. Simple Agreements for Future Equity Simple Agreements for Future Equity - Related Party During 2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements with related parties Alco, DNX and William Bryant (See Note 11 - Debt 3,567,000 15 3,567,000 909,418 1,212,557 The Company utilizes a combination of scenario-based methods and Monte Carlo simulation to determine the fair value of the Related Party SAFE liability as of the valuation dates. Key inputs into these models included the timing and probability of the identified scenarios, and for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility. On December 14, 2023, all outstanding principal related to the Related Party SAFEs at a carrying value of $ 6,049,766 11,039 Simple Agreements for Future Equity - Third Party During 2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements with third party investors (the “Third Party SAFEs”) pursuant to which the Company received gross proceeds in the amount of $ 269,000 15 269,000 68,582 91,443 The Company utilizes a combination of scenario-based methods and Monte Carlo simulation to determine the fair value of the Third Party SAFE liability as of the valuation dates. Key inputs into these models included the timing and probability of the identified scenarios, and for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility. On December 14, 2023, all outstanding principal related to the Third Party SAFEs at a carrying value of $ 456,234 833	16. Simple Agreements for Future Equity Simple Agreements for Future Equity-Related Party During 2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements with related parties Alco, DNX and William Bryant (See Note 14-Debt 3,567,000 15 3,567,000 2,752,430 4,078,431 The Company utilizes a combination of scenario-based methods and Monte Carlo simulation to determine the fair value of the Related Party SAFE liability as of the valuation dates. Key inputs into these models included the timing and probability of the identified scenarios, and for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility. On September 2, 2022, the Company modified the SAFE agreements pursuant to approval by the holders. In accordance with the modified terms, in the event of an Equity Financing or SPAC Transaction, the Related Party SAFEs will automatically convert into shares of the Company’s common or preferred stock at the lesser of (a) the Discount Price for an Equity Financing (Liquidity Price (as defined in the agreements) for a SPAC Transaction) or (b) the conversion price obtained by dividing $ 50,000,000 1,602,174 On December 14, 2023, all outstanding principal related to the Related Party SAFEs at a carrying value of $ 6,049,766 11,039 Simple Agreements for Future Equity-Third Party During 2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements with third party investors (the “Third Party SAFEs”) pursuant to which the Company received gross proceeds in the amount of $ 269,000 15 269,000 207,570 307,569 The Company utilizes a combination of scenario-based methods and Monte Carlo simulation to determine the fair value of the Third Party SAFE liability as of the valuation dates. Key inputs into these models included the timing and probability of the identified scenarios, and for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility. On September 2, 2022, the Company modified the Third Party SAFE agreements pursuant to approval by the holders. In accordance with the modified terms, in the event of an Equity Financing or SPAC Transaction, the Third Party SAFEs will automatically convert into shares of the Company’s common or preferred stock at the lesser of (a) the Discount Price for an Equity Financing (Liquidity Price (as defined in the agreements) for a SPAC Transaction) or (b) the conversion price obtained by dividing $ 50,000,000 120,826 On December 14, 2023, all outstanding principal related to the Third Party SAFEs at a carrying value of $ 456,234 833

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended	12 Months Ended
Commitments and Contingencies	Jun. 30, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	14. Commitments and Contingencies Leases The Company has operating leases for its real estate across multiple states. The operating leases have remaining lease terms of approximately 0.26 The lease agreements generally do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach to derive an appropriate incremental borrowing rate to discount remaining lease payments. Leases with an initial term of twelve months or less are not recorded on the balance sheet. There are no material residual guarantees associated with any of the Company’s leases, and there are no significant restrictions or covenants included in the Company’s lease agreements. Certain leases include variable payments related to common area maintenance and property taxes, which are billed by the landlord, as is customary with these types of charges for office space. The Company has not entered into any lease arrangements with related parties. The Company’s existing leases contain escalation clauses and renewal options. The Company is not reasonably certain that renewal options will be exercised upon expiration of the initial terms of its existing leases. The Company entered into a sublease which it has identified as an operating lease prior to the adoption of ASC 842 Leases The components of lease expense for the three months ended June 30, 2024 and 2023, are as follows: Schedule of Components of Lease Expense Components of lease expense: 2024 2023 For the Three Months Ended June 30, Components of lease expense: 2024 2023 Operating lease cost $ 46,140 $ 50,440 Lease impairment cost - - Sublease income (52,542 ) (51,082 ) Total lease (income) cost $ (6,402 ) $ (642 ) The components of lease expense for the six months ended June 30, 2024 and 2023, are as follows: Components of lease expense: 2024 2023 For the Six Months Ended June 30, Components of lease expense: 2024 2023 Operating lease cost $ 93,384 $ 101,888 Lease impairment cost - - Sublease income (105,084 ) (102,165 ) Total lease (income) cost $ (11,700 ) $ (277 ) Supplemental cash flow information related to leases are as follows: Schedule of Supplemental Cash Flow Information Related to Leases Supplemental cash flow information: 2024 2023 For the Six Months Ended June 30, Supplemental cash flow information: 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Non-cash lease expense (operating cash flow) $ 87,579 $ 86,320 Change in lease liabilities (operating cash flow) (152,335 ) (138,804 ) Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Related to Leases Operating leases: June 30, 2024 December 31, 2023 Operating lease right-of-use assets $ 46,434 $ 134,013 Operating lease liability, current 81,708 234,043 Operating lease liability, non-current - Total operating lease liabilities $ 81,708 $ 234,043 Weighted-average remaining lease term: June 30, 2024 December 31, 2023 Operating leases (in years) 0.26 0.76 Weighted-average discount rate: June 30, 2024 December 31, 2023 Operating leases 6.83 % 6.76 % Future minimum lease payments under non-cancellable lease as of June 30, 2024, are as follows: Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease Maturities of lease liabilities: Year Ending December 31, Remainder of 2024 $ 82,679 Year Ending December 31, 2024 $ - Total undiscounted cash flows 82,679 Less discounting (971 ) Present value of lease liabilities $ 81,708 Cantor Fee Agreement In connection with the Merger, 7GC previously agreed to pay Cantor Fitzgerald & Co. (“Cantor” or “CF&CO”) an Original Deferred Fee of $ 8,050,000 4,050,000 8,050,000 4,000,000 Pursuant to the Fee Reduction Agreement, the Company agreed to use its reasonable best efforts to have the registration statement declared effective by the SEC by the 120th calendar day after December 29, 2023, the date of the initial filing thereof, and to maintain the effectiveness of such registration statement until the earliest to occur of (i) the second anniversary of the date of the effectiveness thereof, (ii) the Cantor Fee Shares shall have been sold, transferred, disposed of or exchanged by Cantor, and (iii) the Cantor Fee Shares issued to Cantor may be sold without registration pursuant to Rule 144 under the Securities Act (such obligations, the “Cantor Registration Rights Obligations”). Although the Company issued the Cantor Fee Shares, as of June 30, 2024, the Company has not satisfied its Cantor Registration Rights Obligations. As such, the Company cannot conclude that it has settled its outstanding obligations to Cantor. Therefore, neither criteria under ASC 405 for extinguishment and derecognition of the liability were satisfied and the $ 4,000,000 At each interim and annual period after December 31, 2023, the Company will monitor its compliance with the Cantor Registration Rights Obligations to determine whether the entire amount of the Reduced Deferred Fee has become due and payable in cash, or the Company’s obligations have been satisfied and the remaining liability should be derecognized. At such time as the Company’s obligations under the Fee Reduction Agreement have been satisfied the relief of the liability will be recorded through equity. Roth Addendum to Letter Agreements On October 13, 2022, Roth Capital Partners, LLC (“Roth”) and Legacy Banzai entered into the Roth Engagement Letter, pursuant to which Legacy Banzai engaged Roth as a financial advisor in connection with the Merger and, on October 14, 2022, MKM and 7GC entered into the MKM Engagement Letter, pursuant to which 7GC engaged MKM as a financial advisor in connection with the Merger. In February 2023, Roth acquired MKM. On December 8, 2023, the Company received an invoice from Roth for an advisory fee in the amount of $ 1,100,000 6,813 1,106,813 On February 2, 2024, the Company and Roth entered into an addendum to (i) the engagement letter, dated October 13, 2022, by and between Roth and Legacy Banzai, and (ii) the engagement letter, dated October 14, 2022, by and between Roth (as successor to MKM Partners, LLC) and 7GC (such engagement agreements, collectively, the “Roth Engagement Agreements,” and such addendum, the “Roth Addendum”). Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred in 2024, and owed under the Roth Engagement Agreements (collectively, the “Roth Fee”), the Company (i) issued to Roth 3,500 300,000 300,000 12,000 12,000 300,000 On February 2, 2024, the Company issued the 3,500 278,833 300,000 300,000 3,500 806,813 577,513 Legal Matters In the regular course of business affairs and operations, the Company is subject to possible loss contingencies arising from third-party litigation and federal, state, and local environmental, labor, health and safety laws and regulations. The Company assesses the probability that they may incur a liability in connection with certain of these lawsuits. The Company’s assessments are made in accordance with generally accepted accounting principles, as codified in ASC 450-20, and is not an admission of any liability on the part of the Company or any of its subsidiaries. In certain cases that are in the early stages and in light of the uncertainties surrounding them, the Company does not currently possess sufficient information to determine a range of reasonably possible liability.	17. Commitments and Contingencies Leases The Company has operating leases for its real estate across multiple states. The operating leases have remaining lease terms of approximately 0.76 The lease agreements generally do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach to derive an appropriate incremental borrowing rate to discount remaining lease payments. Leases with an initial term of twelve months or less are not recorded on the balance sheet. There are no material residual guarantees associated with any of the Company’s leases, and there are no significant restrictions or covenants included in the Company’s lease agreements. Certain leases include variable payments related to common area maintenance and property taxes, which are billed by the landlord, as is customary with these types of charges for office space. The Company has not entered into any lease arrangements with related parties. The Company’s existing leases contain escalation clauses and renewal options. The Company is not reasonably certain that renewal options will be exercised upon expiration of the initial terms of its existing leases. Prior to adoption of ASU 2016-02 effective January 1, 2022, the Company accounted for operating lease transactions by recording lease expense on a straight-line basis over the expected term of the lease. The Company entered into a sublease which it has identified as an operating lease prior to the adoption of ASC 842 Leases In evaluating long-lived assets for recoverability, the Company calculated the fair value of the sublease using its best estimate of future cash flows expected to result from the use of the asset. When undiscounted cash flows to be generated through the sublease is less than the carrying value of the underlying asset, the asset is deemed impaired. If it is determined that assets are impaired, an impairment loss is recognized for the amount that the asset’s book value exceeds its fair value. Based on the expected future cash flows, the Company recognized an impairment loss upon adoption of ASC 842 Leases 303,327 The components of lease expense, are as follows: Schedule of Components of Lease Expense For the Year Ended December 31, Components of lease expense: 2023 2022 Operating lease cost $ 199,611 $ 191,483 Lease impairment cost - 303,327 Sublease income (204,324 ) (177,588 ) Total lease (income) cost $ (4,713 ) $ 317,222 Supplemental cash flow information related to leases are as follows: Schedule of Supplemental Cash Flow Information Related to Leases For the Year Ended December 31, Supplemental cash flow information: 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Non-cash lease expense (operating cash flow) $ 173,245 $ 152,018 Non-cash impairment of right to use assets (operating cash flow) - (303,327 ) Change in lease liabilities (operating cash flow) (284,963 ) (243,596 ) Operating lease right-of-use assets obtained in exchange for lease obligations: Operating leases $ - $ 762,603 Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Related to Leases Operating leases: December 31, December 31, Operating lease right-of-use assets $ 134,013 $ 307,258 Operating lease liability, current 234,043 284,963 Operating lease liability, long-term - 234,043 Total operating lease liabilities $ 234,043 $ 519,006 Weighted-average remaining lease term: December 31, December 31, Operating leases (in years) 0.76 1.76 Weighted-average discount rate: December 31, December 31, Operating leases 6.76 % 6.74 % Future minimum lease payments under non-cancellable lease as of December 31, 2023, are as follows: Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease Maturities of lease liabilities: Maturities of lease liabilities: Year Ending December 31, 2024 $ 240,818 Total undiscounted cash flows 240,818 Less discounting (6,775 ) Present value of lease liabilities $ 234,043 Cantor Fee Agreement In connection with the Merger, 7GC previously agreed to pay Cantor an Original Deferred Fee of $ 8,050,000 4,050,000 8,050,000 4,000,000 400,000 Note 4-Merger Pursuant to the Fee Reduction Agreement, the Company also agreed to use its reasonable best efforts to have the registration statement declared effective by the SEC by the 120th calendar day after December 29, 2023, the date of the initial filing thereof, and to maintain the effectiveness of such registration statement until the earliest to occur of (i) the second anniversary of the date of the effectiveness thereof, (ii) the Cantor Fee Shares shall have been sold, transferred, disposed of or exchanged by Cantor, and (iii) the Cantor Fee Shares issued to Cantor may be sold without registration pursuant to Rule 144 under the Securities Act (such obligations, the “Cantor Registration Rights Obligations”). On December 28, 2023, the Company and Cantor amended the Fee Reduction Agreement to provide that the Reduced Deferred Fee was payable in the form of 22,279 22,279 2,450,639 110.00 4,000,000 At each interim period after December 31, 2023, the Company will monitor its compliance with the Cantor Registration Rights Obligations to determine whether the entire amount of the Reduced Deferred Fee has become due and payable in cash, or the Company’s obligations have been satisfied and the remaining liability should be derecognized. At such time as the Company’s obligations under the Fee Reduction Agreement have been satisfied the relief of the liability will be recorded through equity. Legal Matters In the regular course of business affairs and operations, we are subject to possible loss contingencies arising from third-party litigation and federal, state, and local environmental, labor, health and safety laws and regulations. We assess the probability that we could incur liability in connection with certain of these lawsuits. Our assessments are made in accordance with generally accepted accounting principles, as codified in ASC 450-20, and is not an admission of any liability on the part of the Company or any of its subsidiaries. In certain cases that are in the early stages and in light of the uncertainties surrounding them, we do not currently possess sufficient information to determine a range of reasonably possible liability.

Equity

Equity	6 Months Ended	12 Months Ended
Equity	Jun. 30, 2024	Dec. 31, 2023
Equity [Abstract]
Equity	15. Equity Class A and B Common Stock The Company is authorized to issue up to 275,000,000 25,000,000 25,000,000 0.0001 As discussed in Note 4 - Reverse Merger Capitalization with 7GC & Co. Holdings Inc. The Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each matter properly submitted to the stockholders entitled to vote thereon. There were 3,003,810 692,676 2,311,134 2,585,296 274,162 2,311,134 May 22, 2024 Equity Financing On May 22, 2024, Banzai entered into a securities purchase agreement with accredited investors, providing for the issuance and sale of 104,556 173,222 277,778 9.00 9.00 0.0050 2.5 A.G.P./Alliance Global Partners (“AGP”) acted as placement agent for the May 2024 Offering, pursuant to a placement agency agreement, dated May 22, 2024, between the Company and AGP (the “Placement Agency Agreement”). Under the Placement Agency Agreement, AGP received a fee in the form of (a) a cash fee equal to 7.0% of the aggregate purchase price paid by each purchaser of securities that were sold in the May 2024 Offering (the “Cash Fee”); provided, however, that the Cash Fee was reduced by an amount equal to $ 25,000 The Company additionally incurred approximately $ 409,000 May 22, 2024 Common Warrants As discussed above, on May 22, 2024, in conjunction with the issuance and sale of 104,556 277,778 9.00 9.00 five years 87 4.6 0 722,000 May 22, 2024 Pre-Funded Warrants As discussed above, on May 22, 2024, in conjunction with the issuance and sale of 104,556 173,222 660,000 May 22, 2024 Placement Agent Warrants As discussed above, on May 22, 2024, in conjunction with the issuance and sale of 104,556 16,667 100,000 9.00 9.00 five years 87 4.6 0 Preferred Stock The Company is authorized to issue 75,000,000 0.0001 no Yorkville Standby Equity Purchase Agreement (“SEPA”) On December 14, 2023, the Company entered into the SEPA with YA II PN, LTD, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (“Yorkville”) in connection with the Merger. Pursuant to the SEPA, subject to certain conditions, the Company shall have the option, but not the obligation, to sell to Yorkville, and Yorkville shall subscribe for, an aggregate amount of up to up to $ 100,000,000 0.0001 Each advance (each, an “Advance”) the Company requests under the SEPA (notice of such request, an “Advance Notice”) may be for a number of shares of Class A common stock up to the greater of (i) 10,000 9.99 (i) 95 (ii) 96 Any purchase under an Advance would be subject to certain limitations, including that Yorkville shall not purchase or acquire any shares that would result in it and its affiliates beneficially owning more than 9.99 19.99 0.0001 The SEPA Option was determined to be a freestanding financial instrument which did not meet the criteria to be accounted for as a derivative instrument or to be recognized within equity. Pursuant to ASC 815 Derivatives and Hedging 0 In connection with the execution of the SEPA, the Company agreed to pay a commitment fee of $ 500,000 14,201 Pursuant to the terms of the SEPA, at any time that there is a balance outstanding under the Yorkville Promissory Notes, Yorkville has the right to receive shares to pay down the principal balance, and may select the timing and delivery of such shares (via an “Investor Notice”), in an amount up to the outstanding principal balance on the Yorkville Promissory Notes at a purchase price equal to the lower of (i) $ 500.00 90 100.00 The Floor Price shall be adjusted (downwards only) to equal 20% of the average VWAP for the five trading days immediately prior to the date of effectiveness of the initial Registration Statement. 75 100.00 There were no Advance Notices issued pursuant to the SEPA during the period ended June 30, 2024 or as of the date that these financial statements were issued, apart from the Premium Advance which was issued pursuant to the terms of the Amended Debt Agreement (see Note 11 - Debt	18. Equity Class A and B Common Stock The Company is authorized to issue up to 275,000,000 250,000,000 25,000,000 0.0001 As discussed in Note 4-Reverse Merger Capitalization with 7GC & Co. Holdings Inc. Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each matter properly submitted to the stockholders entitled to vote thereon. Preferred Stock The Company is authorized to issue 75,000,000 0.0001 no On December 14, 2023, pursuant to the Merger, 2,328,823 28,629 Note 4-Reverse Merger Capitalization with 7GC & Co. Holdings Inc. Restricted Stock In connection with the acquisition of Demio and High Attendance, the Company issued restricted stock to the selling securityholders and founders of Demio. 14,916 1,638 Yorkville Standby Equity Purchase Agreement (“SEPA”) On December 14, 2023, the Company entered into the SEPA with YA II PN, LTD, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (“Yorkville”) in connection with the Merger. Pursuant to the SEPA, subject to certain conditions, the Company shall have the option, but not the obligation, to sell to Yorkville, and Yorkville shall subscribe for, an aggregate amount of up to up to $ 100,000,000 0.0001 Each advance (each, an “Advance”) the Company requests under the SEPA (notice of such request, an “Advance Notice”) may be for a number of shares of Class A common stock up to the greater of (i) 10,000 shares or (ii) such amount as is equal to 100% of the average daily volume traded of Class A common stock during the five trading days immediately prior to the date the Company requests each Advance; 9.99 i) 95 ii) 96 Any purchase under an Advance would be subject to certain limitations, including that Yorkville shall not purchase or acquire any shares that would result in it and its affiliates beneficially owning more than 9.99 19.99 0.0001 The SEPA Option was determined to be a freestanding financial instrument which did not meet the criteria to be accounted for as a derivative instrument or to be recognized within equity. Pursuant to ASC 815 Derivatives and Hedging 0 In connection with the execution of the SEPA, the Company paid a cash structuring fee to Yorkville in the amount of $ 35,000 6,000 3,288,000 500,000 3,823,000 Pursuant to the terms of the SEPA, at any time that there is a balance outstanding under the Yorkville Convertible Note, Yorkville has the right to receive shares to pay down the principal balance, and may select the timing and delivery of such shares (via an “Investor Notice”), in an amount up to the outstanding principal balance on the Yorkville Convertible Note at a purchase price equal to the lower of (i) $ 10.00 90 2.00 The Floor Price shall be adjusted (downwards only) to equal 20% of the average VWAP for the five trading days immediately prior to the date of effectiveness of the initial Registration Statement. 75 2.00 Note 21 Subsequent Events There were no Advance Notices issued pursuant to the SEPA during the year ended December 31, 2023 or as of the date that these financial statements were issued. Cantor Fee Agreement On December 28, 2023, the Company issued 22,279 Note 17-Commitments and Contingencies

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended	12 Months Ended
Stock-Based Compensation	Jun. 30, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	16. Stock-Based Compensation During 2023, the Company adopted the 2023 Employee Stock Purchase Plan (the “Purchase Plan”). The Purchase Plan permits eligible employees of the Company and certain designated companies as determined by the Board of Directors, to purchase shares of the Company’s Common Stock. The aggregate number of shares of common stock that may be purchased pursuant to the Purchase Plan is equal to 2% of the fully diluted common stock determined at the Close of the Merger Agreement, determined to be 11,443 10 January 1, 2033 11,443 11,443 During 2023, the Company adopted the 2023 Equity Incentive Plan (the “Plan”). The Plan permits the granting of incentive stock options, nonstatutory stock options, SARs, restricted stock awards, RSU awards, performance awards, and other awards. to employees, directors, and consultants. The aggregate number of shares of common stock that may be issued will not exceed approximately 12.5% of the fully diluted common stock determined at the Close of the Merger, determined to be 71,522 ten years January 1, 2033 71,522 35,276 71,522 The Company accounts for stock-based payments pursuant to ASC 718 Stock Compensation The following table summarizes assumptions used to compute the fair value of options granted: Summary of Assumptions Used to Compute Fair Value June 30, 2024 June 30, 2023 Stock price $ 0.29 0.61 $ 8.22 9.56 Exercise price $ 0.29 5.00 $ 11.98 Expected volatility 75.00 85.00 % 80.00 99.03 % Expected term (in years) 5.75 10.00 5.25 6.08 Risk-free interest rate 4.20 4.50 % 3.46 4.31 % A summary of stock option activity under the Plan is as follows: Summary of Stock Option Activity Shares Weighted Weighted Intrinsic Outstanding at December 31, 2023 14,962 $ 293.50 8.43 $ 103,662 Granted 27,970 145.70 9.87 Exercised — — Expired — — Forfeited (9,283 ) 239.11 Outstanding at June 30, 2024 33,649 $ 185.69 9.17 $ 1,807 Exercisable at June 30, 2024 8,675 $ 248.23 8.34 $ 1,807 In connection with issuances under the Plan, the Company recorded stock-based compensation expense of $ 457,231 620,987 8.60 426.61 1,262,655 2,575,808 3.80 2.97 RSUs During the three and six months ended June 30, 2024, the Company began issuing RSUs to employees and to non-employee directors. Each RSU entitles the recipient to one share of Class A Common Stock upon vesting. We measure the fair value of RSUs using the stock price on the date of grant. Stock-based compensation expense for employee-granted RSUs is recorded ratably over their vesting period of four years A summary of the activity with respect to, and status of, RSUs during the six months ended June 30, 2024 is presented below: Summary of Activity with Respect Status of, RSUs Units Weighted Average Outstanding at December 31, 2023 — $ — Granted 17,851 26.64 Vested — — Forfeited (293 ) 14.65 Outstanding at June 30, 2024 17,558 $ 26.84 For the six months ended June 30, 2024, the Company recorded stock-based compensation expense of $ 208,178 263,144 1.3	19. Stock-Based Compensation Prior to the Merger, the Company established the Banzai International, Inc. 2016 Equity Incentive Plan (“the 2016 Plan”) on April 26, 2016, to enable the Company to attract, incentivize and retain eligible individuals through the granting of awards in the Company. The maximum number of options that may be issued over the term of the Plan were initially set at 8,000 48,000 11,443 During 2023, the Company adopted the 2023 Equity Incentive Plan (the “2023 Plan”). The 2023 Plan permits the granting of incentive stock options, nonstatutory stock options, SARs, restricted stock awards, RSU awards, performance awards, and other awards. to employees, directors, and consultants. The aggregate number of shares of common stock that may be issued will not exceed approximately 12.5% of the fully diluted common stock determined at the Close of the Merger. In addition, the aggregate number of shares of common stock will automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2024 and ending on January 1, 2033 The Company accounts for stock-based payments pursuant to ASC 718 Stock Compensation zero On December 3, 2023, the Board of Directors of Banzai approved the repricing of 7,193 257.50 The incremental compensation cost was measured as the fair value of the stock options immediately before and immediately after the modification. The Company determined the total incremental compensation cost from the modification to be $ 113,475 23,849 89,626 In connection with the Merger, each option of Banzai that was outstanding and unexercised immediately prior to the Effective Time (whether vested or unvested) was assumed by 7GC and converted into an option to acquire an adjusted number of shares of Common Stock at an adjusted exercise price per share (the “Substitute Options”), based on the Option Exchange Ratio (of 0.6147 Upon the closing of the Merger, the outstanding and unexercised Banzai stock options became options to purchase an aggregate 14,962 293.50 The following table summarizes assumptions used to compute the fair value of options granted: Summary of Assumptions Used to Compute Fair Value December 31, December 31, Stock price $ 8.38 11.98 $ 1.54 Exercise price $ 8.38 11.98 $ 1.04 Expected volatility 80.00 110.95 % 53.61 55.30 % Expected term (in years) 5.00 6.08 5.94 6.08 Risk-free interest rate 3.46 4.31 % 1.95 2.85 % A summary of stock option activity under the Plan is as follows: Summary of Stock Option Activity Shares Weighted Weighted Intrinsic Outstanding at December 31, 2021 14,634 $ 57.50 7.20 $ 369,102 Retroactive application of recapitalization (Note 4) (6,024 ) 36.05 Outstanding at December 31, 2021, after effect of Merger (Note 4) 9,610 93.55 Granted 4,702 138.50 Exercised (171 ) 62.00 10,835 Expired (2,411 ) 69.00 Forfeited (4,310 ) 129.50 Outstanding at December 31, 2022 7,420 $ 106.44 7.95 $ 3,433,946 Granted 16,440 500.50 Exercised (353 ) 109.56 4,440 Expired (258 ) 598.50 Forfeited (8,287 ) 538.00 Outstanding at December 31, 2023 14,962 $ 293.50 8.43 $ 103,662 Exercisable at December 31, 2023 6,900 $ 211.50 7.56 $ 103,251 In connection with issuances under the Plan, the Company recorded stock-based compensation expense of $ 1,245,796 770,336 4.86 0.77 2,594,571 160,203 2.73 2.74

Income Taxes

Income Taxes	6 Months Ended	12 Months Ended
Income Taxes	Jun. 30, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	17. Income Taxes The Company estimates an annual effective tax rate of 0 Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate Schedule of Components of Income Tax Provision (Benefit) Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities Due to the Company’s history of losses since inception, there is not enough evidence at this time to support that the Company will generate future income of a sufficient amount and nature to utilize the benefits of its net deferred tax assets. Accordingly, the deferred tax assets have been reduced by a full valuation allowance, since the Company cannot currently support that realization of its deferred tax assets is more likely than not. At June 30, 2024, the Company had no unrecognized tax benefits that would reduce the Company’s effective tax rate if recognized.	20. Income Taxes A reconciliation of the statutory U.S. federal income tax rate to the Company’s effective tax rate consists of the following: Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate For the Years Ended December 31, 2023 2022 Statutory federal income tax benefit $ (3,025,315 ) 21.0 % $ (3,248,385 ) 21.0 % State taxes, net of federal tax benefit (219,705 ) 1.5 % (327,095 ) 2.1 % Change in valuation allowance 2,079,231 -14.4 % 1,435,041 -9.3 % Change in state tax rate 462,709 -3.2 % 13,055 -0.1 % Change in fair value estimates (2,050,026 ) 14.2 % 1,610,993 -10.4 % Non-deductible interest-IRC 163(j) 738,993 -5.1 % - 0.0 % Non-deductible transaction/restructuring costs 1,313,792 -9.1 % - 0.0 % Nondeductible warrant issuance expense 552,321 -3.8 % - 0.0 % Other non-deductible expenses 148,000 -1.0 % 516,391 -3.3 % Effective tax rate $ - 0.0 % $ - 0.0 % The components of income tax provision (benefit) are as follows: Schedule of Components of Income Tax Provision (Benefit) 2023 2022 As of December 31, 2023 2022 Federal: Current $ - $ - Deferred - - State and Local: Current - - Deferred - - Total $ - $ - Deferred income taxes reflect the net tax effects of temporary differences between the carrying value of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. The temporary differences that give rise to deferred tax assets and liabilities are as follows: Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities 2023 2022 As of December 31, 2023 2022 Deferred tax assets (liabilities): Net operating loss carryforwards $ 6,368,669 $ 3,744,512 Contribution carryforwards 24,626 20,837 Stock-based compensation 155,404 25,216 Accrual to cash adjustment 1,299 482,109 Startup costs 1,816,143 - Lease Liabilities 52,805 119,971 Right of use assets (30,236 ) (71,024 ) Capitalized R&D costs (Sec. 174) 798,802 451,195 Other (3,363 ) 696 Deferred tax assets gross 9,184,149 4,773,512 Valuation allowance (9,184,149 ) (4,773,512 ) Deferred tax assets, net of allowance $ - $ - As of December 31, 2023, the Company had federal and state net operating loss carryforwards of approximately $ 26,705,200 13,043,900 15,325,300 9,175,400 124,500 26,580,700 10,666,100 2,377,800 The Company has determined, based upon available evidence, that it is more likely than not that all the net deferred tax assets will not be realized and, accordingly, has provided a full valuation allowance against its net deferred tax asset. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, net operating loss carryback potential, and tax planning strategies in making these assessments. The Company has determined that it had no No The Company files tax returns as prescribed by the tax laws of the jurisdictions in which they operate. In the normal course of business, the Company is subject to examination by federal and state jurisdictions where applicable based on the statute of limitations that apply in each jurisdiction. As of December 31, 2023, the 2016 The Company has no open tax audits with any taxing authority as of December 31, 2023.

Subsequent Events

Subsequent Events	6 Months Ended	12 Months Ended
Subsequent Events	Jun. 30, 2024	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	18. Subsequent Events On July 5, 2024, the Company issued 11,765 On July 22, 2024, the Company entered into a subordinated business loan and security agreement (the “Subordinated Business Loan and Security Agreement”) with Agile Lending, LLC and Agile Capital Funding, LLC as the collateral agent. On July 22, 2024 the Company issued a subordinated secured promissory note for an aggregate principal amount of $ 787,500 750,000 37,500 February 5, 2025 42	21. Subsequent Events Yorkville SEPA Supplemental Agreement As previously disclosed, pursuant to the SEPA, dated December 14, 2023, between the Company and Yorkville, Yorkville agreed to advance to the Company, in exchange for convertible promissory notes, a Pre-Paid Advance for an aggregate principal amount of up to $ 3.5 2.0 10 1.5 10 19.99 On February 5, 2024, the Company and Yorkville entered into a supplemental agreement (the “SEPA Supplemental Agreement”) to increase the amount of the Pre-Paid Advance under the SEPA by $ 1.0 4.5 10 1.0 June 14, 2024 0 On March 27, 2024, the Company and Yorkville entered into a supplemental agreement (the “SEPA March Supplemental Agreement”) to increase the amount of the Pre-Paid Advance under the SEPA by $ 1.5 4.5 10 on March 27, 2024 in exchange for a promissory note in the principal amount of $ 1.5 June 14, 2024 0 Yorkville Advance Agreement Amortization Event Waiver On January 24, 2024, Yorkville provided the Company with a waiver with respect to the triggering of an amortization event in January 2024, in terms of the Yorkville Convertible Note Agreement, which would have required the Company to make monthly repayments of amounts outstanding under the Yorkville Convertible Note, with each monthly repayment to be in an amount equal to the sum of (x) $ 1,000,000 10 no Yorkville SEPA Advance Purchase Notices and Yorkville Deferred Fee Settlement In February, 2024, Yorkville submitted two Advance Notice Investor Notices, related to the purchase of common shares of the Company, with the aggregate purchase price of those shares offset against amounts outstanding by the Company under the Pre-Paid Yorkville Convertible Notes. Yorkville purchased a total of 6,888 300,000 38.08 61.15 In March, 2024, Yorkville submitted six Advance Notice Investor Notices, related to the purchase of common shares of the Company, with the aggregate purchase price of those shares offset against amounts outstanding by the Company under the Pre-Paid Yorkville Convertible Notes and to settle the Deferred Fee payable to Yorkville. Yorkville purchased a total of 37,787 14,201 1,200,000 500,000 31.65 35.21 Roth Addendum to Letter Agreements On October 13, 2022, Roth and Legacy Banzai entered into the Roth Engagement Letter, pursuant to which Legacy Banzai engaged Roth as a financial advisor in connection with the Merger and, on October 14, 2022, MKM and 7GC entered into the MKM Engagement Letter, pursuant to which 7GC engaged MKM as a financial advisor in connection with the Merger. In February 2023, Roth acquired MKM. On February 2, 2024, the Company and Roth entered into an addendum to (i) the engagement letter, dated October 13, 2022, by and between Roth and Legacy Banzai, and (ii) the engagement letter, dated October 14, 2022, by and between Roth (as successor to MKM Partners, LLC) and 7GC (such engagement agreements, collectively, the “Roth Engagement Agreements,” and such addendum, the “Roth Addendum”). Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred in 2024, and owed under the Roth Engagement Agreements (collectively, the “Roth Fee”), the Company (i) issued to Roth 3,500 300,000 300,000 12,000 12,000 300,000 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 5, 2024, the Company received a letter (the “Letter”) from the staff at Nasdaq notifying the Company that, for the 30 consecutive business days prior to the date of the Letter, the Company’s Minimum Value of Listed Securities (“MVLS”) was below the minimum of $ 50 50,000,000 In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar days, or until August 5, 2024, to regain compliance. The Letter notes that to regain compliance, the Company’s MVLS must close at or above $ 50 million for a minimum of ten consecutive business days during the compliance period. The Letter further notes that if the Company is unable to satisfy the MVLS requirement prior to such date, the Company may be eligible to transfer the listing of its securities to The Nasdaq Global Market (provided that the Company then satisfies the requirements for continued listing on that market). If the Company does not regain compliance by August 5, 2024, Nasdaq staff will provide written notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel. The Company intends to actively monitor the Company’s MVLS between now and August 5, 2024, and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the MVLS requirement. While the Company is exercising diligent efforts to maintain the listing of its securities on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standards. GEM Agreement On February 5, 2024, the Company and GEM entered into a settlement agreement (the “GEM Settlement Agreement”), pursuant to which (a) the Company and GEM agreed to (i) settle the Company’s obligations under and terminate the binding term sheet entered into between Legacy Banzai and GEM, dated December 13, 2023, and (ii) terminate the share repurchase agreement, dated May 27, 2022, by and among the Company and GEM, and (b) the Company (i) agreed to pay GEM $ 1.2 1.0 100,000 The GEM Promissory Note provides that, in the event the Company fails to make a required monthly payment when due, the Company shall issue to GEM a number of shares of Class A Common Stock equal to the monthly payment amount divided by the VWAP of Class A Common Stock for the trading day immediately preceding the applicable payment due date. In addition, the Company agreed to register on a registration statement 40,000 2,789 Conversion of 7GC Promissory Notes As discussed per Note 14-Debt On February 2, 2024, pursuant to and in accordance with the First Amendment Conversion Provisions, the Sponsor exercised its right to convert the full principal amount under each of the 7GC Notes within 30 days after the Closing, and such conversions were completed on February 2, 2024, resulting in the issuance to the Sponsor of an aggregate of 17,812 Forfeiture and Cancellation of 7GC Sponsor Shares In January 2024, the Company and 7GC entered into an agreement whereby 7GC agreed to forfeit a total of 2,000 Issuance of Shares as Compensation for Marketing Agreement On February 16, 2024, the Company entered into a Marketing Services Agreement with a vendor. This agreement was effective February 19, 2024, and relates to the provision of marketing and distribution services to the Company. Effective as of February 19, 2024, as compensation for these services, the Company agreed to issued to this vendor a total of 3,070 200,000

Asset Disposal

Asset Disposal	12 Months Ended
Asset Disposal	Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Asset Disposal	5. Asset Disposal Disposal of High Attendance Assets On July 1, 2022, the Company sold the assets and liabilities of High Attendance, a subsidiary of the Company, back to its former owner (the “Buyer”), from whom the assets were originally purchased during the year ended December 31, 2020 pursuant to an Asset Purchase Agreement. At the time of the sale, the Buyer was employed by and a securityholder of the Company. The sale was accounted for as a nonmonetary transaction as the Company determined the sale of the High Attendance asset group represents the rescission of the prior acquisition of these assets in the asset acquisition which occurred during the year ended December 31, 2020. The assets and liabilities of High Attendance were exchanged for the cancellation of 1,638 0.0001 17,500 24 In accordance with the provisions of ASC 845 Nonmonetary Transactions 81,908 no

Property and Equipment

Property and Equipment	12 Months Ended
Property and Equipment	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment	9. Property and Equipment Property and equipment, net consisted of the following at the dates indicated: Schedule of Property and Equipment, Net 2023 2022 December 31, 2023 2022 Computers and equipment $ 30,867 $ 30,866 Less: accumulated depreciation (26,223 ) (19,063 ) Property and equipment, net $ 4,644 $ 11,803 Depreciation expense for the years ended December 31, 2023 and 2022 was $ 7,160 9,588

Goodwill

Goodwill	12 Months Ended
Goodwill	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	11. Goodwill The following summarizes our goodwill activity during the years ended December 31, 2023 and 2022: Summary of Goodwill Total Goodwill-December 31, 2021 $ 2,171,526 Impairment - Goodwill-December 31, 2022 2,171,526 Impairment - Goodwill-December 31, 2023 $ 2,171,526 As the Company has one one No

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Jun. 30, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and applicable regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with the instructions to Form 10-Q of Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations of the SEC relating to interim financial statements. The December 31, 2023 balance sheet information was derived from the audited financial statements as of that date. Except as disclosed herein, there has been no material change in the information disclosed in the notes to the consolidated financial statements for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on April 1, 2024. The interim unaudited condensed consolidated financial statements should be read in conjunction with those consolidated financial statements included in the Form 10-K. In the opinion of management, all adjustments considered necessary for a fair statement of the financial statements, consisting solely of normal recurring adjustments, have been made. Operating results for the periods ended June 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. Effective September 19, 2024, the Company completed a one-for-fifty (1-for-50) reverse stock split	Basis of Presentation The Company’s audited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. Effective September 19, 2024, the Company completed a one-for-fifty (1-for-50) reverse stock split
Warrant Liabilities	Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Warrant Liability - related party The warrants originally issued in 7GC’s initial public offering (the “Public Warrants”) are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercise or expiration, and any change in fair value is recognized in the Company’s consolidated statements of operations. The Public Warrants were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based on the listed market price of such warrants. Warrant liabilities are classified as current liabilities on the Company’s consolidated balance sheets. Warrant Liability The GEM Warrants were not considered indexed to the issuer’s stock pursuant to ASC 815, as the holder’s ability to receive in lieu of the Warrant one percent of the total consideration received by the Company’s stockholders in connection with a Change of Control, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company’s control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially measured at fair value with subsequent changes in fair value recognized in earnings each reporting period. The measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected time to conversion).	Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Warrant Liability-related party The Public Warrants are recognized as derivative liabilities in accordance with ASC 815 Derivatives and Hedging The Public Warrants were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liabilities may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Warrant liabilities are classified as current liabilities on the Company’s consolidated balance sheets. Warrant Liability The GEM Warrants were not considered indexed to the issuer’s stock pursuant to ASC 815, as the holder’s ability to receive one percent of the total consideration received by the Company’s stockholders in connection with a Change of Control in lieu of the Warrant, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company’s control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially measured at fair value with subsequent changes in fair value recognized in earnings each reporting period. The measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected time to conversion). The Company determined the Warrants were share issuance costs associated with an aborted offering to purchase equity. Aborted offering costs may not be deferred and charged against proceeds of a subsequent offering. As such, the Company recorded an expense for the corresponding fair value.
Loss Per Share	Loss Per Share Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share excludes, when applicable, the potential impact of stock options and convertible preferred stock because their effect would be anti-dilutive due to the net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same. The calculation of basic and diluted net loss per share attributable to common stock was as follows: Schedule of Basic and Diluted Net Loss Per Share 2024 2023 2024 2023 For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Numerator: Net loss attributable to common stock—basic and diluted $ (4,165,108 ) $ (3,486,053 ) $ (8,665,380 ) $ (7,251,175 ) Denominator: Weighted average shares—basic and diluted 541,836 129,193 444,474 129,127 Net loss per share attributable to common stock—basic and diluted $ (7.69 ) $ (26.98 ) $ (19.50 ) $ (56.16 ) Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be dilutive in future periods are as follows: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share 2024 2023 As of June 30, 2024 2023 Options 33,649 13,405 RSUs 17,558 — Public warrants 230,000 — GEM warrants 16,571 — Common warrants 277,778 — Placement agent warrants 16,667 — Total 592,222 13,405 Antidilutive Securities 592,222 13,405	Loss Per Share Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the year. Diluted net loss per share excludes, when applicable, the potential impact of stock options and convertible preferred stock because their effect would be anti-dilutive due to the net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same. The calculation of basic and diluted net loss per share attributable to common stock was as follows: Schedule of Basic and Diluted Net Loss Per Share 2023 2022 As of December 31, 2023 2022 Numerator: Net loss attributable to common stock-basic and diluted $ (14,406,262 ) $ (15,468,502 ) Denominator: Weighted average shares-basic and diluted 137,074 128,822 Net loss per share attributable to common stock-basic and diluted $ (105.10 ) $ (111.83 ) Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be dilutive in future periods are as follows: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share 2023 2022 As of December 31, 2023 2022 Options 14,962 7,420 Public warrants 230,000 - GEM warrants 16,571 - Total 261,533 7,420 Antidilutive Securities 261,533 7,420
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates all its financial instruments to determine if such instruments contain features that qualify as embedded derivatives. Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated embedded derivatives are classified with the related host contract in the Company’s balance sheet. Refer to Note 7 - Fair Value Measurements Note 11 - Debt	Derivative Financial Instruments The Company evaluates all its financial instruments to determine if such instruments contain features that qualify as embedded derivatives. Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated embedded derivatives are classified with the related host contract in the Company’s balance sheet. Refer to Note 8-Fair Value Measurements Note 14-Debt
Fair Value of Financial Instruments	Fair Value of Financial Instruments In accordance with FASB ASC 820 Fair Value Measurements and Disclosures Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace. Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. The fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management during the three and six months ended June 30, 2024 and 2023. The carrying amount of cash, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued expenses, deferred revenue, and other current liabilities approximated their fair values as of June 30, 2024 and December 31, 2023.	Fair Value of Financial Instruments In accordance with FASB ASC 820 Fair Value Measurements and Disclosures Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace. Level 3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. The fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management during the years ended December 31, 2023 and 2022. The carrying amount of cash, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued expenses, deferred revenue, and other current liabilities approximated their fair values as of December 31, 2023 and 2022. During 2022, the Company carried convertible notes bifurcated embedded derivatives and Simple Agreements for Future Equity (“SAFE”) investments at their fair value (see Note 8-Fair Value Measurements
Recent Accounting Pronouncements	Recent Accounting Pronouncements Recent accounting pronouncements not yet effective In December 2023, the FASB issued ASU 2023-09 (Topic 740), Improvements to income tax disclosures, which enhances the disclosure requirements for the income tax rate reconciliation, domestic and foreign income taxes paid, requiring disclosure of disaggregated income taxes paid by jurisdiction, unrecognized tax benefits, and modifies other income tax-related disclosures. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively. The Company is currently evaluating the effect of adopting this guidance on its consolidated financial statements. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update intend to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. This ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, the addition of a category for other segment items by reportable segment, that all annual segment disclosures be disclosed in interim periods, and other related segment disclosures. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of adopting this guidance on its consolidated financial statements.	Recent Accounting Pronouncements Recent accounting pronouncements not yet effective In December 2023, the FASB issued ASU 2023-09 (Topic 740), Improvements to income tax disclosures, which enhances the disclosure requirements for the income tax rate reconciliation, domestic and foreign income taxes paid, requiring disclosure of disaggregated income taxes paid by jurisdiction, unrecognized tax benefits, and modifies other income tax-related disclosures. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively. The Company is currently evaluating the effect of adopting this guidance on its consolidated financial statements.
Principles of Consolidation		Principles of Consolidation The accompanying audited consolidated financial statements include the accounts of Banzai and its subsidiaries. The Company consolidates all entities over which the Company has the power to govern the financial and operating policies and therefore exercises control, and upon which the Company has a controlling financial interest. The existence and effect of both current voting rights and potential voting rights that are currently exercisable or convertible are considered when assessing whether control of an entity is exercised. The subsidiary is consolidated from the date at which the Company obtains control and is de-consolidated from the date at which control ceases. All intercompany balances and transactions have been eliminated. The accounting policies of the subsidiary has been changed where necessary to ensure consistency with the policies adopted by the Company. In the opinion of management, all necessary adjustments (consisting of normal recurring adjustments, intercompany adjustments, reclassifications and non-recurring adjustments) have been recorded to present fairly our financial position as of December 31, 2023 and 2022, and the results of operations and cash flows for the years ended December 31, 2023 and 2022.
Use of Estimates		Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the audited consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that estimates made as of the date of the financial statements could change in the near term due to one or more future events. Actual results could differ significantly from these estimates. Significant accounting estimates reflected in the Company’s consolidated financial statements include estimates of impairment of goodwill, recognition and measurement of convertible and Simple Agreement for Future Equity (SAFE) notes, including the associated embedded derivatives, determination of the fair value of the warrant liabilities, and recognition and measurement of stock compensation.
Certain Risks and Uncertainties		Certain Risks and Uncertainties The Company’s business and operations are sensitive to general business and economic conditions. These conditions include short-term and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the general condition of the world economy. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse developments in these general business and economic conditions could have a material adverse effect on the Company’s financial condition and the results of its operations. In addition, the Company will compete with many companies that currently have extensive and well-funded products, marketing and sales operations. The Company may be unable to compete successfully against these companies. The Company’s industry is characterized by rapid changes in technology and market demands. As a result, the Company’s products, services, or expertise may become obsolete or unmarketable. The Company’s future success will depend on its ability to adapt to technological advances, anticipate customer and market demands, and enhance its current technology. The Company is also subject to risks which include, but are not limited to, dependence on key personnel, reliance on third parties, successful integration of business acquisitions, protection of proprietary technology, and compliance with regulatory requirements.
Cash		Cash The Company considers all highly liquid investments purchased with original maturities of 90 days or less to be cash equivalents. As of December 31, 2023 and 2022, the Company does no The Company has no significant off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other hedging arrangements. The Company holds cash in banks in excess of federally insured limits. However, the Company believes risk of loss is minimal as the cash is held by large highly rated financial institutions. To reduce its risk associated with the failure of such financial institutions, the Company evaluates at least annually the rating of the financial institutions in which it holds cash. Any material loss that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make other payments and may require the Company to move its cash to other high quality financial institutions. Currently, the Company is reviewing its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits.
Accounts Receivable and Allowance for Credit Losses		Accounts Receivable and Allowance for Credit Losses Accounts receivable consist of balances due from customers as well as from payment service providers. Payment terms range from due upon receipt, to net 30 days. Accounts receivable are stated net of an allowance for credit losses. The allowance for expected credit losses is based on the probability of future collection under the current expected credited loss (“CECL”) impairment model which was adopted by the Company on January 1, 2023, as discussed below within Recent Accounting Pronouncements. The adoption of ASU No. 2016-13, Financial Instruments: Credit Losses (Topic 326) (“ASU 2016-13”) did not have a material impact on these consolidated financial statements. Account balances are written off after all means of collection are exhausted and the balance is deemed uncollectible. Subsequent recoveries are credited to the allowance. Changes in the allowance are recorded as adjustments to credit losses in the period incurred. As of December 31, 2023 and 2022, the Company determined an allowance for credit losses of $ 5,748 107,860 65,013 142,162 The following table presents changes in the allowance for credit losses for the year ended December 31, 2023: Summary of Changes in Allowance for Credit Losses Balance-January 1, 2023 $ 107,860 Change in provision for credit losses (102,112 ) Balance-December 31, 2023 $ 5,748
Property and Equipment		Property and Equipment Property and equipment are recorded at cost and presented net of accumulated depreciation. Major additions and betterments are capitalized while maintenance and repairs, which do not improve or extend the life of the respective assets, are expensed. Property and equipment are depreciated on the straight-line basis over their estimated useful lives ( 3 years
Goodwill		Goodwill Goodwill represents the excess of the purchase price over the fair value of the net identifiable assets acquired in a business combination. Goodwill is reviewed for impairment at least annually, in December, or more frequently if a triggering event occurs between impairment testing dates. As of December 31, 2023, the Company had one The Company’s impairment assessment begins with a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. Qualitative factors may include, macroeconomic conditions, industry and market considerations, cost factors, and other relevant entity and Company specific events. If, based on the qualitative test, the Company determines that it is “more likely than not” that the fair value of a reporting unit is less than its carrying value, then we evaluate goodwill for impairment by comparing the fair value of our reporting unit to its respective carrying value, including its goodwill. If it is determined that it is not likely that the fair value of the reporting unit is less than its carrying value, then no further testing is required. The selection and assessment of qualitative factors used to determine whether it is more likely than not that the fair value of a reporting unit exceeds the carrying value involves significant judgment and estimates. Fair values may be determined using a combination of both income and market-based approaches. There were no
Deferred Offering Costs		Deferred Offering Costs In 2022 and 2023, the Company capitalized fees related to the Merger Agreement (see Note 1-Organization Note 4-Merger Capitalized deferred offering costs consisted of the following, as of December 14, 2023 and December 31, 2022: Summary of Capitalized Deferred Offering Costs December 14, December 31, SPAC-related legal fees $ 2,973,077 $ 1,264,914 Investment bank advisory services 135,000 135,000 Federal Trade Commission filing fees 125,020 125,020 Total deferred offering costs capitalized $ 3,233,097 $ 1,524,934 The entire balance of Deferred Offering Costs capitalized as of December 14, 2023, was reclassified to Additional Paid-in- Capital, on December 14, 2023, in connection with the closing of the Merger. As a result, there was no
Simple Agreements for Future Equity-SAFE		Simple Agreements for Future Equity-SAFE The Company accounts for Simple Agreements for Future Equity (“SAFE”) at fair value in accordance with ASC 480 Distinguishing Liabilities from Equity
Concentration of Business and Credit Risk		Concentration of Business and Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company has no financial instruments with off-balance sheet risk of loss. At December 31, 2023, no customers accounted for 10% or more of accounts receivable. At December 31, 2022, three customers accounted for 10% or more of accounts receivable with concentrations of 21 16 10 47 259,635 At December 31, 2023 and 2022, one supplier accounted for 10% or more of accounts payable.
Leases		Leases The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as right-of-use (“ROU”) assets and the corresponding lease liabilities are included in operating lease liabilities, current and operating lease liabilities, non-current on the Company’s balance sheets. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. ROU assets and lease liabilities are recognized at commencement date and determined using the present value of the future minimum lease payments over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing since the Company’s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when it is reasonably certain that the Company will exercise that option. In addition, the Company does not recognize short-term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company recognizes operating lease expense on a straight-line basis over the lease term. The Company has lease agreements which contain both lease and non-lease components, which it has elected to account for as a single lease component when the payments are fixed. As such, variable lease payments, including those not dependent on an index or rate, such as real estate taxes, common area maintenance, and other costs that are subject to fluctuation from period to period are not included in lease measurement. The Company evaluates long-lived assets for recoverability if there are indicators of potential impairment. Indicators of potential impairment may include subleasing a location for less than the head lease cost. If there are indicators of potential impairment, the Company will test the assets for recoverability. If the undiscounted cash flows estimated to be generated are less than the carrying value of the underlying assets, the assets are deemed impaired. If it is determined that assets are impaired, an impairment loss is calculated based on the amount that the asset’s book value exceeds its fair value.
Revenue Recognition		Revenue Recognition Revenue is generated through Banzai providing marketing and webinar platform subscription software service for a set period of time. The Statement of Work (“SOW”) or Invoice, and the accompanying documents are negotiated and signed by both parties (if applicable). Alternatively, customer contracting is achieved via self service and invoicing is initiated automatically once the customer accepts the terms and conditions on the platform, based on their selection of the desired subscription product. When execution or completion of the contract occurs, the contract is valid and revenue is earned when the service is provided for each period of performance, daily. The amount is paid by the customer based on the contract terms monthly, quarterly, or annually, with the majority paid via credit card processing. The Company recognizes revenue in an amount that reflects the consideration to which it expects to be entitled in exchange for the transfer of promised services to its customers. To determine revenue recognition for contracts with customers, the Company performs the following steps described in ASC 606: (1) identifies the contract with the customer, or Step 1, (2) identifies the performance obligations in the contract, or Step 2, (3) determines the transaction price, or Step 3, (4) allocates the transaction price to the performance obligations in the contract, or Step 4, and (5) recognizes revenue when (or as) the entity satisfies a performance obligation, or Step 5. Revenue from contracts with customers are not recorded until the Company has the approval and commitment from the parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of the consideration is probable. The Company also evaluates the following indicators, amongst others, when determining whether it is acting as a principal in the transaction (and therefore whether to record revenue on a gross basis): (i) whether the Company is primarily responsible for fulfilling the promise to provide the specified good or service, (ii) whether the Company has the inventory risk before the specified good or service has been transferred to a customer or after transfer of control to the customerCan and (iii) whether the Company has the discretion to establish the price for the specified good or service. If the terms of a transaction do not indicate that the Company is acting as a principal in the transaction, then the Company is acting as an agent in the transaction and therefore, the associated revenue is recognized on a net basis (that is revenue net of costs). Revenue is recognized once control passes to the customer. The following indicators are evaluated in determining when control has passed to the customer: (i) whether the Company has a right to payment for the product or service, (ii) whether the customer has legal title to the product or service, (iii) whether the Company has transferred physical possession of the product or service to the customer, (iv) whether the customer has the significant risk and rewards of ownership of the product or service and (v) whether the customer has accepted the product or service. When an arrangement contains more than one performance obligation, the Company will allocate the transaction price to each performance obligation on a relative standalone selling price basis. The Company utilizes the observable price of products and services when they are sold separately to similar customers in order to estimate standalone selling price.
Costs of Revenue		Costs of Revenue Costs of revenue consist primarily of infrastructure, streaming service, data license and contracted services costs, as well as merchant fees and payroll costs.
Advertising Costs		Advertising Costs Advertising costs are expensed as incurred. Advertising costs were $ 941,737 783,764
Stock-Based Compensation		Stock-Based Compensation The Company expenses stock-based compensation to employees and non-employees over the requisite service period based on the estimated grant-date fair value of the awards in accordance with ASC 718, Stock Compensation
Income Taxes		Income Taxes Income taxes are recorded in accordance with ASC 740, Income Taxes
Business Combinations		Business Combinations The Company accounts for business combinations in accordance with FASB ASC 805 (“ASC 805”), Business Combinations

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended	12 Months Ended
Summary of Significant Accounting Policies (Tables)	Jun. 30, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The calculation of basic and diluted net loss per share attributable to common stock was as follows: Schedule of Basic and Diluted Net Loss Per Share 2024 2023 2024 2023 For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Numerator: Net loss attributable to common stock—basic and diluted $ (4,165,108 ) $ (3,486,053 ) $ (8,665,380 ) $ (7,251,175 ) Denominator: Weighted average shares—basic and diluted 541,836 129,193 444,474 129,127 Net loss per share attributable to common stock—basic and diluted $ (7.69 ) $ (26.98 ) $ (19.50 ) $ (56.16 )	The calculation of basic and diluted net loss per share attributable to common stock was as follows: Schedule of Basic and Diluted Net Loss Per Share 2023 2022 As of December 31, 2023 2022 Numerator: Net loss attributable to common stock-basic and diluted $ (14,406,262 ) $ (15,468,502 ) Denominator: Weighted average shares-basic and diluted 137,074 128,822 Net loss per share attributable to common stock-basic and diluted $ (105.10 ) $ (111.83 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be dilutive in future periods are as follows: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share 2024 2023 As of June 30, 2024 2023 Options 33,649 13,405 RSUs 17,558 — Public warrants 230,000 — GEM warrants 16,571 — Common warrants 277,778 — Placement agent warrants 16,667 — Total 592,222 13,405 Antidilutive Securities 592,222 13,405	Securities that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be dilutive in future periods are as follows: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share 2023 2022 As of December 31, 2023 2022 Options 14,962 7,420 Public warrants 230,000 - GEM warrants 16,571 - Total 261,533 7,420 Antidilutive Securities 261,533 7,420
Summary of Changes in Allowance for Credit Losses		The following table presents changes in the allowance for credit losses for the year ended December 31, 2023: Summary of Changes in Allowance for Credit Losses Balance-January 1, 2023 $ 107,860 Change in provision for credit losses (102,112 ) Balance-December 31, 2023 $ 5,748
Summary of Capitalized Deferred Offering Costs		Capitalized deferred offering costs consisted of the following, as of December 14, 2023 and December 31, 2022: Summary of Capitalized Deferred Offering Costs December 14, December 31, SPAC-related legal fees $ 2,973,077 $ 1,264,914 Investment bank advisory services 135,000 135,000 Federal Trade Commission filing fees 125,020 125,020 Total deferred offering costs capitalized $ 3,233,097 $ 1,524,934

Reverse Merger Capitalization_2

Reverse Merger Capitalization with 7GC & Co. Holdings Inc. (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Reconciliation of the Merger to the Company's Consolidated Cash Flows	Schedule of Reconciliation of the Merger to the Company's Consolidated Cash Flows	The following table reconciles the elements of the Merger to the consolidated statements of cash flows: Schedule of Reconciliation of the Merger to the Company's Consolidated Cash Flows Recapitalization Deferred underwriting fees assumed $ 4,000,000 Convertible notes payable assumed 2,550,000 Warrant liabilities assumed 460,000 Less: effect on equity (14,625,462 ) Effect of reverse recapitalization, net of transaction costs $ (7,615,462 )
Schedule of Reconciliation of the Merger to the Company’s Statements of Changes in Stockholders’ Deficit		The following table reconciles the elements of the Merger to the consolidated statements of changes in stockholders’ deficit: Schedule of Reconciliation of the Merger to the Company’s Statements of Changes in Stockholders’ Deficit Recapitalization Cash $ 197,166 Non-cash net working capital assumed (7,812,628 ) Deferred underwriting fees assumed (4,000,000 ) Convertible notes payable assumed (2,550,000 ) Fair value of assumed warrant liabilities (460,000 ) Transaction costs (3,233,097 ) Effect of reverse recapitalization $ (17,858,559 )

Revenue (Tables)

Revenue (Tables)	6 Months Ended	12 Months Ended
Revenue (Tables)	Jun. 30, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Summary of Revenue by Region	The following table summarizes revenue by region based on the billing address of customers for the three months ended June 30, 2024 and 2023: Summary of Revenue by Region Three Months Ended June 30, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue Americas $ 587,712 55 % $ 704,626 59 % Europe, Middle East and Africa (EMEA) 360,666 34 % 389,318 33 % Asia Pacific 119,819 11 % 99,377 8 % Total $ 1,068,197 100 % $ 1,193,321 100 % The following table summarizes revenue by region based on the billing address of customers for the six months ended June 30, 2024 and 2023: Six Months Ended June 30, 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue Americas $ 1,170,539 55 % $ 1,374,401 62 % Europe, Middle East and Africa (EMEA) 746,916 34 % 797,228 30 % Asia Pacific 230,214 11 % 198,753 8 % Total $ 2,147,669 100 % $ 2,370,382 100 %	The following table summarizes revenue by region based on the billing address of customers: Summary of Revenue by Region Year Ended December 31, 2023 2022 Amount Percentage Amount Percentage Americas $ 2,677,050 59 % $ 3,307,129 62 % Europe, Middle East and Africa (EMEA) 1,511,886 33 % 1,588,539 30 % Asia Pacific 372,364 8 % 437,311 8 % Total $ 4,561,300 100 % $ 5,332,979 100 %
Summary of Accounts Receivable, Net	Summary of Accounts Receivable, Net Opening Balance Closing Balance Opening Balance Closing Balance 1/1/2024 6/30/2024 1/1/2023 6/30/2023 Accounts receivable, net $ 105,049 $ 26,161 $ 68,416 $ 109,533	Summary of Accounts Receivable, Net For The Years Ended December 31, 2023 2022 Opening Closing Opening Closing Accounts receivable, net $ 68,416 $ 105,049 $ 74,727 $ 68,416
Summary of Costs to Obtain Contract Activity	The following summarizes the Costs to obtain a contract activity during the three and six months ended June 30, 2024: Summary of Costs to Obtain Contract Activity Balance - December 31, 2023 $ 51,472 Commissions Incurred 31,610 Deferred Commissions Recognized (44,620 ) Balance - March 31, 2024 38,462 Commissions Incurred 48,316 Deferred Commissions Recognized (47,634 ) Balance - June 30, 2024 $ 39,144 The following summarizes the Costs to obtain a contract activity during the three and six months ended June 30, 2023: Balance - December 31, 2022 $ 69,737 Commissions Incurred 88,928 Deferred Commissions Recognized (104,289 ) Balance - March 31, 2023 54,376 Commissions Incurred 60,777 Deferred Commissions Recognized (75,001 ) Balance - June 30, 2023 $ 40,152	The following summarizes the Costs to obtain a contract activity during the years ended December 31, 2023 and 2022: Summary of Costs to Obtain Contract Activity Balance-December 31, 2021 $ 90,662 Commissions Incurred 343,003 Deferred Commissions Recognized (363,928 ) Balance-December 31, 2022 69,737 Commissions Incurred 242,810 Deferred Commissions Recognized (261,075 ) Balance-December 31, 2023 $ 51,472

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended	12 Months Ended
Fair Value Measurements (Tables)	Jun. 30, 2024	Dec. 31, 2023
Class of Warrant or Right [Line Items]
Schedule of Fair Value on Recurring Basis	The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis at June 30, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Schedule of Fair Value on Recurring Basis Description Level June 30, 2024 December 31, 2023 Liabilities: Warrant liabilities - public 1 $ 230,000 $ 575,000 GEM warrant liabilities 3 $ 79,000 $ 641,000 Yorkville convertible note 3 $ 2,013,000 $ 1,766,000	The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis at December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Schedule of Fair Value on Recurring Basis Description Level December 31, December 31, Liabilities: Warrant liabilities-public 2 $ 575,000 $ - GEM warrant liabilities 3 $ 641,000 $ - Yorkville convertible note 3 $ 1,766,000 $ - Bifurcated embedded derivative liabilities 3 $ - $ 845,473 Bifurcated embedded derivative liabilities-related party 3 $ - $ 1,936,827 SAFE 3 $ - $ 663,804 SAFE-related party 3 $ - $ 8,802,196
Summary of Changes in Fair Value of Yorkville Convertible Note	The following tables set forth a summary of the changes in the fair value of the Yorkville convertible notes which is a Level 3 financial liability measured at fair value on a recurring basis: Summary of Changes in Fair Value of Yorkville Convertible Note Fair Value Balance at December 31, 2023 $ 1,766,000 Issuance of Yorkville convertible note 2,250,000 Loss on debt issuance 171,000 Payment in shares to settle Yorkville convertible notes (1,667,000 ) Change in fair value 544,000 Balance at March 31, 2024 3,064,000 Payment in shares to settle Yorkville convertible notes (335,000 ) Repayment in cash of Yorkville convertible notes (750,000 ) Change in fair value 34,000 Balance at June 30, 2024 $ 2,013,000	The following tables set forth a summary of the changes in the fair value of the Yorkville convertible note which is a Level 3 financial liability measured at fair value on a recurring basis: Summary of Changes in Fair Value of Yorkville Convertible Note Fair Value Balance at December 31, 2022 $ - Issuance of yorkville convertible note 1,800,000 Change in fair value (34,000 ) Balance at December 31, 2023 $ 1,766,000
Schedule of Derivative Liabilities	The following table sets forth a summary of the changes in the fair value of the bifurcated embedded derivative liabilities for the six months ended June 30, 2023, related to the Related Party and Third Party Convertible Debt, respectively, which are Level 3 financial liabilities that are measured at fair value on a recurring basis: Schedule of Derivative Liabilities Related Party Third Party Fair Value Related Party Third Party Balance at December 31, 2022 $ 1,936,827 $ 845,473 Issuance of convertible notes with bifurcated embedded derivative 707,000 — Change in fair value 137,285 32,415 Balance at March 31, 2023 2,781,112 877,888 Issuance of convertible notes with bifurcated embedded derivative 419,451 330,390 Change in fair value (478,198 ) (194,643 ) Balance at June 30, 2023 $ 2,722,365 $ 1,013,635	The following tables set forth a summary of the changes in the fair value of the bifurcated embedded derivative liability, related to the Related Party and Third Party Convertible Debt, respectively, which are Level 3 financial liabilities that are measured at fair value on a recurring basis: Schedule of Derivative Liabilities Fair Value Related Party Third Party Balance at December 31, 2021 $ - $ 4,000 Issuance of convertible notes with bifurcated embedded derivatives 1,398,595 586,405 Issuance of CP BF convertible notes with bifurcated embedded derivative 1,375 625 Extinguishment of Old Alco Note derivative (70,000 ) - Change in fair value 606,857 254,443 Balance at December 31, 2022 1,936,827 845,473 Issuance of convertible notes with bifurcated embedded derivative 1,126,451 559,390 Change in fair value (3,063,278 ) (1,404,863 ) Balance at December 31, 2023 $ - $ -
Schedule of Fair Value Measurements	The following tables set forth a summary of the activity of the Related Party and Third Party SAFE liabilities, respectively (See Note 13 - Simple Agreements for Future Equity Schedule of Fair Value Measurements Related Party Third Party Fair Value Related Party Third Party Balance at December 31, 2022 $ 8,802,196 $ 663,804 Change in fair value 303,139 22,861 Balance at March 31, 2023 9,105,335 686,665 Change in fair value 909,418 68,582 Balance at June 30, 2023 $ 10,014,753 $ 755,247	The following tables set forth a summary of the activity of the Related Party and Third Party SAFE liabilities, respectively (See Note 16-Simple Agreements for Future Equity Schedule of Fair Value Measurements Fair Value Related Party Third Party Balance at December 31, 2021 $ 3,121,591 $ 235,409 Change in fair value 4,078,431 307,569 Loss on modification 1,602,174 120,826 Balance at December 31, 2022 8,802,196 663,804 Change in fair value (2,752,430 ) (207,570 ) Conversion of SAFEs (6,049,766 ) (456,234 ) Balance at December 31, 2023 $ - $ -
Public Warrants Liability [Member]
Class of Warrant or Right [Line Items]
Summary of Changes in the Fair Value of the Warrants Liability	The following tables set forth a summary of the changes in the fair value of the Public Warrants liability which are Level 1 financial liabilities that are measured at fair value on a recurring basis: Summary of Changes in the Fair Value of the Warrants Liability Fair Value Balance at December 31, 2023 $ 575,000 Change in fair value (115,000 ) Balance at March 31, 2024 460,000 Change in fair value (230,000 ) Balance at June 30, 2024 $ 230,000	The following tables set forth a summary of the changes in the fair value of the Public Warrants liability which are Level 2 financial liabilities that are measured at fair value on a recurring basis: Summary of Changes in the Fair Value of the Warrants Liability Fair Value Balance at December 31, 2022 $ - Merger date assumption of public warrants 460,000 Change in fair value 115,000 Balance at December 31, 2023 $ 575,000
Gem Warrants Liability [Member]
Class of Warrant or Right [Line Items]
Summary of Changes in the Fair Value of the Warrants Liability	The following tables set forth a summary of the changes in the fair value of the GEM Warrants liability which are Level 3 financial liabilities that are measured at fair value on a recurring basis: Summary of Changes in the Fair Value of the Warrants Liability Fair Value Balance at December 31, 2023 $ 641,000 Change in fair value (408,000 ) Balance at March 31, 2024 233,000 Change in fair value (154,000 ) Balance at June 30, 2024 $ 79,000	The following tables set forth a summary of the changes in the fair value of the GEM Warrants liability which are Level 3 financial liabilities that are measured at fair value on a recurring basis: Summary of Changes in the Fair Value of the Warrants Liability Fair Value Balance at December 31, 2022 $ - Issuance of GEM warrants 2,448,000 Change in fair value (1,807,000 ) Balance at December 31, 2023 $ 641,000

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	6 Months Ended	12 Months Ended
Prepaid Expenses and Other Current Assets (Tables)	Jun. 30, 2024	Dec. 31, 2023
Prepaid Expenses And Other Current Assets
Summary of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following at the dates indicated: Summary of Prepaid Expenses and Other Current Assets June 30, 2024 December 31, 2023 Prepaid expenses and other current assets: Service Trade $ 302,055 $ 364,384 Prepaid insurance costs 282,265 17,661 Prepaid advertising and marketing costs 259,438 11,074 Prepaid software costs 97,912 29,887 Prepaid commissions 39,144 51,472 Prepaid data license and subscription costs 34,375 53,124 Prepaid merchant fees 28,488 26,224 Prepaid consulting costs 26,539 120,332 Other current assets 10,720 66,997 Total prepaid expenses and other current assets $ 1,080,936 $ 741,155	Prepaid expenses and other current assets consisted of the following at the dates indicated: Summary of Prepaid Expenses and Other Current Assets 2023 2022 December 31, 2023 2022 Prepaid expenses and other current assets: Service Trade $ 364,384 $ 97,875 Prepaid consulting costs 120,332 3,124 Prepaid data license and subscription costs 53,124 40,000 Prepaid commissions 51,472 69,737 Prepaid software costs 29,887 10,255 Prepaid merchant fees 26,224 26,401 Prepaid insurance costs 17,661 15,430 Prepaid advertising and marketing costs 11,074 32,178 Other current assets 66,997 38,507 Total prepaid expenses and other current assets $ 741,155 $ 333,507

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended	12 Months Ended
Accrued Expenses and Other Current Liabilities (Tables)	Jun. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Summary of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following at the dates indicated: Summary of Accrued Expenses and Other Current Liabilities June 30, 2024 December 31, 2023 Accrued expenses and other current liabilities: Accrued accounting and professional services costs $ 2,458,192 $ 1,511,889 Accrued subscription costs 510,549 22,110 Sales tax payable 363,883 314,873 Excise tax payable 223,717 223,717 Accrued legal costs 159,417 2,694,439 Accrued payroll and benefit costs 123,335 185,504 Deposits 52,000 54,102 Accrued streaming service costs 48,218 37,765 Accrued offering costs - - Other current liabilities 324,717 149,841 Total accrued expenses and other current liabilities $ 4,264,028 $ 5,194,240	Accrued and other current liabilities consisted of the following at the dates indicated: Summary of Accrued Expenses and Other Current Liabilities December 31, December 31, Accrued and other current liabilities: Accrued legal costs $ 2,694,439 $ 31,355 Accrued accounting and professional services costs 1,511,889 94,573 Sales tax payable 314,873 230,617 Excise tax payable 223,717 - Accrued payroll and benefit costs 185,504 95,947 Deposits 54,102 - Accrued streaming service costs 37,765 - Accrued subscription costs 22,110 28,774 Accrued offering costs - 261,090 Other current liabilities 149,841 3,017 Total accrued and other current liabilities $ 5,194,240 $ 745,373

Deferred Revenue (Tables)

Deferred Revenue (Tables)	6 Months Ended	12 Months Ended
Deferred Revenue (Tables)	Jun. 30, 2024	Dec. 31, 2023
Deferred Revenue
Summary of Changes in Deferred Revenue	The change in deferred revenue was as follows for the periods indicated: Summary of Changes in Deferred Revenue Six Months Ended Year Ended June 30, 2024 December 31, 2023 Deferred revenue, beginning of period $ 1,214,096 $ 930,436 Billings 2,255,811 4,781,924 Revenue recognized (prior year deferred revenue) (861,496 ) (930,436 ) Revenue recognized (current year deferred revenue) (1,286,173 ) (3,567,828 ) Deferred revenue, end of period $ 1,322,238 $ 1,214,096	The change in deferred revenue was as follows for the periods indicated: Summary of Changes in Deferred Revenue 2023 2022 December 31, 2023 2022 Deferred revenue, beginning of period $ 930,436 $ 1,060,040 Billings 4,781,924 5,040,665 Revenue recognized (prior year deferred revenue) (930,436 ) (1,004,697 ) Revenue recognized (current year deferred revenue) (3,567,828 ) (4,165,572 ) Deferred revenue, end of period $ 1,214,096 $ 930,436

Debt (Tables)

Debt (Tables)	6 Months Ended	12 Months Ended
Debt (Tables)	Jun. 30, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Schedule of Related Party and Third Related Party Convertible Notes	The following table presents the CP BF convertible notes as of June 30, 2024: Summary of Convertible Notes Face value of the CB BF convertible notes $ 1,821,345 Debt discount, net (26,757 ) Carrying value of the CB BF convertible notes 1,794,588 Accrued interest 1,135,983 Total CB BF convertible notes and accrued interest $ 2,930,571 The following table presents the CP BF convertible notes as of December 31, 2023: Face value of the CB BF convertible notes $ 1,821,345 Debt discount, net (41,983 ) Carrying value of the CB BF convertible notes 1,779,362 Accrued interest 914,479 Total CB BF convertible notes and accrued interest $ 2,693,841 The following table presents the CP BF term note as of June 30, 2024: Face value of the CB BF term note $ 6,500,000 Debt discount, net (76,353 ) Carrying value of the CB BF term note 6,423,647 Accrued interest 664,562 Total CB BF term note and accrued interest $ 7,088,209 The following table presents the CP BF term note as of December 31, 2023: Face value of the CB BF term note $ 6,500,000 Debt discount, net (129,586 ) Carrying value of the CB BF term note 6,370,414 Accrued interest 289,373 Total CB BF term note and accrued interest $ 6,659,787	The following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2023: Schedule of Related Party and Third Related Party Convertible Notes Related Party Third Party Face value of the convertible notes $ 6,783,538 $ 3,196,206 Debt discount, net (131,867 ) (83,688 ) Carrying value of the convertible notes 6,651,671 3,112,518 Accrued interest 619,697 233,714 Conversion of convertible notes (7,271,368 ) (3,346,232 ) Total convertible notes and accrued interest $ - $ - The following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2022: Related Party Third Party Face value of the convertible notes $ 4,200,538 $ 1,761,206 Debt discount, net (849,656 ) (398,034 ) Carrying value of the convertible notes 3,350,882 1,363,172 Accrued interest 155,626 45,654 Total convertible notes and accrued interest $ 3,506,508 $ 1,408,826
Summary of Convertible Notes		The following table presents the CP BF convertible notes as of December 31, 2023: Summary of Convertible Notes Face value of the CB BF convertible notes $ 1,821,345 Debt discount, net (41,983 ) Carrying value of the CB BF convertible notes 1,779,362 Accrued interest 914,479 Total CB BF convertible notes and accrued interest $ 2,693,841 The following table presents the CP BF convertible notes as of December 31, 2022: Face value of the CB BF convertible notes $ 1,821,345 Debt discount, net (63,715 ) Carrying value of the CB BF convertible notes 1,757,630 Accrued interest 518,904 Total CB BF convertible notes and accrued interest $ 2,276,534
Summary of Term Notes		The following table presents the CP BF term note as of December 31, 2023: Summary of Term Notes Face value of the CB BF term note $ 6,500,000 Debt discount, net (129,586 ) Carrying value of the CB BF term note 6,370,414 Accrued interest 289,373 Total CB BF term note and accrued interest $ 6,659,787 The following table presents the CP BF term note as of December 31, 2022: Face value of the CB BF term note $ 6,500,000 Debt discount, net (192,911 ) Carrying value of the CB BF term note 6,307,089 Accrued interest 186,962 Total CB BF term note and accrued interest $ 6,494,051
Related Party And Third Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Schedule of Related Party and Third Related Party Convertible Notes	The following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2023: Summary of Related Party and Third Party Convertible Notes Related Party Third Party Face value of the convertible notes $ 6,783,538 $ 3,196,206 Debt discount, net (131,867 ) (83,688 ) Carrying value of the convertible notes 6,651,671 3,112,518 Accrued interest 619,697 233,714 Conversion of convertible notes (7,271,368 ) (3,346,232 ) Total convertible notes and accrued interest $ — $ —

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended	12 Months Ended
Commitments and Contingencies (Tables)	Jun. 30, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Components of Lease Expense	The components of lease expense for the three months ended June 30, 2024 and 2023, are as follows: Schedule of Components of Lease Expense Components of lease expense: 2024 2023 For the Three Months Ended June 30, Components of lease expense: 2024 2023 Operating lease cost $ 46,140 $ 50,440 Lease impairment cost - - Sublease income (52,542 ) (51,082 ) Total lease (income) cost $ (6,402 ) $ (642 ) The components of lease expense for the six months ended June 30, 2024 and 2023, are as follows: Components of lease expense: 2024 2023 For the Six Months Ended June 30, Components of lease expense: 2024 2023 Operating lease cost $ 93,384 $ 101,888 Lease impairment cost - - Sublease income (105,084 ) (102,165 ) Total lease (income) cost $ (11,700 ) $ (277 )	The components of lease expense, are as follows: Schedule of Components of Lease Expense For the Year Ended December 31, Components of lease expense: 2023 2022 Operating lease cost $ 199,611 $ 191,483 Lease impairment cost - 303,327 Sublease income (204,324 ) (177,588 ) Total lease (income) cost $ (4,713 ) $ 317,222
Schedule of Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases are as follows: Schedule of Supplemental Cash Flow Information Related to Leases Supplemental cash flow information: 2024 2023 For the Six Months Ended June 30, Supplemental cash flow information: 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Non-cash lease expense (operating cash flow) $ 87,579 $ 86,320 Change in lease liabilities (operating cash flow) (152,335 ) (138,804 )	Supplemental cash flow information related to leases are as follows: Schedule of Supplemental Cash Flow Information Related to Leases For the Year Ended December 31, Supplemental cash flow information: 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Non-cash lease expense (operating cash flow) $ 173,245 $ 152,018 Non-cash impairment of right to use assets (operating cash flow) - (303,327 ) Change in lease liabilities (operating cash flow) (284,963 ) (243,596 ) Operating lease right-of-use assets obtained in exchange for lease obligations: Operating leases $ - $ 762,603
Schedule of Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Related to Leases Operating leases: June 30, 2024 December 31, 2023 Operating lease right-of-use assets $ 46,434 $ 134,013 Operating lease liability, current 81,708 234,043 Operating lease liability, non-current - Total operating lease liabilities $ 81,708 $ 234,043 Weighted-average remaining lease term: June 30, 2024 December 31, 2023 Operating leases (in years) 0.26 0.76 Weighted-average discount rate: June 30, 2024 December 31, 2023 Operating leases 6.83 % 6.76 %	Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Related to Leases Operating leases: December 31, December 31, Operating lease right-of-use assets $ 134,013 $ 307,258 Operating lease liability, current 234,043 284,963 Operating lease liability, long-term - 234,043 Total operating lease liabilities $ 234,043 $ 519,006 Weighted-average remaining lease term: December 31, December 31, Operating leases (in years) 0.76 1.76 Weighted-average discount rate: December 31, December 31, Operating leases 6.76 % 6.74 %
Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease	Future minimum lease payments under non-cancellable lease as of June 30, 2024, are as follows: Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease Maturities of lease liabilities: Year Ending December 31, Remainder of 2024 $ 82,679 Year Ending December 31, 2024 $ - Total undiscounted cash flows 82,679 Less discounting (971 ) Present value of lease liabilities $ 81,708	Future minimum lease payments under non-cancellable lease as of December 31, 2023, are as follows: Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease Maturities of lease liabilities: Maturities of lease liabilities: Year Ending December 31, 2024 $ 240,818 Total undiscounted cash flows 240,818 Less discounting (6,775 ) Present value of lease liabilities $ 234,043

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended	12 Months Ended
Stock-Based Compensation (Tables)	Jun. 30, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Assumptions Used to Compute Fair Value	The following table summarizes assumptions used to compute the fair value of options granted: Summary of Assumptions Used to Compute Fair Value June 30, 2024 June 30, 2023 Stock price $ 0.29 0.61 $ 8.22 9.56 Exercise price $ 0.29 5.00 $ 11.98 Expected volatility 75.00 85.00 % 80.00 99.03 % Expected term (in years) 5.75 10.00 5.25 6.08 Risk-free interest rate 4.20 4.50 % 3.46 4.31 %	The following table summarizes assumptions used to compute the fair value of options granted: Summary of Assumptions Used to Compute Fair Value December 31, December 31, Stock price $ 8.38 11.98 $ 1.54 Exercise price $ 8.38 11.98 $ 1.04 Expected volatility 80.00 110.95 % 53.61 55.30 % Expected term (in years) 5.00 6.08 5.94 6.08 Risk-free interest rate 3.46 4.31 % 1.95 2.85 %
Summary of Stock Option Activity	A summary of stock option activity under the Plan is as follows: Summary of Stock Option Activity Shares Weighted Weighted Intrinsic Outstanding at December 31, 2023 14,962 $ 293.50 8.43 $ 103,662 Granted 27,970 145.70 9.87 Exercised — — Expired — — Forfeited (9,283 ) 239.11 Outstanding at June 30, 2024 33,649 $ 185.69 9.17 $ 1,807 Exercisable at June 30, 2024 8,675 $ 248.23 8.34 $ 1,807	A summary of stock option activity under the Plan is as follows: Summary of Stock Option Activity Shares Weighted Weighted Intrinsic Outstanding at December 31, 2021 14,634 $ 57.50 7.20 $ 369,102 Retroactive application of recapitalization (Note 4) (6,024 ) 36.05 Outstanding at December 31, 2021, after effect of Merger (Note 4) 9,610 93.55 Granted 4,702 138.50 Exercised (171 ) 62.00 10,835 Expired (2,411 ) 69.00 Forfeited (4,310 ) 129.50 Outstanding at December 31, 2022 7,420 $ 106.44 7.95 $ 3,433,946 Granted 16,440 500.50 Exercised (353 ) 109.56 4,440 Expired (258 ) 598.50 Forfeited (8,287 ) 538.00 Outstanding at December 31, 2023 14,962 $ 293.50 8.43 $ 103,662 Exercisable at December 31, 2023 6,900 $ 211.50 7.56 $ 103,251
Summary of Activity with Respect Status of, RSUs	A summary of the activity with respect to, and status of, RSUs during the six months ended June 30, 2024 is presented below: Summary of Activity with Respect Status of, RSUs Units Weighted Average Outstanding at December 31, 2023 — $ — Granted 17,851 26.64 Vested — — Forfeited (293 ) 14.65 Outstanding at June 30, 2024 17,558 $ 26.84

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended	12 Months Ended
Income Taxes (Tables)	Jun. 30, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate	Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate	A reconciliation of the statutory U.S. federal income tax rate to the Company’s effective tax rate consists of the following: Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate For the Years Ended December 31, 2023 2022 Statutory federal income tax benefit $ (3,025,315 ) 21.0 % $ (3,248,385 ) 21.0 % State taxes, net of federal tax benefit (219,705 ) 1.5 % (327,095 ) 2.1 % Change in valuation allowance 2,079,231 -14.4 % 1,435,041 -9.3 % Change in state tax rate 462,709 -3.2 % 13,055 -0.1 % Change in fair value estimates (2,050,026 ) 14.2 % 1,610,993 -10.4 % Non-deductible interest-IRC 163(j) 738,993 -5.1 % - 0.0 % Non-deductible transaction/restructuring costs 1,313,792 -9.1 % - 0.0 % Nondeductible warrant issuance expense 552,321 -3.8 % - 0.0 % Other non-deductible expenses 148,000 -1.0 % 516,391 -3.3 % Effective tax rate $ - 0.0 % $ - 0.0 %
Schedule of Components of Income Tax Provision (Benefit)	Schedule of Components of Income Tax Provision (Benefit)	The components of income tax provision (benefit) are as follows: Schedule of Components of Income Tax Provision (Benefit) 2023 2022 As of December 31, 2023 2022 Federal: Current $ - $ - Deferred - - State and Local: Current - - Deferred - - Total $ - $ -
Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities	Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities	Deferred income taxes reflect the net tax effects of temporary differences between the carrying value of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. The temporary differences that give rise to deferred tax assets and liabilities are as follows: Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities 2023 2022 As of December 31, 2023 2022 Deferred tax assets (liabilities): Net operating loss carryforwards $ 6,368,669 $ 3,744,512 Contribution carryforwards 24,626 20,837 Stock-based compensation 155,404 25,216 Accrual to cash adjustment 1,299 482,109 Startup costs 1,816,143 - Lease Liabilities 52,805 119,971 Right of use assets (30,236 ) (71,024 ) Capitalized R&D costs (Sec. 174) 798,802 451,195 Other (3,363 ) 696 Deferred tax assets gross 9,184,149 4,773,512 Valuation allowance (9,184,149 ) (4,773,512 ) Deferred tax assets, net of allowance $ - $ -

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
Property and Equipment (Tables)	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following at the dates indicated: Schedule of Property and Equipment, Net 2023 2022 December 31, 2023 2022 Computers and equipment $ 30,867 $ 30,866 Less: accumulated depreciation (26,223 ) (19,063 ) Property and equipment, net $ 4,644 $ 11,803

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
Goodwill (Tables)	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Goodwill	The following summarizes our goodwill activity during the years ended December 31, 2023 and 2022: Summary of Goodwill Total Goodwill-December 31, 2021 $ 2,171,526 Impairment - Goodwill-December 31, 2022 2,171,526 Impairment - Goodwill-December 31, 2023 $ 2,171,526

Organization (Details Narrative

Organization (Details Narrative) - USD ($)			1 Months Ended	6 Months Ended	12 Months Ended
Organization (Details Narrative) - USD ($)	Dec. 14, 2023	Aug. 04, 2023	Dec. 31, 2022	Jun. 30, 2024	Dec. 31, 2023
Entity Incorporation, Date of Incorporation				Sep. 30, 2015	Sep. 30, 2015
Common stock, par value			$ 0.0001	$ 0.0001	$ 0.0001
Seven GC Common Stock [Member]
Common stock, par value		$ 0.0001
Business combination provisional information initial accounting incomplete reduction consideration transferred		$ 100,000,000
Shares issued price per share		$ 10
Hyros Inc [Member]
Percentage of voting interests planned to acquire			100%
Business combination price of acquisition expected			$ 110,000,000
Banzai International Inc [Member]
Asset acquisition, consideration transferred				$ 100,000,000	$ 100,000,000
Business combination provisional information initial accounting incomplete reduction consideration transferred	$ 100,000,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
Going Concern (Details Narrative) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 500,000		$ 2,100,000
Net cash used in operating activities	3,812,695	$ 4,046,650	1,550,781	$ 5,168,175
Accumulated deficit	$ 55,431,704		$ 46,766,324	$ 32,360,062

Schedule of Basic and Diluted N

Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Net loss attributable to common stock-basic and diluted	$ (4,165,108)	$ (3,486,053)	$ (8,665,380)	$ (7,251,175)	$ (14,406,262)	$ (15,468,502)
Weighted average shares-basic	541,836	129,193	444,474	129,127	137,074	128,822
Weighted average shares-diluted	541,836	129,193	444,474	129,127	137,074	128,822
Net loss per share attributable to common stock-basic	$ (7.69)	$ (26.98)	$ (19.50)	$ (56.16)	$ (105.10)	$ (111.83)
Net loss per share attributable to common stock-diluted	$ (7.69)	$ (26.98)	$ (19.50)	$ (56.16)	$ (105.10)	$ (111.83)

Schedule of Antidilutive Securi

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	592,222	13,405	261,533	7,420
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	33,649	13,405	14,962	7,420
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	17,558
Public Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	230,000		230,000
Gem Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	16,571		16,571
Common Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	277,778
Placement Agent Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	16,667

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative)		3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 19, 2024	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2023 USD ($) Integer	Dec. 31, 2022 USD ($)	Dec. 14, 2023 USD ($)
Product Information [Line Items]
Cash equivalents						$ 0	$ 0	$ 0	$ 0
Allowance for credit losses						5,748	$ 5,748	$ 5,748	107,860
Bad debt expenses for accounts receivable						65,013			142,162
Number of operating segments							1	1
Goodwill, impairment loss						0			0
Deferred offering costs									1,524,934	$ 3,233,097
Revenue		$ 1,068,197	$ 1,193,321	$ 2,147,669	$ 2,370,382	4,561,300			5,332,979
Advertising costs						$ 941,737			783,764
Three Customers [Member]
Product Information [Line Items]
Revenue									$ 259,635
Customer Concentration Risk [Member] \| Customer One [Member] \| Accounts Receivable [Member]
Product Information [Line Items]
Concentration risk, percentage									21%
Customer Concentration Risk [Member] \| Customer Two [Member] \| Accounts Receivable [Member]
Product Information [Line Items]
Concentration risk, percentage									16%
Customer Concentration Risk [Member] \| Customer Three [Member] \| Accounts Receivable [Member]
Product Information [Line Items]
Concentration risk, percentage									10%
Customer Concentration Risk [Member] \| Three Customers [Member] \| Accounts Receivable [Member]
Product Information [Line Items]
Concentration risk, percentage									47%
Computer Equipment [Member]
Product Information [Line Items]
Property and equipment estimated useful lives						3 years	3 years	3 years
Subsequent Event [Member]
Product Information [Line Items]
Reverse stock split	one-for-fifty (1-for-50) reverse stock split

Reverse Merger Capitalization_3

Reverse Merger Capitalization with 7GC & Co. Holdings Inc. (Details Narrative)											6 Months Ended	12 Months Ended
	Dec. 28, 2023 shares	Dec. 14, 2023 USD ($) $ / shares shares	Dec. 13, 2023 USD ($) $ / shares shares	Dec. 12, 2023 USD ($) Tradingday $ / shares	Nov. 16, 2023 shares	Oct. 03, 2023 shares	Aug. 24, 2023 $ / shares	Aug. 04, 2023 $ / shares shares	May 27, 2022 USD ($)	Jan. 01, 2022 shares	Jun. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 $ / shares shares	Nov. 08, 2023 USD ($) shares	Sep. 13, 2023 USD ($)	Oct. 10, 2022 USD ($)	Feb. 19, 2021 USD ($)
Business Acquisition [Line Items]
Common stock par value \| $ / shares											$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized		350,000,000									275,000,000	275,000,000	275,000,000
Preferred stock, shares authorized		75,000,000									75,000,000	75,000,000	75,000,000
Preferred stock, par value \| $ / shares		$ 0.0001									$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued											3,003,810	2,585,296	3,935,892
Common stock, shares outstanding											3,003,810	2,585,296	3,935,892
Preferred stock, shares outstanding											0	0	0
Common Stock [Member]
Business Acquisition [Line Items]
Common stock, shares authorized		105,000,000
Yorkville Standby Equity Purchase Agreement [Member]
Business Acquisition [Line Items]
Principal amount agreed to advance \| $		$ 3,500,000
Increased principal amount agreed to advance \| $		1,000,000
Aggregate principal amount \| $		$ 4,500,000
Share Transfer Agreements And Alco Promissory Notes [Member]
Business Acquisition [Line Items]
Aggregate principal amount \| $			$ 2,000,000												$ 1,500,000
Share transfer agreement description												for each $10.00 in principal borrowed under the New Alco Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held by the Sponsor, in exchange for the right of Alco to receive three shares of Class A Common Stock, in each case, at (and contingent upon) the Closing, with such forfeited and issued shares capped at an amount equal to 12,000.
Debt instrument conversion price per share \| $ / shares			$ 10
Forfeited and issued shares capped			12,000
Debt instrument, interest rate			8%
Debt instrument, maturity date range, start												Jan. 10, 2024
Debt instrument, maturity date range, end												Sep. 30, 2024
Gem Agreements [Member]
Business Acquisition [Line Items]
Debt instrument, interest rate			0%
Equity commitment by investor \| $									$ 100,000,000
Amount divided on number of equity interests to obtain quotient \| $									$ 650,000,000
Convertible debenture \| $			$ 2,000,000
Convertible debenture maturity period			5 years
Seven G C Promissory Notes [Member]
Business Acquisition [Line Items]
Debt instrument conversion price per share \| $ / shares				$ 2.86
Maximum borrowing capacity \| $				$ 2,300,000
Debt instrument, convertible, threshold trading days \| Tradingday				30
CpB Senior Convertible Notes [Member]
Business Acquisition [Line Items]
Debt instrument conversion price per share \| $ / shares							$ 217.43
Convertible written notice period							5 days
CpB Senior Convertible Notes [Member] \| First Senior Convertible Note [Member]
Business Acquisition [Line Items]
Aggregate principal amount \| $																$ 321,345	$ 1,500,000
Cantor Fee Agreement [Member] \| 7GC & Co. Holdings Inc. [Member] \| Cantor Fitzgerald [Member]
Business Acquisition [Line Items]
Deferred underwriting fees forfeit \| $														$ 4,050,000
Deferred underwriting fees payable \| $														8,050,000
Increase decrease in deferred underwriting fees \| $														$ 4,000,000
Deferred underwriting fees payable in shares														400,000
Forfeited Private Placement Warrants [Member] \| Sponsor Forfeiture Agreement [Member]
Business Acquisition [Line Items]
Warrants issued								7,350,000
Warrants price per share \| $ / shares								$ 11.50
Banzai International Inc [Member]
Business Acquisition [Line Items]
Exchange ratio		0.6147
Enterprise valuation amount \| $		$ 100,000,000
Common stock, shares outstanding										6,359,139
Asset acquisition, consideration transferred \| $		$ 100,000,000
Common stock shares issued										6,359,139
Increase of reclassification of series a preferred stock into common stock										28,629
Common Stock [Member]
Business Acquisition [Line Items]
Common stock, shares issued											3,003,810	2,585,296
Common stock, shares outstanding											3,003,810	2,585,296
Common Stock [Member] \| Banzai International Inc [Member]
Business Acquisition [Line Items]
Common stock par value \| $ / shares		$ 0.0001
Exchange ratio		10
Common stock, shares outstanding												2,585,297	3,935,892
Common stock shares issued												2,585,297	3,935,892
Decrease in stock due to retrospective impact of recapitalization										1,758,003
Common Stock [Member] \| Banzai International Inc [Member] \| Gem Agreements [Member]
Business Acquisition [Line Items]
Percentage of right to purchase of total equity interests									3%
Seven G C Class A Common Stock [Member]
Business Acquisition [Line Items]
Common stock par value \| $ / shares		$ 0.0001
Number of shares held by security holders		3,207,428
Redemption price per share \| $ / shares		$ 10.76
Aggregate redemption amount \| $		$ 34,524,065
Common Class A [Member]
Business Acquisition [Line Items]
Common stock par value \| $ / shares		$ 0.0001
Common stock, shares authorized		5,000,000									25,000,000	250,000,000	250,000,000
Common stock, shares issued											692,676	274,162	51,219
Common stock, shares outstanding											692,676	274,162	51,219
Common Class A [Member] \| Share Transfer Agreements And Alco Promissory Notes [Member]
Business Acquisition [Line Items]
Common stock shares issued			16,500		1,500	150,000
Common Class A [Member] \| Gem Agreements [Member]
Business Acquisition [Line Items]
Percentage of right to purchase of total equity interests			3%
Common Class A [Member] \| Seven G C Promissory Notes [Member]
Business Acquisition [Line Items]
Debt instrument, convertible, threshold trading days \| Tradingday				30
Common Class A [Member] \| Cantor Fee Agreement [Member]
Business Acquisition [Line Items]
Common stock shares issued	22,279
Common Class A [Member] \| Banzai International Inc [Member]
Business Acquisition [Line Items]
Common stock par value \| $ / shares		$ 0.0001
Common stock, shares outstanding										39,139		274,162	51,219
Preferred stock, convertible, conversion ratio		1
Common stock shares issued										39,139		274,162	51,219
Decrease in stock due to retrospective impact of recapitalization										15,082
Common Class B [Member]
Business Acquisition [Line Items]
Common stock, shares authorized		25,000,000									25,000,000	25,000,000	25,000,000
Common stock, shares issued											2,311,134	2,311,134	3,884,673
Common stock, shares outstanding											2,311,134	2,311,134	3,884,673
Common Class B [Member] \| Banzai International Inc [Member]
Business Acquisition [Line Items]
Common stock par value \| $ / shares		$ 0.0001
Common stock, convertible, conversion ratio		1
Common stock, shares outstanding										6,320,000		2,311,134	3,884,673
Common stock shares issued										6,320,000		2,311,134	3,884,673
Decrease in stock due to retrospective impact of recapitalization										2,435,327
Series A Preferred Stock [Member] \| Banzai International Inc [Member]
Business Acquisition [Line Items]
Preferred stock, par value \| $ / shares		$ 0.0001
Preferred stock, shares outstanding										2,328,823
Preferred stock, convertible, conversion ratio		1
Decrease in stock due to retrospective impact of recapitalization										897,380
Seven G C Class B Common Stock [Member] \| Share Transfer Agreements And Alco Promissory Notes [Member]
Business Acquisition [Line Items]
Forfeiture of common stock shares			16,500		1,500	3,000
Banzai International Inc [Member]
Business Acquisition [Line Items]
Exchange ratio		0.6147
Enterprise valuation amount \| $		$ 100,000,000
Asset acquisition, consideration transferred \| $											$ 100,000,000	$ 100,000,000
Banzai International Inc [Member] \| Common Stock [Member]
Business Acquisition [Line Items]
Common stock par value \| $ / shares		$ 0.0001
Banzai International Inc [Member] \| Common Class A [Member]
Business Acquisition [Line Items]
Common stock par value \| $ / shares		$ 0.0001
Banzai International Inc [Member] \| Common Class B [Member]
Business Acquisition [Line Items]
Common stock, convertible, conversion ratio		1

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)			3 Months Ended
Related Party Transactions (Details Narrative) - USD ($)	Feb. 09, 2023	Dec. 21, 2022	Jun. 30, 2023	Jun. 30, 2024	Feb. 02, 2024	Dec. 31, 2023	Dec. 14, 2023	Oct. 03, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Common stock par value				$ 0.0001		$ 0.0001			$ 0.0001
Aggregate principal amount							$ 3,500,000
Due to related party				$ 324,717		$ 149,841			$ 3,017
7GC & Co. Holdings LLC [Member]
Related Party Transaction [Line Items]
Debt instrument conversion price per share		$ 10
Convertible notes					$ 2,540,092
Loans payable current						2,540,091
7GC & Co. Holdings LLC [Member] \| Working Capital Loans [Member]
Related Party Transaction [Line Items]
Debt instrument conversion price per share								$ 10
Aggregate principal amount								$ 500,000
Debt instrument, interest rate								0%
Sponsor Member \| 7GC & Co. Holdings LLC [Member]
Related Party Transaction [Line Items]
Due to related party						$ 67,118
Sponsor Member \| 7GC & Co. Holdings LLC [Member] \| Working Capital Drawdowns And Extension Drawdowns Member
Related Party Transaction [Line Items]
Maximum borrowing capacity		$ 2,300,000
Common stock par value		$ 0.0001
Proceeds from related party debt		$ 1,100,000
Sponsor Member \| 7GC & Co. Holdings LLC [Member] \| Working Capital Drawdowns [Member]
Related Party Transaction [Line Items]
Maximum borrowing capacity		500,000
Proceeds from related party debt	$ 177,500	900,000	$ 122,500
Outstanding principal amount			500,000
Sponsor Member \| 7GC & Co. Holdings LLC [Member] \| Extension Drawdowns [Member]
Related Party Transaction [Line Items]
Maximum borrowing capacity		1,800,000
Proceeds from related party debt		$ 200,000	900,000
Outstanding principal amount			$ 1,800,000

Summary of Revenue by Region (D

Summary of Revenue by Region (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Summary of Revenue by Region (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Amount	$ 1,068,197	$ 1,193,321	$ 2,147,669	$ 2,370,382	$ 4,561,300	$ 5,332,979
Geographic Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100%	100%	100%	100%	100%	100%
Americas [Member]
Disaggregation of Revenue [Line Items]
Amount	$ 587,712	$ 704,626	$ 1,170,539	$ 1,374,401	$ 2,677,050	$ 3,307,129
Americas [Member] \| Geographic Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Disaggregation of Revenue [Line Items]
Percentage of Revenue	55%	59%	55%	62%	59%	62%
EMEA [Member]
Disaggregation of Revenue [Line Items]
Amount	$ 360,666	$ 389,318	$ 746,916	$ 797,228	$ 1,511,886	$ 1,588,539
EMEA [Member] \| Geographic Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Disaggregation of Revenue [Line Items]
Percentage of Revenue	34%	33%	34%	30%	33%	30%
Asia Pacific [Member]
Disaggregation of Revenue [Line Items]
Amount	$ 119,819	$ 99,377	$ 230,214	$ 198,753	$ 372,364	$ 437,311
Asia Pacific [Member] \| Geographic Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Disaggregation of Revenue [Line Items]
Percentage of Revenue	11%	8%	11%	8%	8%	8%

Summary of Accounts Receivable,

Summary of Accounts Receivable, Net (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Opening Balance	$ 105,049	$ 109,533	$ 68,416	$ 74,727
Closing Balance	$ 26,161	$ 105,049	$ 109,533	$ 68,416

Summary of Costs to Obtain Cont

Summary of Costs to Obtain Contract Activity (Details) - USD ($)	3 Months Ended				12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Capitalized contract cost, beginning balance	$ 38,462	$ 51,472	$ 54,376	$ 69,737	$ 69,737	$ 90,662
Commissions Incurred	48,316	31,610	60,777	88,928	242,810	343,003
Deferred Commissions Recognized	(47,634)	(44,620)	(75,001)	(104,289)	(261,075)	(363,928)
Capitalized contract cost, ending balance	$ 39,144	$ 38,462	$ 40,152	$ 54,376	$ 51,472	$ 69,737

Revenue (Details Narrative)

Revenue (Details Narrative)	3 Months Ended		6 Months Ended		12 Months Ended
Revenue (Details Narrative)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) Integer	Dec. 31, 2022 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2021 USD ($)
Disaggregation of Revenue [Line Items]
Payment Term			30 days		30 years
Accounts receivable contractual term			The Company receives payments from customers based upon agreed-upon contractual terms, typically within 30 days of invoicing the customer.		The Company receives payments from customers based upon agreed-upon contractual terms, typically within 30 days of invoicing the customer.
Commission expenses	$ 61,146	$ 91,243	$ 143,288	$ 190,619	$ 299,450	$ 434,446
Capitalized commissions	$ 39,144	$ 40,152	$ 39,144	$ 40,152	$ 51,472	69,737	$ 38,462	$ 54,376	$ 90,662
Customer vendor \| Integer					1
Exchanged services					$ 375,000	$ 293,500
Demio [Member]
Disaggregation of Revenue [Line Items]
Performance obligations, timing			The performance obligations identified include access to the suite and platform, within the parameters established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of webinars and hosts as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Demio services over time which corresponds with the period of time that access to the service is provided.		The performance obligations identified include access to the suite and platform, within the parameters established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of webinars and hosts as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Demio services over time which corresponds with the period of time that access to the service is provided.
Reach [Member]
Disaggregation of Revenue [Line Items]
Performance obligations, timing			The performance obligations identified include access to the suite and platform, within the parameters established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of simultaneous published events as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Reach services over time which corresponds with the timing the service is rendered.		The performance obligations identified include access to the suite and platform, within the parameters established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of simultaneous published events as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Reach services over time which corresponds with the timing the service is rendered.

Schedule of Fair Value on Recur

Schedule of Fair Value on Recurring Basis (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Liabilities:
Bifurcated embedded derivative liabilities-related party	$ 0	$ 0
Related Party [Member]
Liabilities:
Bifurcated embedded derivative liabilities-related party			$ 1,936,827
Fair Value, Inputs, Level 2 [Member]
Liabilities:
Warrant liabilities-public	230,000	575,000
Fair Value, Inputs, Level 3 [Member]
Liabilities:
GEM warrant liabilities	79,000	641,000
Yorkville convertible note	$ 2,013,000	1,766,000
Bifurcated embedded derivative liabilities-related party			845,473
SAFE-related party			663,804
Fair Value, Inputs, Level 3 [Member] \| Related Party [Member]
Liabilities:
Bifurcated embedded derivative liabilities-related party			1,936,827
SAFE-related party			$ 8,802,196

Summary of Changes in the Fair

Summary of Changes in the Fair Value of the Warrants Liability (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2024	Dec. 31, 2023
Public Warrants Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance at December 31, 2022	$ 460,000	$ 575,000
Balance at December 31, 2023	230,000	230,000	$ 575,000
Public Warrants Liability [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value	(230,000)	(115,000)
Change in fair value	230,000	115,000
Public Warrants Liability [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance at December 31, 2022		575,000
Change in fair value			115,000
Balance at December 31, 2023			575,000
Merger date assumption of public warrants			460,000
Change in fair value			(115,000)
Public Warrants Liability [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance at December 31, 2022		641,000
Change in fair value			(1,807,000)
Balance at December 31, 2023			641,000
Change in fair value			1,807,000
Issuance of GEM warrants			2,448,000
Gem Warrants Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance at December 31, 2022	233,000	641,000
Balance at December 31, 2023	79,000	79,000	$ 641,000
Gem Warrants Liability [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value	(154,000)	(408,000)
Change in fair value	$ 154,000	$ 408,000

Summary of Changes in Fair Valu

Summary of Changes in Fair Value of Yorkville Convertible Note (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss on debt issuance			$ 171,000
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance at December 31, 2022			1,766,000
Balance at December 31, 2023	2,013,000		2,013,000		1,766,000
Fair Value, Inputs, Level 3 [Member] \| Convertible Debt [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance at December 31, 2022	3,064,000		1,766,000
Issuance of yorkville convertible note			2,250,000		1,800,000
Loss on debt issuance			171,000
Payment in shares to settle Yorkville convertible notes	(335,000)		(1,667,000)
Change in fair value	34,000		544,000		(34,000)
Repayment in cash of Yorkville convertible notes	(750,000)
Balance at December 31, 2023	$ 2,013,000		$ 2,013,000		$ 1,766,000

Schedule of Derivative Liabilit

Schedule of Derivative Liabilities (Details) - USD ($)	3 Months Ended			6 Months Ended		12 Months Ended
Schedule of Derivative Liabilities (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Balance		$ 2,781,112	$ 1,936,827		$ 1,936,827	$ 1,936,827
Issuance of convertible notes with bifurcated embedded derivative		419,451	707,000			1,126,451	1,398,595
Change in fair value		(478,198)	137,285		(340,913)	(3,063,278)	606,857
Balance		2,722,365	2,781,112		2,722,365		1,936,827
Issuance of CP BF convertible notes with bifurcated embedded derivative							1,375
Extinguishment of Old Alco Note derivative							(70,000)
Third Party Convertible Debt [Member]
Defined Benefit Plan Disclosure [Line Items]
Balance		877,888	845,473		845,473	845,473	4,000
Issuance of convertible notes with bifurcated embedded derivative		330,390				559,390	586,405
Change in fair value		(194,643)	32,415			(1,404,863)	254,443
Balance		$ 1,013,635	$ 877,888		$ 1,013,635		845,473
Issuance of CP BF convertible notes with bifurcated embedded derivative							625
Extinguishment of Old Alco Note derivative

Schedule of Fair Value Measurem

Schedule of Fair Value Measurements (Details) - USD ($)	3 Months Ended			6 Months Ended		12 Months Ended
Schedule of Fair Value Measurements (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Balance		$ 9,105,335	$ 8,802,196		$ 8,802,196	$ 8,802,196	$ 3,121,591
Change in fair value		909,418	303,139		1,212,557	(2,752,430)	4,078,431
Balance		10,014,753	9,105,335		10,014,753		8,802,196
Loss on modification							1,602,174
Conversion of SAFEs						(6,049,766)
Third Party Convertible Debt [Member]
Defined Benefit Plan Disclosure [Line Items]
Balance		686,665	663,804		663,804	663,804	235,409
Change in fair value		68,582	22,861			(207,570)	307,569
Balance		$ 755,247	$ 686,665		$ 755,247		663,804
Loss on modification							$ 120,826
Conversion of SAFEs						$ (456,234)

Fair Value Measurements (Detail

Fair Value Measurements (Details Narrative) - USD ($)		6 Months Ended	12 Months Ended
Fair Value Measurements (Details Narrative) - USD ($)	Dec. 14, 2023	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2021
Class of Warrant or Right [Line Items]
Bifurcated embedded derivative liabilities		$ 0	$ 0
Face value of the convertible notes	$ 3,500,000
Conversion upon simple agreements for future equity		0	0
Simple Agreements For Future Equity [Member]
Class of Warrant or Right [Line Items]
Discount price				15%
Face value of the convertible notes				$ 3,836,000
Convertible Debt [Member]
Class of Warrant or Right [Line Items]
Benefit (loss) of changes in the fair value		$ 578,000	$ 34,000
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding		230,000	230,000
Benefit (loss) resulting from a decrease/(increase) in fair value of derivative warrant liabilities	$ 115,000	$ 345,000	$ 1,807,000
Gem Warrants Liability [Member]
Class of Warrant or Right [Line Items]
Benefit (loss) resulting from a decrease/(increase) in fair value of derivative warrant liabilities		$ 562,000

Summary of Prepaid Expenses and

Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Prepaid Expenses And Other Current Assets
Service Trade	$ 302,055	$ 364,384	$ 97,875
Prepaid insurance costs	282,265	17,661	15,430
Prepaid advertising and marketing costs	259,438	11,074	32,178
Prepaid software costs	97,912	29,887	10,255
Prepaid commissions	39,144	51,472	69,737
Prepaid data license and subscription costs	34,375	53,124	40,000
Prepaid merchant fees	28,488	26,224	26,401
Prepaid consulting costs	26,539	120,332	3,124
Other current assets	10,720	66,997	38,507
Total prepaid expenses and other current assets	$ 1,080,936	$ 741,155	$ 333,507

Summary of Accrued Expenses and

Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued accounting and professional services costs	$ 2,458,192	$ 1,511,889	$ 94,573
Accrued subscription costs	510,549	22,110	28,774
Sales tax payable	363,883	314,873	230,617
Excise tax payable	223,717	223,717
Accrued legal costs	159,417	2,694,439	31,355
Accrued payroll and benefit costs	123,335	185,504	95,947
Deposits	52,000	54,102
Accrued streaming service costs	48,218	37,765
Accrued offering costs			261,090
Other current liabilities	324,717	149,841	3,017
Total accrued and other current liabilities	$ 4,264,028	$ 5,194,240	$ 745,373

Summary of Changes in Deferred

Summary of Changes in Deferred Revenue (Details) - USD ($)	6 Months Ended	12 Months Ended
Summary of Changes in Deferred Revenue (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Deferred Revenue
Deferred revenue, beginning of period	$ 1,214,096	$ 930,436	$ 1,060,040
Billings	2,255,811	4,781,924	5,040,665
Revenue recognized (prior year deferred revenue)	(861,496)	(930,436)	(1,004,697)
Revenue recognized (current year deferred revenue)	(1,286,173)	(3,567,828)	(4,165,572)
Deferred revenue, end of period	$ 1,322,238	$ 1,214,096	$ 930,436

Deferred Revenue (Details Narra

Deferred Revenue (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
Deferred Revenue (Details Narrative) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Deferred Revenue
Recognition of deferred revenue	$ 861,496	$ 887,219	$ 930,436

Summary of Related Party and Th

Summary of Related Party and Third Party Convertible Notes (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Face value of the convertible notes	$ 6,783,538	$ 4,200,538
Debt discount, net	(131,867)	(849,656)
Carrying value of the convertible notes	6,651,671	3,350,882
Accrued interest	619,697	155,626
Conversion of convertible notes	(7,271,368)
Total convertible notes and accrued interest		3,506,508
Nonrelated Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Face value of the convertible notes	3,196,206	1,761,206
Debt discount, net	(83,688)	(398,034)
Carrying value of the convertible notes	3,112,518	1,363,172
Accrued interest	233,714	45,654
Conversion of convertible notes	(3,346,232)
Total convertible notes and accrued interest		$ 1,408,826

Summary of Convertible Notes (D

Summary of Convertible Notes (Details) - Loan agreement with cpbf Lending Llc [Member] - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Short-Term Debt [Line Items]
Face value of the CB BF convertible notes		$ 1,821,345	$ 1,821,345
Debt discount, net		(41,983)	(63,715)
Carrying value of the CB BF convertible notes		1,779,362	1,757,630
Accrued interest		914,479	518,904
Total CB BF convertible notes and accrued interest		2,693,841	2,276,534
Face value of the CB BF term note		6,500,000	6,500,000
Debt discount, net		(129,586)	(192,911)
Carrying value of the CB BF term note		6,370,414	6,307,089
Accrued interest		289,373	186,962
Total CB BF term note and accrued interest		6,659,787	6,494,051
Carrying value of the CB BF convertible notes		1,779,362	$ 1,757,630
Convertible Notes [Member]
Short-Term Debt [Line Items]
Face value of the CB BF convertible notes	$ 1,821,345	1,821,345
Debt discount, net	(26,757)	(41,983)
Carrying value of the CB BF convertible notes	1,794,588	1,779,362
Accrued interest	1,135,983	914,479
Total CB BF convertible notes and accrued interest	2,930,571	2,693,841
Carrying value of the CB BF convertible notes	1,794,588	1,779,362
Term Note [Member]
Short-Term Debt [Line Items]
Face value of the CB BF term note	6,500,000	6,500,000
Debt discount, net	(76,353)	(129,586)
Carrying value of the CB BF term note	6,423,647	6,370,414
Accrued interest	664,562	289,373
Total CB BF term note and accrued interest	$ 7,088,209	$ 6,659,787

Debt (Details Narrative)

Debt (Details Narrative)																				3 Months Ended		6 Months Ended			12 Months Ended
Debt (Details Narrative)	Jul. 05, 2024 shares	May 30, 2024 USD ($)	May 22, 2024 USD ($) shares	May 03, 2024 USD ($) $ / shares	Mar. 27, 2024 USD ($)	Mar. 26, 2024 USD ($)	Feb. 09, 2024 USD ($) shares	Feb. 05, 2024 USD ($) shares	Feb. 02, 2024 shares	Dec. 14, 2023 USD ($) $ / shares shares	Dec. 13, 2023 USD ($) $ / shares shares	Dec. 12, 2023 USD ($) Integer	Nov. 16, 2023 USD ($)	Oct. 03, 2023 USD ($) $ / shares	Sep. 13, 2023 USD ($) $ / shares shares	Aug. 30, 2023 USD ($)	Jul. 19, 2022 USD ($)	Mar. 21, 2022 USD ($)	Feb. 19, 2021 USD ($)	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares	Jun. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares	Jun. 30, 2023 USD ($) $ / shares	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) $ / shares	May 31, 2024 USD ($)	Feb. 14, 2024 USD ($) $ / shares	Jan. 31, 2024 $ / shares	Dec. 31, 2023 $ / shares	Dec. 31, 2023	Dec. 31, 2023 Integer	Mar. 31, 2023 USD ($)	Feb. 14, 2023 $ / shares	Dec. 21, 2022 USD ($) $ / shares	Oct. 10, 2022 USD ($)	Sep. 30, 2022 USD ($)	Jul. 31, 2022 USD ($)	May 31, 2022 USD ($)	Dec. 31, 2021
Aggregate principal amount										$ 3,500,000
Proceeds from sale of common stock																						$ 1,854,818		$ 13,362	$ 30,761	$ 5,016
Number of promissory notes In connection with merger																															2	2
Common stock, value issued																				$ 300		$ 300			259	$ 394
Common stock par value \| $ / shares																				$ 0.0001		$ 0.0001				$ 0.0001				$ 0.0001
Repayment of convertible debt																						$ 750,000
Original issuance price \| $ / shares																										$ 1.54
Loss on debt extinguishment																						527,980				$ (56,653)
Modification of convertible notes payable																									9,909
Change in fair value of convertible promissory notes																						$ 578,000			$ (34,000)
Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues \| shares									3,500
CPBF Lending LLC [Member]
Aggregate principal amount																			$ 8,000,000
Debt Instrument, covenant compliance description																						For all respective periods presented, the Company was not in compliance with the Minimum Gross Profit Margin covenant in section 7.14.1 of the Loan Agreement, the Minimum ARR Growth covenant in section 7.14.2 of the Loan Agreement, and the Fixed Charge Coverage Ratio covenant in section 7.14.3 of the Loan Agreement. As a result of the Company’s noncompliance with the financial covenants, the entire principal amount and all unpaid and accrued interest will be classified as current on the Company’s consolidated balance sheets.			For all respective periods presented, the Company was not in compliance with the Minimum Gross Profit Margin covenant in section 7.14.1 of the Loan Agreement, the Minimum ARR Growth covenant in section 7.14.2 of the Loan Agreement, and the Fixed Charge Coverage Ratio covenant in section 7.14.3 of the Loan Agreement. As a result of the Company’s noncompliance with the financial covenants, the entire principal amount and all unpaid and accrued interest will be classified as current on the Company’s consolidated balance sheets.
Additional loan principal amount																			$ 7,000,000
Exit fee percentage																			1%
Debt covenant description																									The Loan Agreement contains customary covenants, including restrictions on the Company’s ability to incur indebtedness, grant liens or security interest on assets, make acquisitions, loans, advances or investments, or sell or otherwise transfer assets, among others. The Loan Agreement also contains other financial covenants related to minimum gross profit margin, minimum ARR (Annual Recurring Revenue) growth rate, and fixed charge ratio, among other financial covenants per the terms of the Loan Agreement.
Derivatives measured at fair value																			$ 3,000
Original Debt Repayment Agreement [Member]
Aggregate principal amount				$ 2,000,000
Premium payment				$ 200,000
Amended Debt Repayment Agreement [Member]
Aggregate principal amount			$ 750,000
Net proceeds from issuance of convertible promissory notes			75,000
Aggregate principal amount																											$ 750,000
Premium payment			75,000
Premium advance			110,040
Debt Instrument, Face Amount			35,040
Premium fair value			$ 115,800
Gem Agreement [Member]
Aggregate principal amount								$ 1,000,000
Common stock, value issued																																							$ 100,000,000
Cash agreed to pay								1,200,000
Monthly installments								100,000
Payment of debt								1,200,000
Gem Agreement [Member] \| Gem Warrant [Member]
Percentage of right to convert warrant to common shares																																							3%
Gem Agreement [Member] \| Gem Term Sheet [Member]
Common stock, value issued										2,000,000
Convertible Debt										$ 2,000,000	$ 2,000,000														$ 2,000,000
Debt Instrument term										5 years	5 years
Coupon rate										0%	0%
Debt instrument fee amount																									2,000,000
Yorkville Standby Equity Purchase Agreement [Member]
Debt discount upon issuance						$ 250,000		100,000
Aggregate principal amount						1,500,000		1,000,000												1,000,000		$ 1,000,000
Net proceeds from issuance of convertible promissory notes						$ 1,250,000		900,000
Increased Principal Amount Agreed to Advance								1,000,000
Aggregate principal amount								$ 4,500,000
Maximum floor price \| $ / shares																													$ 2
Floor price \| $ / shares																												$ 14.70
Yorkville Standby Equity Purchase Agreement [Member] \| Subsequent Event [Member]
Debt instrument, interest rate					0%			0%
Aggregate principal amount					$ 1,500,000			$ 1,000,000
Debt instrument, maturity date					Jun. 14, 2024			Jun. 14, 2024
Increased Principal Amount Agreed to Advance					$ 1,500,000			$ 1,000,000
Aggregate principal amount					$ 4,500,000			$ 4,500,000
Yorkville Advisors Global LP [Member] \| Amended Debt Repayment Agreement [Member]
Debt instrument, interest rate			18%
Debt instrument, maturity date			Sep. 25, 2024
Yorkville Advisors Global LP [Member] \| Standby Equity Purchase Agreement [Member]
Debt discount upon issuance										$ 200,000
Net proceeds from issuance of convertible promissory notes										$ 1,800,000
Prepayment premium										10%
7GC & Co. Holdings LLC [Member]
Debt instrument conversion price per share \| $ / shares																																			$ 10
Loans payable current																									2,540,091
Standby Equity Purchase Agreement [Member] \| Yorkville Advisors Global LP [Member]
Debt discount upon issuance										$ 200,000
Net proceeds from issuance of convertible promissory notes										1,800,000
Debt Instrument, Face Amount																				300,000		800,000
Prepayment premium			10%
Standby Equity Purchase Agreement [Member] \| Yorkville Advisors Global LP [Member] \| Amended Debt Repayment Agreement [Member]
Debt instrument, interest rate			0%
Alco August Promissory Note [Member]
Proceeds from sale of common stock		$ 4,000,000
Alco August Promissory Note [Member] \| Alco [Member]
Debt instrument, interest rate																8%
Interest expense																				2,908		8,357
Interest expense debt																				2,992		5,983
Debt related commitement fees and debt issuance costs																				84		2,374
Aggregate principal amount																$ 150,000
Debt instrument, maturity date																Apr. 29, 2024
Debt instrument unamortized debt issuance costs gross																$ 3,711
Principal amount outstanding																				150,000		150,000			150,000
Accrued interest outstanding																				10,027		10,027			$ 4,044
Alco September Promissory Note [Member]
Debt instrument, maturity date range, end																									Sep. 30, 2024
Alco September Promissory Note [Member] \| Measurement Input, Discount for Lack of Marketability [Member] \| Put Option [Member]
Lock-up period											180 days		180 days	180 days	180 days
Maximum borrowing capacity														$ 500,000	$ 1,000,000
Holding period for shares											5 months 26 days		7 months 6 days	8 months 19 days	9 months 7 days
Net proceeds from issuance of convertible promissory notes														$ 500,000	$ 1,000,000
Estimated re-levered equity volatility rate											47%		54%	52%	54%
Commensurate risk-free rate											5.20%		5.20%	5.40%	5.30%
Estimated re-levered equity volatility rate											9%		11.50%	11.50%	12.50%
Expected percentage of completing the merger											100%		100%	80%	80%
Alco September Promissory Note [Member] \| Alco Share Transfer Agreements [Member] \| 7GC & Co. Holdings Inc. [Member]
Debt instrument conversion price per share \| $ / shares											$ 500
Debt Conversion, Converted Instrument, Shares Issued \| shares											3,000
Alco September Promissory Note [Member] \| Alco October Share Transfer Agreement [Member] \| 7GC & Co. Holdings LLC [Member]
Debt Conversion, Description																									for each $500.00 in principal borrowed under the Alco September Promissory Note, the Sponsor agreed to forfeit one share of 7GC Class B Common Stock held by the Sponsor, in exchange for the right of Alco to receive one New Banzai Class A Share
Debt instrument conversion price per share \| $ / shares															$ 500
Debt Conversion, Converted Instrument, Shares Issued \| shares															3,000
Lock-up period															180 days
Alco September Promissory Note [Member] \| Alco [Member]
Debt instrument, interest rate															8%
Debt discount upon issuance															$ 638,808
Interest expense																				95,935		187,498
Interest expense debt																				29,918		59,836
Debt related commitement fees and debt issuance costs																				66,017		127,662
Aggregate principal amount															$ 1,500,000
Debt instrument, maturity date															Sep. 30, 2024
Principal amount outstanding																				1,500,000		1,500,000			$ 1,500,000
Accrued interest outstanding																				90,411		$ 90,411			$ 30,575
Debt issuance costs															$ 8,588
Alco November Promissory Note [Member]
Proceeds from sale of common stock		$ 4,000,000
Alco November Promissory Note [Member] \| Alco Share Transfer Agreements [Member] \| 7GC & Co. Holdings Inc. [Member]
Debt Conversion, Description																						for each $500.00 in principal borrowed under the Alco September and November Promissory Notes, the Sponsor agreed to forfeit one share of 7GC Class B Common Stock held by the Sponsor, in exchange for the right of Alco to receive one New Banzai Class A Share. For each $500.00 in principal borrowed under the December Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held by the Sponsor, in exchange for the right of Alco to receive three New Banzai Class A Shares. Such forfeited and issued shares under the Alco September, November, and December Promissory Notes are capped at an amount equal to 3,000, 1,500, and 12,000, respectively
Debt Conversion, Converted Instrument, Shares Issued \| shares											1,500
Alco November Promissory Note [Member] \| Alco November Share Transfer Agreement [Member] \| 7GC & Co. Holdings LLC [Member]
Debt Conversion, Description																									for each $500.00 in principal borrowed under the Alco November Promissory Note, the Sponsor agreed to forfeit one share of 7GC Class B Common Stock held by the Sponsor, in exchange for the right of Alco to receive one New Banzai Class A Share
Debt instrument conversion price per share \| $ / shares															$ 500
Debt Conversion, Converted Instrument, Shares Issued \| shares															1,500
Lock-up period															180 days
Alco November Promissory Note [Member] \| December 2023 Share Transfer Agreement [Member] \| 7GC & Co. Holdings LLC [Member]
Debt Conversion, Description																									for each $500.00 in principal borrowed under the December 2023 Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held by the Sponsor, in exchange for the right of Alco to receive three New Banzai Class A Shares
Debt instrument conversion price per share \| $ / shares															$ 500
Debt Conversion, Converted Instrument, Shares Issued \| shares															12,000
Lock-up period															180 days
Alco November Promissory Note [Member] \| Alco [Member]
Debt instrument, interest rate													8%
Interest expense																				31,036		$ 217,249
Interest expense debt																				14,959		29,918
Debt related commitement fees and debt issuance costs																				45,995		187,331
Debt instrument, maturity date													Apr. 13, 2024
Debt instrument unamortized debt issuance costs gross													$ 363,905
Principal amount outstanding																				750,000		750,000			$ 750,000
Accrued interest outstanding																				37,315		37,315			7,397
Alco December Promissory Note [Member] \| Alco Share Transfer Agreements [Member] \| 7GC & Co. Holdings Inc. [Member]
Debt Conversion, Converted Instrument, Shares Issued \| shares											12,000
Lock-up period											180 days
Alco December Promissory Note [Member] \| Alco [Member]
Debt instrument, interest rate											8%
Interest expense																				317,667		549,883
Interest expense debt																				39,890		79,780
Debt related commitement fees and debt issuance costs																				277,777		470,103
Debt instrument, maturity date											Dec. 31, 2024
Debt instrument unamortized debt issuance costs gross											$ 1,496,252
Principal amount outstanding																				2,000,000		2,000,000			2,000,000
Accrued interest outstanding																				$ 87,670		$ 87,670			7,890
Seven GC Promissory Notes [Member]
Loans payable current							$ 2,540,091																		2,540,091
Outstanding principal amount																									2,550,000
Modification of convertible notes payable												$ 9,909													9,909
Debt instrument, convertible, threshold trading days \| Integer												30
Term Note [Member] \| CPBF Lending LLC [Member]
Debt instrument, interest rate																			14%																					14%
Aggregate principal amount																			$ 6,500,000
Paid in kind interest																																								1.50%
Effective interest rate percentage																										16%					16%
Percentage of additional borrowing principal amount																			81.25%
Frequency of periodic interest payment																			monthly
Cash interest default percentage																			20%
Interest payable-in-kind default percentage																			0%
Capitalized debt issuance costs																			$ 310,589
Convertible Debt [Member] \| CPBF Lending LLC [Member]
Aggregate principal amount																			$ 1,500,000
Paid in kind interest																																								15.50%
Effective interest rate percentage																				16%	16%	16%		16%
Percentage of additional borrowing principal amount																			18.75%
Accrued interest payable-in-kind																			15.50%
Capitalized debt issuance costs																			$ 71,674
Medium-Term Note [Member] \| CPBF Lending LLC [Member]
Effective interest rate percentage																				16%	16%	16%		16%
December 2022 Seven GC Note [Member]
Aggregate principal amount														$ 250,000																					$ 2,300,000
First Amendment Convertible Note [Member]
Amendment fee										23,748
First Amendment Convertible Note [Member] \| CPBF Lending LLC [Member]
Aggregate principal amount																																				$ 321,345
Third Party Convertible Notes [Member]
Debt discount upon issuance																					$ 0			$ 330,390
Interest expense																					142,353			293,977
Interest expense debt																					37,845			72,562
Debt related commitement fees and debt issuance costs																					104,508			221,415
Yorkville Convertible Note [Member]
Interest expense																									0
Aggregate principal amount										$ 1,800,000															1,766,000
Outstanding principal amount																									$ 2,000,000
Original issuance price \| $ / shares										$ 10.96																				1.88
Estimated equity volatility										43%															71%
Time to maturity										6 months															5 months 15 days
Discounted market interest rate										14.90%															14%
Risk free rate										5.30%															5.28%
Probability of optional redemption rate										10%															10%
Change in fair value of convertible promissory notes																									$ 34,000
Yorkville Convertible Note [Member] \| Yorkville Advisors Global LP [Member] \| Standby Equity Purchase Agreement [Member]
Debt instrument, interest rate										0%
Aggregate principal amount										$ 2,000,000
Debt instrument, maturity date										Jun. 14, 2024
Repayment of convertible debt										$ 1,000,000
Percentage of repayment of convertible debt, amount										10%
Debt instrument, increase in interest rate										18%
Yorkville Convertible Note [Member] \| Standby Equity Purchase Agreement [Member] \| Yorkville Advisors Global LP [Member]
Aggregate principal amount										$ 2,000,000
Yorkville Convertible Notes [Member]
Interest expense																				$ 80,760		$ 80,760
Aggregate principal amount																				2,013,000		2,013,000			1,766,000
Outstanding principal amount																				$ 1,950,000		$ 1,950,000			$ 2,000,000
Original issuance price \| $ / shares																				$ 0.17		$ 0.17								1.88
Estimated equity volatility																						125%			71%
Time to maturity																						2 months 26 days			5 months 15 days
Discounted market interest rate																						20.60%			14%
Risk free rate																						5.48%			5.28%
Probability of optional redemption rate																						75%			10%
Gain (loss) on change in fair value of convertible notes liability																				$ 34,000		$ 578,000
Yorkville Convertible Notes [Member] \| Standby Equity Purchase Agreement [Member] \| Yorkville Advisors Global LP [Member]
Repayment of convertible debt			$ 1,000,000
Percentage of repayment of convertible debt, amount			10%
Loan agreement with cpbf Lending Llc [Member]
Principal amount outstanding																									$ 6,500,000	$ 6,500,000
Loan agreement with cpbf Lending Llc [Member] \| Term Note [Member]
Interest expense debt																				267,359	264,320	533,707		523,763
Loan agreement with cpbf Lending Llc [Member] \| Convertible Debt [Member]
Interest expense																									422,507	319,743
Interest expense debt																									395,575	303,121
Debt related commitement fees and debt issuance costs																									26,932	$ 16,622
Effective interest rate percentage																										16%					16%
Debt issuance costs incurred during the period gross																										$ 2,000
Loan agreement with cpbf Lending Llc [Member] \| Medium-Term Note [Member]
Interest expense																				294,613	284,097	586,940		562,261	1,140,106	1,110,296
Interest expense debt																									1,058,230	1,042,291
Debt related commitement fees and debt issuance costs																				27,254	19,777	53,233		38,498	81,876	$ 68,006
Convertible Debt [Member] \| Term Note [Member]
Interest expense debt																				112,908	95,534	221,504		187,394
Convertible Debt [Member] \| Medium-Term Note [Member]
Interest expense																				121,448	101,719	237,859		200,151
Debt related commitement fees and debt issuance costs																				$ 8,540	6,185	$ 16,355		12,757
2022 Convertible Notes [Member]
Interest expense																									1,063,093
Interest expense debt																									188,059
Debt related commitement fees and debt issuance costs																									875,034
Related party convertible notes [Member]
Debt instrument, interest rate																							8%			8%					8%
Debt discount upon issuance																					707,000			1,126,451	1,126,451	$ 1,311,025
Interest expense																					552,403			935,687	2,307,013
Interest expense debt																					125,352			215,774	464,071
Debt related commitement fees and debt issuance costs																					$ 427,051			$ 719,913	$ 1,842,942
Debt instrument conversion feature																							The Related Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company to be issued to other investors upon a Qualified Financing (as defined in the agreement) at a conversion price equal to the lesser of (i) 80% of the per share price paid by the cash purchasers of such Qualified Financing Securities (as defined in the agreement) in the Qualified Financing, or (ii) the conversion price obtained by dividing $50,000,000 by the Fully Diluted Capitalization (as defined in the agreement). If not sooner converted or prepaid, the Convertible Notes are payable no later than the earlier of (a) the written demand by the holders of a majority-in-interest of the Notes then outstanding on or after September 1, 2023, (b) consummation of a Liquidity Event (as defined in the agreement), or (c) the written demand by the Majority Holders (as defined in the agreement) after an Event of Default (as defined in the agreement) has occurred. In the event of a Liquidity Event (as defined below) while this Note is outstanding, immediately prior to the closing of such Liquidity Event and in full satisfaction of this Note, an amount equal to the greater of (a) the Outstanding Amount, or (b) two times (2x) the principal amount of this Note then outstanding shall become immediately due and payable in cash.
Aggregate principal amount										$ 7,271,368
Debt issuance costs																										18,248
Conversion of stock \| shares										22,929
Debt instrument conversion percentage																							80%
Conversion price \| $ / shares																							$ 50,000,000
Bifurcated derivative																										$ 1,292,777
Nonrelated Party [Member]
Debt instrument, interest rate																							8%
Debt instrument conversion feature																							The Third Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company to be issued to other investors upon a Qualified Financing (as defined in the agreement) at a conversion price equal to the lesser of (i) 80% of the per share price paid by the cash purchasers of such Qualified Financing Securities (as defined in the agreement) in the Qualified Financing, or (ii) the conversion price obtained by dividing $50,000,000 by the Fully Diluted Capitalization (as defined in the agreement). If not sooner converted or prepaid, the Convertible Notes are payable no later than the earlier of (a) the written demand by the holders of a majority-in-interest of the Notes then outstanding on or after September 1, 2023, (b) consummation of a Liquidity Event (as defined in the agreement), or (c) the written demand by the Majority Holders (as defined in the agreement) after an Event of Default (as defined in the agreement) has occurred. In the event of a Liquidity Event (as defined below) while this Note is outstanding, immediately prior to the closing of such Liquidity Event and in full satisfaction of this Note, an amount equal to the greater of (a) the Outstanding Amount, or (b) two times (2x) the principal amount of this Note then outstanding shall become immediately due and payable in cash.		The Third Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company to be issued to other investors upon a Qualified Financing (as defined in the agreement).	The Third Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company to be issued to other investors upon a Qualified Financing (as defined in the agreement).
Aggregate principal amount										$ 3,346,232
Conversion of stock \| shares										10,597
Debt instrument conversion percentage																							80%
Conversion price \| $ / shares																							$ 500,000
Nonrelated Party [Member] \| Additional Subordinated Convertible Notes 2022[Member]
Debt discount																									$ 559,390	$ 548,871
Nonrelated Party [Member] \| Additional Subordinated Convertible Notes 2022[Member] \| Bifurcated Derivative Portion [Member]
Debt discount																										541,223
Nonrelated Party [Member] \| Additional Subordinated Convertible Notes 2022[Member] \| Debt Portion [Member]
Debt discount																										$ 7,648
Third Party Creditors [Member] \| 2022 Third Party Convertible Notes [Member]
Aggregate principal amount																																					$ 1,761,206
Third Party Creditors [Member] \| Third Party Convertible Notes [Member]
Aggregate principal amount																																					1,435,000
Minimum [Member]
Original issuance price \| $ / shares																				$ 0.29	$ 8.22	$ 0.29		$ 8.22						8.38
Time to maturity																						5 years 9 months		5 years 3 months	5 years	5 years 11 months 8 days
Minimum [Member] \| Yorkville Standby Equity Purchase Agreement [Member]
Maximum floor price \| $ / shares										$ 2
Minimum [Member] \| Alco September Promissory Note [Member] \| Measurement Input, Discount for Lack of Marketability [Member] \| Put Option [Member]
Estimated re-levered equity volatility rate											7.50%		9.50%	10%	10.70%
Estimated re-levered equity volatility rate											7.50%		9.50%	10%	10.70%
Maximum [Member]
Original issuance price \| $ / shares																				$ 0.61	$ 9.56	$ 0.61		$ 9.56						11.98
Time to maturity																						10 years		6 years 29 days	6 years 29 days	6 years 29 days
Maximum [Member] \| Gem Agreement [Member] \| Share Purchase Agreement [Member]
Common stock, value issued										$ 100,000,000
Maximum [Member] \| Yorkville Standby Equity Purchase Agreement [Member]
Maximum floor price \| $ / shares										$ 100
Maximum [Member] \| Yorkville Advisors Global LP [Member] \| Standby Equity Purchase Agreement [Member]
Aggregate principal amount										$ 3,500,000
Maximum [Member] \| Yorkville Advisors Global LP [Member] \| Standby Equity Purchase Agreement [Member] \| Subsequent Event [Member]
Aggregate principal amount																												$ 7,000,000
Maximum [Member] \| Yorkville Advisors Global LP [Member] \| Standby Equity Purchase Agreement [Member] \| Share-Based Payment Arrangement, Tranche Two [Member]
Aggregate principal amount										$ 7,000,000
Maximum [Member] \| Alco September Promissory Note [Member] \| Measurement Input, Discount for Lack of Marketability [Member] \| Put Option [Member]
Estimated re-levered equity volatility rate											12%		15%	15%	16%
Estimated re-levered equity volatility rate											12%		15%	15%	16%
Maximum [Member] \| Alco November Promissory Note [Member] \| Alco [Member]
Aggregate principal amount													$ 750,000
Maximum [Member] \| Alco December Promissory Note [Member] \| Alco [Member]
Aggregate principal amount											$ 2,000,000
Weighted Average [Member] \| Alco September Promissory Note [Member]
Estimated re-levered equity volatility rate											9%		11.50%	11.50%	12.50%
Common Class A [Member]
Common stock par value \| $ / shares										$ 0.0001
Common Class A [Member] \| Original Debt Repayment Agreement [Member]
Common stock par value \| $ / shares				$ 0.0001
Common Class A [Member] \| Amended Debt Repayment Agreement [Member]
Share purchase \| shares			12,000
Common Class A [Member] \| Gem Agreement [Member]
Convertible Debt																				$ 600,000		$ 600,000
Shares issuable under the terms of promissory note \| shares								40,000
Shares issued under the terms of promissory note \| shares																						20,902
Common Class A [Member] \| Gem Agreement [Member] \| Subsequent Event [Member]
Shares issuable under the terms of promissory note \| shares								40,000
Shares issued under the terms of promissory note \| shares								2,789
Share purchase \| shares	11,765
Common Class A [Member] \| Gem Agreement [Member] \| Gem Term Sheet [Member] \| Gem Warrant [Member]
Percentage of right to convert warrant to common shares										3%	3%
Common Class A [Member] \| Conversion Of 7Gc Promissory Notes [Member] \| Sponsor Member
Stock Issued During Period, Shares, New Issues \| shares							17,812
Common Class A [Member] \| Conversion Of 7Gc Promissory Notes [Member] \| Sponsor Member \| Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues \| shares									17,812
Common Class A [Member] \| Yorkville Standby Equity Purchase Agreement [Member]
Common stock par value \| $ / shares										$ 0.0001																								$ 0.0001
Share purchase \| shares										6,000
Conversion of stock \| shares																						28,910
Common Class A [Member] \| Yorkville Advisors Global LP [Member] \| Standby Equity Purchase Agreement [Member]
Conversion rate percentage of common stock outstanding										9.99%
Common Class A [Member] \| Yorkville Advisors Global LP [Member] \| Standby Equity Purchase Agreement [Member] \| Share-Based Payment Arrangement, Tranche Two [Member]
Aggregate principal amount										$ 1,500,000
Common Class A [Member] \| Standby Equity Purchase Agreement [Member] \| Yorkville Advisors Global LP [Member]
Conversion rate percentage of common stock outstanding			9.99%
Conversion of stock \| shares																				20,176		35,940
Common Class A [Member] \| Seven GC Promissory Notes [Member]
Debt instrument conversion price per share \| $ / shares																														$ 10
Common stock par value \| $ / shares														$ 0.0001
Alco [Member]
Equity percentage owned percentage																		15%
Debt discount upon issuance																										$ 151,000
Interest expense debt																										$ 124,621
Debt instrument conversion feature																		The outstanding principal and interest under the Old Alco Note was, at the Holder’s election, either (i) effective upon the closing of an Equity Financing (as defined in the agreement), to be converted into shares of the same series of preferred stock of the Company issued to other investors in the Equity Financing (the “Equity Financing Securities”) at a conversion price equal to 85% of the price per share of Equity Financing Securities paid by the other investors in the Equity Financing, with any resulting fraction of a share rounded to the nearest whole share (with 0.5 being rounded up) (the “Conversion Option”) or (ii) immediately prior to the closing of an Equity Financing, become due and payable in cash.
Aggregate principal amount																	$ 2,101,744	$ 2,000,000
Effective interest rate percentage																										20%
Debt instrument conversion percentage																		85%
Contractual interest																										$ 100,274
Amortization of the discount																										$ 24,347
Loss on debt extinguishment																	$ 56,653
Alco [Member] \| Alco August Promissory Note [Member]
Debt instrument, interest rate																8%
Interest expense																									$ 4,494
Interest expense debt																									4,044
Debt related commitement fees and debt issuance costs																									450
Aggregate principal amount													$ 750,000		$ 1,500,000	$ 150,000
Debt instrument, maturity date																Apr. 29, 2024
Debt instrument unamortized debt issuance costs gross																$ 3,711
Principal amount outstanding																									150,000
Accrued interest outstanding																									4,044
Alco [Member] \| Alco September Promissory Note [Member]
Equity percentage owned percentage																															10%
Debt instrument, interest rate															8%
Debt discount upon issuance															$ 638,808
Interest expense																									478,815
Interest expense debt																									30,575
Debt related commitement fees and debt issuance costs																									448,240
Debt instrument, maturity date															Jan. 10, 2024
Principal amount outstanding																									1,500,000
Accrued interest outstanding																									30,575
Debt issuance costs															$ 8,588
Alco [Member] \| Alco November Promissory Note [Member]
Debt instrument, interest rate													8%
Interest expense																									94,005
Interest expense debt																									7,397
Debt related commitement fees and debt issuance costs																									86,608
Debt instrument, maturity date													Apr. 13, 2024
Principal amount outstanding																									750,000
Accrued interest outstanding																									7,397
Debt issuance costs													$ 363,905
Alco [Member] \| Alco December Promissory Note [Member]
Debt instrument, interest rate											8%
Interest expense																									39,087
Interest expense debt																									7,890
Debt related commitement fees and debt issuance costs																									31,197
Aggregate principal amount											$ 2,000,000
Debt instrument, maturity date											Dec. 31, 2024
Principal amount outstanding																									2,000,000
Accrued interest outstanding																									$ 7,890
Debt issuance costs											$ 1,496,252
Alco [Member] \| Series A Preferred Stock [Member]
Equity percentage owned percentage																		5%								5%					5%
Alco [Member] \| Series A Preferred Stock [Member] \| Alco August Promissory Note [Member]
Equity percentage owned percentage																10%
DNX [Member] \| Series A Preferred Stock [Member] \| Minimum [Member]
Equity percentage owned percentage																										5%					5%
DNX [Member] \| Series A Preferred Stock [Member] \| Minimum [Member] \| Related party convertible notes [Member]
Equity percentage owned percentage																							5%
Alco Manson Ward And DNX [Member]
Aggregate principal amount																																					$ 4,200,538	$ 4,200,538
Alco Manson Ward DNX And William Bryant [Member] \| Related party convertible notes [Member]
Aggregate principal amount																							$ 2,583,000										$ 2,583,000

Warrant Liabilities (Details Na

Warrant Liabilities (Details Narrative) - USD ($)				6 Months Ended	12 Months Ended
Warrant Liabilities (Details Narrative) - USD ($)	Dec. 15, 2023	Dec. 14, 2023	Dec. 13, 2023	Jun. 30, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022	May 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Warrants exercise price description.				The Public Warrants have an exercise price of $575.00 per share, subject to adjustments, and will expire five years from the Merger Closing Date. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation.	The Public Warrants have an exercise price of $575.00 per share, subject to adjustments, and will expire five years from the Merger Closing Date. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation.
Contractual term				60 days
Share price warrants							$ 1.54
Fair value of warrants	$ 2,448,000			$ 79,000	$ 641,000
Class of warrants or rights threshold limit for the then issued and outstanding shares of Common Stock	9.99%
Warrants exercisable description					Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants:
Common stock value				300	$ 259		$ 394
Gem Agreement [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Common stock value								$ 100,000,000
Gem Agreement [Member] \| Gem Term Sheet [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Common stock value		$ 2,000,000
Convertible debenture		$ 2,000,000	$ 2,000,000		2,000,000
Debt Instrument, Term		5 years	5 years
Coupon rate		0%	0%
Debt Instrument, Fee Amount					$ 2,000,000
Gem Agreement [Member] \| Gem Warrant [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Warrants exercise price description.					The exercise price will be adjusted to 105% of the then-current exercise price if on the one-year anniversary date of the Effective Time, the GEM Warrant has not been exercised in full and the average closing price per share of Class A Common Stock for the 10 days preceding the anniversary date is less than 90% of the initial exercise price. GEM may exercise the GEM Warrant at any time and from time to time until December 14, 2026. The terms of the GEM Warrant provide that the exercise price of the GEM Warrant, and the number of shares of Class A Common Stock for which the GEM Warrant may be exercised, are subject to adjustment to account for increases or decreases in the number of outstanding shares of New Banzai Common Stock resulting from stock splits, reverse stock splits, consolidations, combinations and reclassifications. Additionally, the GEM Warrant contains weighted average anti-dilution provisions that provide that if the Company issues shares of common stock, or securities convertible into or exercisable or exchange for, shares of common stock at a price per share that is less than 90% of the exercise price then in effect or without consideration, then the exercise price of the GEM Warrant upon each such issuance will be adjusted to the price equal to 105% of the consideration per share paid for such common stock or other securities. In the event of a Change of Control, if the Surviving Corporation does not have registered class of equity securities and common shares listed on a U.S. national securities exchange, then the Holder is entitled to receive one percent of the total consideration received by the Company’s stockholders and the GEM Warrants will expire upon payment.
Warrants price per share	$ 324.50
Warrants purchased	16,571
Class of warrants or rights threshold limit for the then issued and outstanding shares of Common Stock	9.99%
Percentage of right to convert warrant to common shares								3%
Warrants and rights outstanding								$ 650,000,000
Gem Agreement [Member] \| Gem Warrant [Member] \| GEM Financing Arrangement [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Warrants exercise price description.	The exercise price will be adjusted to 105% of the then-current exercise price if on the one-year anniversary date of the Effective Time, the GEM Warrant has not been exercised in full and the average closing price per share of Class A Common Stock for the 10 days preceding the anniversary date is less than 90% of the initial exercise price. GEM may exercise the GEM Warrant at any time and from time to time until December 14, 2026. The terms of the GEM Warrant provide that the exercise price of the GEM Warrant, and the number of shares of Class A Common Stock for which the GEM Warrant may be exercised, are subject to adjustment to account for increases or decreases in the number of outstanding shares of New Banzai Common Stock resulting from stock splits, reverse stock splits, consolidations, combinations and reclassifications. Additionally, the GEM Warrant contains weighted average anti-dilution provisions that provide that if the Company issues shares of common stock, or securities convertible into or exercisable or exchange for, shares of common stock at a price per share that is less than 90% of the exercise price then in effect or without consideration, then the exercise price of the GEM Warrant upon each such issuance will be adjusted to the price equal to 105% of the consideration per share paid for such common stock or other securities. In the event of a Change of Control, if the Surviving Corporation does not have registered class of equity securities and common shares listed on a U.S. national securities exchange, then the Holder is entitled to receive one percent of the total consideration received by the Company’s stockholders and the GEM Warrants will expire upon payment.
Warrants price per share	$ 6.49
Warrants purchased	828,533
Common Class A [Member] \| Gem Agreement [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Convertible debenture				$ 600,000
Common Class A [Member] \| Gem Agreement [Member] \| Gem Warrant [Member] \| Gem Term Sheet [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Percentage of right to convert warrant to common shares		3%	3%
Public Warrants [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Warrants outstanding				230,000	230,000
Warrants price per share				$ 575	$ 575
Warrant expiration period				5 years		5 years
Redemption trigger price				$ 900	900
Share price warrants				$ 0.01	$ 0.01
Public Warrants [Member] \| Common Class A [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Warrants exercisable				0	0
Redemption trigger price				$ 900	$ 900
Share price warrants				$ 900
Warrants price per share				0	0

Simple Agreements for Future _2

Simple Agreements for Future Equity (Details Narrative) - USD ($)			3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 14, 2023	Sep. 02, 2022	Jun. 30, 2023	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Proceeds From Simple Agreement For Future Equity							$ 3,567,000
Common or preferred stock discount							15%
Third Party Safes [Member]
Defined Benefit Plan Disclosure [Line Items]
Proceeds From Simple Agreement For Future Equity							$ 269,000
Common or preferred stock discount							15%
Fair value of SAFE liability							$ 269,000
Loss on change in fair value of SAFE liability			$ 68,582	$ 91,443
Debt instrument carrying amount	$ 456,234
Debt Conversion, Converted Instrument, Shares Issued	833
Fair value of SAFE liability							269,000
Gain Loss On Change in Fair Value of SAFE liability		$ 120,826			$ 207,570	$ 307,569
Numerator used for obtaining conversion price		$ 50,000,000
Third Party Safes [Member] \| Common Class A [Member]
Defined Benefit Plan Disclosure [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	833
Alco, DNX and William Bryant [Member]
Defined Benefit Plan Disclosure [Line Items]
Proceeds From Simple Agreement For Future Equity							$ 3,567,000
Common or preferred stock discount							15%
Fair value of SAFE liability							$ 3,567,000
Loss on change in fair value of SAFE liability			$ 909,418	$ 1,212,557
Debt instrument carrying amount	$ 6,049,766
Debt Conversion, Converted Instrument, Shares Issued	11,039
Fair value of SAFE liability							$ 3,567,000
Gain Loss On Change in Fair Value of SAFE liability		$ 1,602,174			$ 2,752,430	$ 4,078,431
Numerator used for obtaining conversion price		$ 50,000,000
Alco, DNX and William Bryant [Member] \| Common Class A [Member]
Defined Benefit Plan Disclosure [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	11,039

Schedule of Components of Lease

Schedule of Components of Lease Expense (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Schedule of Components of Lease Expense (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Components of lease expense:
Operating lease cost	$ 46,140	$ 50,440	$ 93,384	$ 101,888	$ 199,611	$ 191,483
Lease impairment cost						303,327
Sublease income	(52,542)	(51,082)	(105,084)	(102,165)	(204,324)	(177,588)
Total lease (income) cost	$ (6,402)	$ (642)	$ (11,700)	$ (277)	$ (4,713)	$ 317,222

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Information Related to Leases (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Non-cash lease expense (operating cash flow)			$ 87,579	$ 86,320	$ 173,245	$ 152,018
Change in lease liabilities (operating cash flow)			(152,335)	(138,804)	(284,963)	(243,596)
Non-cash impairment of right to use assets (operating cash flow)						(303,327)
Operating leases						$ 762,603

Schedule of Supplemental Balanc

Schedule of Supplemental Balance Sheet Information Related to Leases (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating leases:
Operating lease right-of-use assets	$ 46,434	$ 134,013	$ 307,258
Operating lease liability, current	81,708	234,043	284,963
Operating lease liability, long-term			234,043
Total operating lease liabilities	$ 81,708	$ 234,043	$ 519,006
Weighted-average remaining lease term:
Operating leases (in years)	3 months 3 days	9 months 3 days	1 year 9 months 3 days
Weighted-average discount rate:
Operating leases	6.83%	6.76%	6.74%

Schedule of Future Minimum Leas

Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Maturities of lease liabilities:
Remainder of 2024	$ 82,679
Year Ending December 31, 2024		$ 240,818
Total undiscounted cash flows	82,679	240,818
Less discounting	(971)	(6,775)
Present value of lease liabilities	$ 81,708	$ 234,043	$ 519,006

Commitments and Contingencies_2

Commitments and Contingencies (Details Narrative) - USD ($)

3 Months Ended

6 Months Ended

12 Months Ended

May 15, 2024

Mar. 29, 2024

Feb. 02, 2024

Dec. 28, 2023

Dec. 08, 2023

Jun. 30, 2024

Jun. 30, 2023

Jun. 30, 2024

Jun. 30, 2023

Dec. 31, 2023

Dec. 31, 2022

Nov. 08, 2023

Operating leases have remaining lease terms

3 months 3 days

9 months 3 days

Addendum To Letter Agreements Description

Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred
in 2024, and owed under the Roth Engagement Agreements (collectively, the “Roth Fee”), the Company (i) issued to Roth 3,500
shares (the “Roth Shares”) of the Company’s Class A Common Stock, and (ii) on or before June 30, 2024, will pay to
Roth an amount in cash equal to $300,000 or, if the Company determines that such payment should not be made in cash due to the Company’s
cash position at such time, issue to Roth a number of shares of Class A Common Stock equal to $300,000 divided by the daily VWAP for
the trading day immediately preceding June 30, 2024 (any such shares, the “Additional Roth Shares”). The Company registered
the Roth Shares and 12,000 shares of Class A Common Stock (in addition to the Roth Shares) on a registration statement to cover any
issuances of Additional Roth Shares

Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred
in 2024, and owed under the Roth Engagement Agreements (collectively, the “Roth Fee”), the Company (i) issued to Roth 3,500
shares (the “Roth Shares”) of the Company’s Class A Common Stock on February 2, 2024, and (ii) on or before June 30,
2024, will pay to Roth an amount in cash equal to $300,000 or, if the Company determines that such payment should not be made in cash
due to the Company’s cash position at such time, issue to Roth a number of shares of Class A Common Stock equal to $300,000 divided
by the daily VWAP for the trading day immediately preceding June 30, 2024 (any such shares, the “Additional Roth Shares”).
The Company registered the Roth Shares and 12,000 shares of Class A Common Stock (in addition to the Roth Shares) on a registration
statement to cover any issuances of Additional Roth Shares

Gain on extinguishment of liability

$ 527,980

$ (56,653)

Lease impairment cost

$ 303,327

Stock price

$ 1.54

Subsequent Event [Member]

Shares issued, shares

3,500

7GC & Co. Holdings LLC [Member] | Cantor Fitzgerald [Member] | New Banzai Class A Shares [Member]

Increase decrease in deferred underwriting fees

$ 400,000

Cantor Fee Agreement [Member] | 7GC & Co. Holdings Inc. [Member] | Cantor Fitzgerald [Member]

Deferred underwriting fees payable

8,050,000

Deferred underwriting fees payable

4,050,000

Increase decrease in deferred underwriting fees

4,000,000

Cantor Fee Agreement [Member] | 7GC & Co. Holdings LLC [Member] | Cantor Fitzgerald [Member]

Deferred underwriting fees payable

8,050,000

Deferred underwriting fees payable

4,050,000

Increase decrease in deferred underwriting fees

4,000,000

$ 4,000,000

Cantor Fee Agreement [Member] | 7GC & Co. Holdings LLC [Member] | Cantor Fitzgerald [Member] | Common Class A [Member]

Stock issued during period shares issued for services

22,279

Stock issued during period value issued for services

$ 2,450,639

Stock price

$ 110

Roth Addendum To Letter Agreements [Member]

Advisory fee

$ 1,100,000

Advisor transaction expenses

$ 6,813

Accrued expenses

$ 300,000

300,000

1,106,813

Shares issued, shares

3,500

Shares issued, value

$ 278,833

Contractual obligation

$ 806,813

Gain on extinguishment of liability

$ 577,513

Roth Addendum To Letter Agreements [Member] | Common Class A [Member]

Shares issued, shares

3,500

Shares issued, shares

$ 300,000

Shares issued, cash

$ 300,000

Stock issued during period shares additional shares

12,000

Roth Addendum To Letter Agreements [Member] | Common Class A [Member] | Subsequent Event [Member]

Shares issued, shares

$ 300,000

Shares issued, cash

$ 300,000

Stock issued during period shares additional shares

12,000

Equity (Details Narrative)

Equity (Details Narrative)						1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
Equity (Details Narrative)	May 22, 2024 USD ($) $ / shares shares	Dec. 28, 2023 shares	Dec. 14, 2023 USD ($) $ / shares shares	Feb. 14, 2023 USD ($) $ / shares	Feb. 19, 2021 shares	Mar. 31, 2024 shares	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2024 $ / shares	Jul. 01, 2022 $ / shares
Class of Stock [Line Items]
Common stock, shares authorized			350,000,000				275,000,000		275,000,000		275,000,000	275,000,000
Common stock par value \| $ / shares							$ 0.0001		$ 0.0001		$ 0.0001	$ 0.0001
Common stock voting rights									The Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each matter properly submitted to the stockholders entitled to vote thereon.		Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each matter properly submitted to the stockholders entitled to vote thereon.
Common stock, shares issued							3,003,810		3,003,810		2,585,296	3,935,892
Common stock, shares outstanding							3,003,810		3,003,810		2,585,296	3,935,892
Original issuance price \| $ / shares												$ 1.54
Cash fee payments \| $	$ 25,000
Preferred stock, shares authorized			75,000,000				75,000,000		75,000,000		75,000,000	75,000,000
Preferred stock, par value \| $ / shares			$ 0.0001				$ 0.0001		$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares outstanding							0		0		0	0
General and administrative expense \| $							$ 4,319,014	$ 2,929,150	$ 8,627,943	$ 6,099,213	$ 12,905,073	$ 9,275,251
Yorkville Standby Equity Purchase Agreement [Member]
Class of Stock [Line Items]
Description of equity facility financing agreement									10,000		10,000 shares or (ii) such amount as is equal to 100% of the average daily volume traded of Class A common stock during the five trading days immediately prior to the date the Company requests each Advance;
Percentage of lowest daily Volume Weighted Average Price			90%
Fair Value Of Standby Equity Purchase Agreement \| $			$ 0				0		$ 0		$ 0
Stock issued during period value acquisitions \| $			$ 500,000				$ 500,000		$ 500,000
Maximum floor price \| $ / shares													$ 2
Floor price adjustment			The Floor Price shall be adjusted (downwards only) to equal 20% of the average VWAP for the five trading days immediately prior to the date of effectiveness of the initial Registration Statement.
Maximum percentage of closing price on trading day			75%
Maximum conversion price \| $ / shares			$ 2
General and administrative expense \| $			$ 3,823,000
Alliance Global Partners [Member]
Class of Stock [Line Items]
Securities purchase price and percentage description	(a) a cash fee equal to 7.0% of the aggregate purchase price paid by each purchaser of securities that were sold in the May 2024 Offering (the “Cash Fee”); provided, however, that the Cash Fee was reduced by an amount equal to $25,000 to be paid to the Company’s financial advisor, and (b) warrants (the “Placement Agent Warrants”) to purchase Class A Common Stock equal to 6% of the aggregate number of shares of Class A Common Stock sold in the May 2024 Offering at an exercise price per share equal to 110% of the price per share of Class A Common Stock sold in the May 2024 Offering. The Company recognized the Placement Agent Warrants as a stock issuance cost as they are issued for services in connection with an offering.
Cash fee payments \| $	$ 409,000
Prefunded Warrants [Member]
Class of Stock [Line Items]
Net of issuance costs \| $	660,000
Common Warrants [Member]
Class of Stock [Line Items]
Net of issuance costs \| $	$ 722,000
Common Warrants [Member] \| Measurement Input, Share Price [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	9
Common Warrants [Member] \| Measurement Input, Exercise Price [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	9
Common Warrants [Member] \| Measurement Input, Price Volatility [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	87
Common Warrants [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	4.6
Common Warrants [Member] \| Measurement Input, Expected Dividend Rate [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	0
Placement Agent Warrants [Member]
Class of Stock [Line Items]
Issuane of warrants	16,667
Net of issuance costs \| $	$ 100,000
Placement Agent Warrants [Member] \| Measurement Input, Share Price [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	9
Placement Agent Warrants [Member] \| Measurement Input, Exercise Price [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	9
Placement Agent Warrants [Member] \| Measurement Input, Price Volatility [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	87
Placement Agent Warrants [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	4.6
Placement Agent Warrants [Member] \| Measurement Input, Expected Dividend Rate [Member]
Class of Stock [Line Items]
Warrants and rights outstanding measurement input	0
Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Original issuance price \| $ / shares	$ 9
Proceeds from issuance of warrants \| $	$ 2,500,000
Securities Purchase Agreement [Member] \| Prefunded Warrants [Member]
Class of Stock [Line Items]
Issuane of warrants	173,222
Warrants exercise price \| $ / shares	$ 0.0050
Securities Purchase Agreement [Member] \| Common Warrants [Member]
Class of Stock [Line Items]
Issuane of warrants	277,778
Warrants exercise price \| $ / shares	$ 9
Common Class A [Member]
Class of Stock [Line Items]
Common stock, shares authorized			5,000,000				25,000,000		25,000,000		250,000,000	250,000,000
Common stock par value \| $ / shares			$ 0.0001
Common stock, shares issued							692,676		692,676		274,162	51,219
Common stock, shares outstanding							692,676		692,676		274,162	51,219
Common Class A [Member] \| Banzai International Inc [Member]
Class of Stock [Line Items]
Common stock, shares outstanding			28,629
Conversion of stock shares converted			2,328,823
Common Class A [Member] \| Demio [Member] \| Shareholders And Founders [Member] \| Restricted Stock [Member]
Class of Stock [Line Items]
Shares issued to GEM, shares					14,916
Common Class A [Member] \| High Attendance [Member] \| Restricted Stock [Member]
Class of Stock [Line Items]
Common stock par value \| $ / shares														$ 0.0001
Common Class A [Member] \| High Attendance [Member] \| Shareholders And Founders [Member] \| Restricted Stock [Member]
Class of Stock [Line Items]
Shares issued to GEM, shares					1,638
Common Class A [Member] \| Yorkville Standby Equity Purchase Agreement [Member]
Class of Stock [Line Items]
Common stock par value \| $ / shares			$ 0.0001	$ 0.0001
Total consideration payable in shares of class A common stock \| $			$ 100,000,000	$ 100,000,000
Description of equity facility financing agreement			9.99%	9.99%
Percentage of average daily Volume Weighted Average Price			95%	95%
Percentage of lowest daily Volume Weighted Average Price			96%	96%
Percentage of voting power			9.99%	9.99%
Percentage of outstanding shares			19.99%	19.99%
Stock issued during period value acquisitions						14,201
Common stock price per share \| $ / shares			$ 10
Maximum conversion price \| $ / shares			$ 100
Conversion of stock shares converted									28,910
Cash structuring fee \| $			$ 35,000
Stock issued during period shares acquisitions			6,000
Stock issued during period value acquisitions \| $			$ 3,288,000
Common Class A [Member] \| Cantor Fee Agreement [Member]
Class of Stock [Line Items]
Stock issued during period shares acquisitions		22,279
Common Class A [Member] \| Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Shares issued to GEM, shares	104,556
Common Class B [Member]
Class of Stock [Line Items]
Common stock, shares authorized			25,000,000				25,000,000		25,000,000		25,000,000	25,000,000
Common stock, shares issued							2,311,134		2,311,134		2,311,134	3,884,673
Common stock, shares outstanding							2,311,134		2,311,134		2,311,134	3,884,673
Common Class B [Member] \| Yorkville Standby Equity Purchase Agreement [Member]
Class of Stock [Line Items]
Common stock par value \| $ / shares			$ 0.0001	$ 0.0001
Percentage of outstanding shares			19.99%	19.99%
Common Stock [Member]
Class of Stock [Line Items]
Common stock, shares issued							3,003,810		3,003,810		2,585,296
Common stock, shares outstanding							3,003,810		3,003,810		2,585,296
Class A Common Stock [Member] \| Yorkville Standby Equity Purchase Agreement [Member]
Class of Stock [Line Items]
Common stock price per share \| $ / shares			$ 500
Maximum [Member]
Class of Stock [Line Items]
Common stock, shares authorized							275,000,000		275,000,000		275,000,000
Original issuance price \| $ / shares							$ 0.61	$ 9.56	$ 0.61	$ 9.56	$ 11.98
Maximum [Member] \| Yorkville Standby Equity Purchase Agreement [Member]
Class of Stock [Line Items]
Maximum floor price \| $ / shares			100
Minimum [Member]
Class of Stock [Line Items]
Original issuance price \| $ / shares							$ 0.29	$ 8.22	$ 0.29	$ 8.22	$ 8.38
Minimum [Member] \| Yorkville Standby Equity Purchase Agreement [Member]
Class of Stock [Line Items]
Maximum floor price \| $ / shares			$ 2

Summary of Assumptions Used to

Summary of Assumptions Used to Compute Fair Value (Details) - $ / shares	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock price				$ 1.54
Exercise price		$ 11.98		$ 1.04
Expected volatility minimum	75%	80%	80%	53.61%
Expected volatility maximum	85%	99.03%	110.95%	55.30%
Risk-free interest rate, minimum	4.20%	3.46%	3.46%	1.95%
Risk-free interest rate, maximum	4.50%	4.31%	4.31%	2.85%
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock price	$ 0.29	$ 8.22	$ 8.38
Exercise price	$ 0.29		$ 8.38
Time to maturity	5 years 9 months	5 years 3 months	5 years	5 years 11 months 8 days
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock price	$ 0.61	$ 9.56	$ 11.98
Exercise price	$ 5		$ 11.98
Time to maturity	10 years	6 years 29 days	6 years 29 days	6 years 29 days

Summary of Stock Option Activit

Summary of Stock Option Activity (Details) - USD ($)		6 Months Ended	12 Months Ended
Summary of Stock Option Activity (Details) - USD ($)	Dec. 31, 2021	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Shares Underlying Options, Beginning balance		14,962	7,420	9,610
Weighted Average Exercise Price, Beginning Balance		$ 293.50	$ 106.44	$ 93.55
Weighted Average Remaining Contractual Term (in years), Outstanding		9 years 2 months 1 day	8 years 5 months 4 days	7 years 11 months 12 days
Intrinsic Value, Outstanding, Beginning Balance		$ 103,662	$ 3,433,946
Shares Underlying Options, Granted		27,970	16,440	4,702
Weighted Average Exercise Price, Granted		$ 145.70	$ 500.50	$ 138.50
Weighted Average Remaining Contractual Term (in years), Granted		9 years 10 months 13 days
Shares Underlying Options, Exercised			353	171
Weighted Average Exercise Price, Exercised			$ 109.56	$ 62
Shares Underlying Options, Expired			258	2,411
Weighted Average Exercise Price, Expired			$ 598.50	$ 69
Shares Underlying Options, Forfeited		(9,283)	(8,287)	(4,310)
Weighted Average Exercise Price, Forfeited		$ 239.11	$ 538	$ 129.50
Shares Underlying Options, Ending balance	9,610	33,649	14,962	7,420
Weighted Average Exercise Price, Ending Balance	$ 93.55	$ 185.69	$ 293.50	$ 106.44
Intrinsic Value, Outstanding, Ending balance		$ 1,807	$ 103,662	$ 3,433,946
Shares Underlying Options, Exercisable		8,675	6,900
Weighted Average Exercise Price, Exercisable		$ 248.23	$ 211.50
Weighted Average Remaining Contractual Term (in years), Exercisable		8 years 4 months 2 days	7 years 6 months 21 days
Intrinsic Value, Exercisable		$ 1,807	$ 103,251
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		(14,962)	(7,420)	(9,610)
Shares Underlying Options, Exercised			(353)	(171)
Intrinsic Value, Outstanding, Exercised			$ 4,440	$ 10,835
Shares Underlying Options, Expired			(258)	(2,411)
Shares Underlying Options, Exercisable		8,675	6,900
Previously Reported [Member]
Shares Underlying Options, Beginning balance	14,634
Weighted Average Exercise Price, Beginning Balance	$ 57.50
Weighted Average Remaining Contractual Term (in years), Outstanding	7 years 2 months 12 days
Intrinsic Value, Outstanding, Beginning Balance	$ 369,102
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	(14,634)
Revision of Prior Period, Adjustment [Member]
Shares Underlying Options, Beginning balance	6,024
Weighted Average Exercise Price, Beginning Balance	$ 36.05
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	(6,024)

Summary of Activity with Respec

Summary of Activity with Respect Status of, RSUs (Details) - Restricted Stock Units (RSUs) [Member]	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Units, Outstanding Beginning Balance \| shares
Weighted Average Grant Date Fair Value, Beginning balance Outstanding \| $ / shares
Granted \| shares	17,851
Weighted Average Grant Date Fair Value, Granted \| $ / shares	$ 26.64
Forfeited \| shares	(293)
Weighted Average Grant Date Fair Value, Forfeited \| $ / shares	$ 14.65
Units, Outstanding Ending Balance \| shares	17,558
Weighted Average Grant Date Fair Value, Ending Balance Outstanding \| $ / shares	$ 26.84

Stock-Based Compensation (Detai

Stock-Based Compensation (Details Narrative) - USD ($)			6 Months Ended		12 Months Ended
Stock-Based Compensation (Details Narrative) - USD ($)	Dec. 03, 2023	Jul. 19, 2017	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 14, 2023	Dec. 31, 2021	Apr. 26, 2016
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average grant date fair value			$ 8.60	$ 426.61	$ 4.86	$ 0.77
Unrecognized compensation expense related to unvested options			$ 1,262,655	$ 2,575,808	$ 2,594,571	$ 160,203
Period for unrecognized compensation expense related to unvested options yet has not been recognized			3 years 9 months 18 days	2 years 11 months 19 days	2 years 8 months 23 days	2 years 8 months 26 days
Common stock, shares authorized			275,000,000		275,000,000	275,000,000	350,000,000
Expected dividend yield					0%
Repricing outstanding stock option	7,193
Exercise price	$ 257.50
Incremental compensation cost	$ 113,475
Vested stock based compensation expense	23,849
Unvested stock based compensation expense	$ 89,626
Exercise price per share			$ 185.69		$ 293.50	$ 106.44	$ 293.50	$ 93.55
Option to purchase aggregate number of shares			33,649		14,962	7,420	14,962	9,610
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Period for unrecognized compensation expense related to unvested options yet has not been recognized			1 year 3 months 18 days
Vesting period			4 years
Unrecognized compensation cost			$ 263,144
Substitute Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Exercise price per share							$ 0.6147
General and Administrative Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense			457,231	$ 620,987	$ 1,245,796	$ 770,336
General and Administrative Expense [Member] \| Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense			$ 208,178
Common Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, shares authorized							105,000,000
2023 Equity Employee Stock Purchase [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity incentive plan, description			The aggregate number of shares of common stock that may be purchased pursuant to the Purchase Plan is equal to 2% of the fully diluted common stock determined at the Close of the Merger Agreement, determined to be 11,443. In addition, the aggregate number of shares of common stock that remain available to be awarded under the Purchase Plan, will automatically increase on January 1 of each year for a period of 10 years commencing on January 1, 2024 and ending on January 1, 2033, in an amount equal to the lesser of one percent (1%) of the total number of shares of the fully diluted common stock determined as of December 31 of the preceding year, or a number of shares of common stock equal to two hundred percent (200%) of the initial share reserve of 11,443
Expiration period			10 years
Expiration date			Jan. 01, 2033
2023 Equity Employee Stock Purchase [Member] \| Common Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved for future issuance			11,443
Initial share reserve			11,443
Stock options awarded			11,443		11,443
2023 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity incentive plan, description			The aggregate number of shares of common stock that may be issued will not exceed approximately 12.5% of the fully diluted common stock determined at the Close of the Merger, determined to be 71,522. In addition, the aggregate number of shares of common stock that remain available to be awarded under the Plan, will automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2024 and ending on January 1, 2033, in an amount equal to 5% of the total number of shares of the fully diluted common stock determined as of the day prior to such increase. The aggregate maximum number of shares of common stock that may be issued pursuant to the exercise of incentive stock options is approximately three times the total number of shares of common stock initially reserved for issuance, which were 71,522.		The aggregate number of shares of common stock that may be issued will not exceed approximately 12.5% of the fully diluted common stock determined at the Close of the Merger. In addition, the aggregate number of shares of common stock will automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2024 and ending on January 1, 2033, in an amount equal to 5% of the total number of shares of the fully diluted common stock determined as of the day prior to such increase. The aggregate maximum number of shares of common stock that may be issued pursuant to the exercise of incentive stock options is approximately three times the total number of shares of common stock initially reserved for issuance.
Expiration period			10 years
Expiration date			Jan. 01, 2033		Jan. 01, 2033
Stock options awarded					11,443
2023 Equity Incentive Plan [Member] \| Common Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved for future issuance			71,522
Initial share reserve			71,522
Stock options awarded			35,276		71,522
2016 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, shares authorized									8,000
Number of increase decrease of non-vested options		48,000

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
Income Taxes (Details Narrative) - USD ($)	Jun. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Effective Income Tax Rate Reconciliation [Line Items]
Effective tax rate, percentage	0%	0%	0%	0%
Federal net operating loss carryforwards			$ 26,705,200	$ 15,325,300
State net operating loss carryforwards			13,043,900	9,175,400
Uncertain tax benefits			0	0
Interest and penalties			$ 0	$ 0
Open tax year			2016
Open tax audits, description			The Company has no open tax audits with any taxing authority as of December 31, 2023.
Domestic Tax Jurisdiction [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Operating loss carryforwards to expire			$ 124,500
Operating loss carryforwards indefinitely			26,580,700
State and Local Jurisdiction [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Operating loss carryforwards to expire			10,666,100
Operating loss carryforwards indefinitely			$ 2,377,800

Summary of Changes in Allowance

Summary of Changes in Allowance for Credit Losses (Details)	12 Months Ended
Summary of Changes in Allowance for Credit Losses (Details)	Dec. 31, 2023 USD ($)
Subsequent Events [Abstract]
Balance-January 1, 2023	$ 107,860
Change in provision for credit losses	(102,112)
Balance-December 31, 2023	$ 5,748

Summary of Capitalized Deferred

Summary of Capitalized Deferred Offering Costs (Details) - USD ($)	Dec. 31, 2023	Dec. 14, 2023	Dec. 31, 2022
Total deferred offering costs capitalized		$ 3,233,097	$ 1,524,934
SPAC Related Legal Fees [Member]
Total deferred offering costs capitalized		2,973,077	1,264,914
Investment Bank Advisory Services [Member]
Total deferred offering costs capitalized		135,000	135,000
Federal Trade Commission Filing Fees [Member]
Total deferred offering costs capitalized		$ 125,020	$ 125,020

Schedule of Reconciliation of t

Schedule of Reconciliation of the Merger to the Company's Consolidated Cash Flows (Details) - Recapitalization [Member]	Dec. 14, 2023 USD ($)
Reclassification [Line Items]
Deferred underwriting fees assumed	$ 4,000,000
Convertible notes payable assumed	2,550,000
Warrant liabilities assumed	460,000
Less: effect on equity	(14,625,462)
Effect of reverse recapitalization, net of transaction costs	$ (7,615,462)

Schedule of Reconciliation of_2

Schedule of Reconciliation of the Merger to the Company’s Statements of Changes in Stockholders’ Deficit (Details) - Recapitalization [Member]	Dec. 14, 2023 USD ($)
Reclassification [Line Items]
Cash	$ 197,166
Non-cash net working capital assumed	(7,812,628)
Deferred underwriting fees assumed	(4,000,000)
Convertible notes payable assumed	(2,550,000)
Fair value of assumed warrant liabilities	(460,000)
Transaction costs	(3,233,097)
Effect of reverse recapitalization	$ (17,858,559)

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)

1 Months Ended

6 Months Ended

12 Months Ended

Jul. 22, 2024

Jul. 05, 2024

May 15, 2024

Mar. 29, 2024

Mar. 27, 2024

Feb. 19, 2024

Feb. 09, 2024

Feb. 05, 2024

Feb. 02, 2024

Jan. 24, 2024

Dec. 14, 2023

Mar. 31, 2024

Feb. 29, 2024

Jun. 30, 2024

Dec. 31, 2023

Mar. 26, 2024

Jan. 31, 2024

Subsequent Event [Line Items]

Principal amount

$ 3,500,000

Addendum To Letter Agreements Description

Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred
in 2024, and owed under the Roth Engagement Agreements (collectively, the “Roth Fee”), the Company (i) issued to Roth 3,500
shares (the “Roth Shares”) of the Company’s Class A Common Stock on February 2, 2024, and (ii) on or before June 30,
2024, will pay to Roth an amount in cash equal to $300,000 or, if the Company determines that such payment should not be made in cash
due to the Company’s cash position at such time, issue to Roth a number of shares of Class A Common Stock equal to $300,000 divided
by the daily VWAP for the trading day immediately preceding June 30, 2024 (any such shares, the “Additional Roth Shares”).
The Company registered the Roth Shares and 12,000 shares of Class A Common Stock (in addition to the Roth Shares) on a registration
statement to cover any issuances of Additional Roth Shares

Yorkville Standby Equity Purchase Agreement [Member]

Subsequent Event [Line Items]

Principal amount

$ 1,000,000

$ 1,500,000

Principal amount

3,500,000

Pre paid Aadvance funded on merger

$ 2,000,000

Discount on pre paid advance funded on merger

10%

Pre paid advance funded on registration

$ 1,500,000

Discount on pre paid advance funded on registration

10%

Percentage of excess shares issued and outstanding

19.99%

Increased principal amount agreed to advance

1,000,000

Aggregate principal amount.

4,500,000

Yorkville Convertible Note Agreement [Member]

Subsequent Event [Line Items]

Convertible note, term

On
January 24, 2024, Yorkville provided the Company with a waiver with respect to the triggering of an amortization event in January 2024,
in terms of the Yorkville Convertible Note Agreement, which would have required the Company to make monthly repayments of amounts outstanding
under the Yorkville Convertible Note, with each monthly repayment to be in an amount equal to the sum of (x) $1,000,000, plus (y) 10%
in respect of such amount, and (z) all outstanding accrued and unpaid interest as of each payment date. As a result of the waiver, no
repayments were required by the Company, and the floor price

Roth Addendum To Letter Agreements [Member]

Subsequent Event [Line Items]

Shares issued to GEM, shares

3,500

Subsequent Event [Member]

Subsequent Event [Line Items]

Shares issued to GEM, shares

3,500

Minimum net tangible assets upon consummation of business combination

50,000,000

Total assets and total revenue

50,000,000

Subsequent Event [Member] | Yorkville Standby Equity Purchase Agreement [Member]

Subsequent Event [Line Items]

Principal amount

$ 1,500,000

$ 1,000,000

Debt instrument, maturity date

Jun. 14, 2024

Increased principal amount agreed to advance

$ 1,500,000

$ 1,000,000

Aggregate principal amount.

$ 4,500,000

Discount on additional pre paid advance amount

10%

Debt instrument, interest rate

Subsequent Event [Member] | Yorkville Convertible Note Agreement [Member]

Subsequent Event [Line Items]

Monthly installments

$ 1,000,000

Percentage of outstanding monthly repayments

10%

Repayments

$ 0

Subsequent Event [Member] | Yorkville SEPA Advance Purchase Notices [Member]

Subsequent Event [Line Items]

Purchase of common shares

6,888

Purchase of common shares

$ 300,000

Subsequent Event [Member] | Yorkville SEPA Advance Purchase Notices [Member] | Minimum [Member]

Subsequent Event [Line Items]

Debt instrument conversion price per share

$ 38.08

Subsequent Event [Member] | Yorkville SEPA Advance Purchase Notices [Member] | Maximum [Member]

Subsequent Event [Line Items]

Debt instrument conversion price per share

$ 61.15

Subsequent Event [Member] | Pre Paid Yorkville Convertible Notes [Member]

Subsequent Event [Line Items]

Purchase of common shares

37,787

Purchase of common shares

$ 1,200,000

Subsequent Event [Member] | Yorkville Deferred Fee Settlement [Member]

Subsequent Event [Line Items]

Purchase of common shares

14,201

Purchase of common shares

$ 500,000

Subsequent Event [Member] | Yorkville Deferred Fee Settlement [Member] | Minimum [Member]

Subsequent Event [Line Items]

Debt instrument conversion price per share

$ 31.65

Subsequent Event [Member] | Yorkville Deferred Fee Settlement [Member] | Maximum [Member]

Subsequent Event [Line Items]

Debt instrument conversion price per share

$ 35.21

Subsequent Event [Member] | Gem Agreement [Member]

Subsequent Event [Line Items]

Principal amount

$ 1,000,000

Monthly installments

100,000

Cash agreed to pay

1,200,000

Subsequent Event [Member] | Marketing Services Agreement [Member]

Subsequent Event [Line Items]

Ordinary shares issued

3,070

Ordinary shares issued value

$ 200,000

Subsequent Event [Member] | Subordinated Business Loan and Security Agreement [Member]

Subsequent Event [Line Items]

Principal amount

$ 787,500

Proceeds from debt

750,000

Agent fees

$ 37,500

Debt instrument, maturity date

Feb. 05, 2025

Debt instrument, interest rate

42%

Common Class A [Member] | Yorkville Standby Equity Purchase Agreement [Member]

Subsequent Event [Line Items]

Common stock shares issued

6,000

Common Class A [Member] | Roth Addendum To Letter Agreements [Member]

Subsequent Event [Line Items]

Shares issued to GEM, shares

3,500

Shares issued, shares

$ 300,000

Shares issued, cash

$ 300,000

Stock issued during period shares additional shares

12,000

Common Class A [Member] | Conversion Of 7Gc Promissory Notes [Member] | Sponsor Member

Subsequent Event [Line Items]

Shares issued to GEM, shares

17,812

Common Class A [Member] | Subsequent Event [Member]

Subsequent Event [Line Items]

Forfeiture of common stock shares

2,000

Common Class A [Member] | Subsequent Event [Member] | Roth Addendum To Letter Agreements [Member]

Subsequent Event [Line Items]

Shares issued, shares

$ 300,000

Shares issued, cash

$ 300,000

Stock issued during period shares additional shares

12,000

Common Class A [Member] | Subsequent Event [Member] | Conversion Of 7Gc Promissory Notes [Member] | Sponsor Member

Subsequent Event [Line Items]

Shares issued to GEM, shares

17,812

Gem Agreement [Member]

Subsequent Event [Line Items]

Principal amount

1,000,000

Monthly installments

100,000

Cash agreed to pay

$ 1,200,000

Gem Agreement [Member] | Common Class A [Member]

Subsequent Event [Line Items]

Shares issuable under the terms of promissory note

40,000

Shares issued under the terms of promissory note

20,902

Gem Agreement [Member] | Common Class A [Member] | Subsequent Event [Member]

Subsequent Event [Line Items]

Common stock shares issued

11,765

Shares issuable under the terms of promissory note

40,000

Shares issued under the terms of promissory note

2,789

Asset Disposal (Details Narrati

Asset Disposal (Details Narrative) - USD ($)	Jul. 01, 2022	Jun. 30, 2024	Dec. 31, 2023	Dec. 14, 2023	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Common stock par value		$ 0.0001	$ 0.0001		$ 0.0001
Common Class A [Member]
Restructuring Cost and Reserve [Line Items]
Common stock par value				$ 0.0001
High Attendance [Member]
Restructuring Cost and Reserve [Line Items]
Cancellation of shares	81,908
Liabilities relating to purchased assets	$ 17,500
Gain (loss) from cancellation of shares	$ 0
High Attendance [Member] \| Common Class A [Member] \| Restricted Stock [Member]
Restructuring Cost and Reserve [Line Items]
Cancellation of shares	1,638
Common stock par value	$ 0.0001
Common stock vesting term	24 months

Schedule of Property and Equipm

Schedule of Property and Equipment, Net (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation		$ (26,223)	$ (19,063)
Property and equipment, net	$ 1,819	4,644	11,803
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computers and equipment		$ 30,867	$ 30,866

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Property and Equipment (Details Narrative) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 1,261	$ 1,621	$ 2,825	$ 4,025	$ 7,160	$ 9,588

Summary of Goodwill (Details)

Summary of Goodwill (Details) - USD ($)	12 Months Ended
Summary of Goodwill (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill, balance	$ 2,171,526	$ 2,171,526
Impairment	0	0
Goodwill, balance	$ 2,171,526	$ 2,171,526

Schedule of Related Party and T

Schedule of Related Party and Third Related Party Convertible Notes (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Face value of the convertible notes	$ 6,783,538	$ 4,200,538
Debt discount, net	(131,867)	(849,656)
Carrying value of the convertible notes	6,651,671	3,350,882
Accrued interest	619,697	155,626
Conversion of convertible notes	(7,271,368)
Total convertible notes and accrued interest		3,506,508
Nonrelated Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Face value of the convertible notes	3,196,206	1,761,206
Debt discount, net	(83,688)	(398,034)
Carrying value of the convertible notes	3,112,518	1,363,172
Accrued interest	233,714	45,654
Conversion of convertible notes	(3,346,232)
Total convertible notes and accrued interest		$ 1,408,826

Summary of Term Notes (Details)

Summary of Term Notes (Details) - Loan agreement with cpbf Lending Llc [Member] - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Short-Term Debt [Line Items]
Face value of the CB BF term note	$ 6,500,000	$ 6,500,000
Debt discount, net	(129,586)	(192,911)
Carrying value of the CB BF term note	6,370,414	6,307,089
Accrued interest	289,373	186,962
Total CB BF term note and accrued interest	$ 6,659,787	$ 6,494,051

Schedule of US Federal Income T

Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Statutory federal income tax benefit					$ (3,025,315)	$ (3,248,385)
Statutory federal income tax benefit, percentage					21%	21%
State taxes, net of federal tax benefit					$ (219,705)	$ (327,095)
State taxes, net of federal tax benefit, percentage					1.50%	2.10%
Change in valuation allowance					$ 2,079,231	$ 1,435,041
Change in valuation allowance, percentage					(14.40%)	(9.30%)
Change in state tax rate					$ 462,709	$ 13,055
Change in state tax rate, percentage					(3.20%)	(0.10%)
Change in fair value estimates					$ (2,050,026)	$ 1,610,993
Change in fair value estimates, percentage					14.20%	(10.40%)
Non-deductible interest-IRC 163(j)					$ 738,993
Non-deductible interest - IRC 163(j), percentage					(5.10%)	0%
Non-deductible transaction restructuring costs					$ 1,313,792
Non-deductible transaction					(9.10%)	0%
Nondeductible warrant issuance expense					$ 552,321
Nondeductible warrant issuance expense, percentage					(3.80%)	0%
Other non-deductible expenses					$ 148,000	$ 516,391
Other non-deductible expenses, percentage					(1.00%)	(3.30%)
Effective tax rate	$ 6,624	$ 12,472	$ 5,691	$ 15,749
Effective tax rate, percentage	0%		0%		0%	0%

Schedule of Components of Incom

Schedule of Components of Income Tax Provision (Benefit) (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Current
Deferred
Current
Deferred
Total	$ 6,624	$ 12,472	$ 5,691	$ 15,749

Schedule of Temporary Differenc

Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets (liabilities):
Net operating loss carryforwards	$ 6,368,669	$ 3,744,512
Contribution carryforwards	24,626	20,837
Stock-based compensation	155,404	25,216
Accrual to cash adjustment	1,299	482,109
Startup costs	1,816,143
Lease Liabilities	52,805	119,971
Right of use assets	(30,236)	(71,024)
Capitalized R&D costs (Sec. 174)	798,802	451,195
Other	(3,363)	696
Deferred tax assets gross	9,184,149	4,773,512
Valuation allowance	(9,184,149)	(4,773,512)
Deferred tax assets, net of allowance

Goodwill (Details Narrative)

Goodwill (Details Narrative)	12 Months Ended
Goodwill (Details Narrative)	Dec. 31, 2023 USD ($)	Dec. 31, 2023	Dec. 31, 2023 Integer	Dec. 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Number of operating segments		1	1
Number of reporting segments \| Integer			1
Impairment of goodwill \| $	$ 0			$ 0